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Abstract 
This thesis describes the synthesis and use of an N-substituted ferrocene bearing a 
proline-derived chiral directing group and diastereoselective lithiation-electrophile 
quench of the pro-Sp hydrogen of the ferrocene to give planar chiral products in >95:5 dr. 
The auxiliary group is found to be stable to lithium bases of types RLi and R2NLi giving 
the same diastereoselectivity. The anti- epimer of the previously mentioned syn auxiliary 
induces lithiation of pro Rp rather than pro Sp hydrogen in >95:5 dr. Upon electrophile 
quench and elimination, the enantiomer of the syn-derived planar chiral imidazolone is 
obtained. Hence, this method provides a practical way to prepare planar chiral 
enantiomers in this series without the use of a more expensive D-proline derived starting 
material. The syn and anti epimers have β, γ-stereogenic centers and the origin of 
stereoselectivity in lithiation appears to be driven by the conformational bias exerted by 
the β-silyloxy moiety in each chiral auxiliary. In the thesis, this conclusion is supported 
using insensitivity of lithiation selectivity to the bulkiness of the base, comparison of 
enantiomers, deuteration experiments, nOe difference studies and computational 
modeling of the ground states and lithiation transition states for both substrates. The 
products are then converted to ligand precursors to make iridium and rhodium complexes. 
Among them, one of the cationic iridium complex is found to be effective in the 
asymmetric hydrogenation of 2-substituted quinolines with enantioselectivities up to 80% 
at pressures as low as 5 atm. 
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Introduction 
Asymmetric synthesis has become a major aspect of modern organic chemistry. 
The stereochemical purity of an organic compound is crucial when dealing with 
biologically active pharmaceuticals and agrochemicals. Synthesis of an optically pure 
compound can be achieved by the use of enantiomerically pure starting material, 
resolution of a racemic mixture or by asymmetric catalysis. A good chiral auxiliary not 
only provides enantiomerically pure compounds but also enables its manipulation using 
simple reagents. Asymmetric catalysis is an important aspect of asymmetric synthesis, 
where stereocenters are established through the use of a chiral catalyst.  
Metal-catalyzed reactions did not play a major role in many classic complex 
natural product syntheses such as Robinson’s1 1917 tropinone synthesis to Eschenmoser2 
and Woodward’s3 1973 coenzyme B12 synthesis. However modern organic syntheses 
often make use of numerous transition-metal catalyzed transformations. The use of 
catalytic reactions has grown in such a way that some of them, for example alkene 
metathesis, have no parallel in traditional organic chemistry. In some cases catalysis 
enhances the rate and generality considerably such as Buchwald-Hartwig amination of 
aryl halides, in some other cases it enhances selectivity, as in asymmetric hydrogenation. 
Asymmetric catalysts hence play a major role in the synthesis of enantiomerically pure 
drugs and agrochemicals by lowering the amount of “undesired” isomer.4 However, 
achieving high levels of stereoselectivity requires considerable innovation, and provides a 
practical challenge for chemists. 
The first part of this dissertation will outline the synthesis of N-substituted planar 
chiral ferrocenes by diastereoselective lithiation-electrophile quench using an inexpensive 
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and readily available proline derived chiral directing group. This approach represents the 
first documented chiral auxiliary with nitrogen directly attached to the ferrocene ring. The 
use of this chiral auxiliary also allows the conversion of ortho-substituted products to 
solely planar chiral ferrocene derivatives. By use of simple reagents, complete 
manipulation of the directing group into primary amines and ligand precursors such as 
imidazolones will be described. The second part will outline the studies on the origin of 
stereochemistry in lithiation of this directing group based on experimental results and 
computational calculations. The presence of β,γ-stereogenic centers arises the question of 
whether the directing group is controlled by the Cp ring or base. The studies on the role 
of the β-silyloxy moiety in determining the origin of stereochemistry will be explained 
with the use of lithiation-substitution reactions of epimers and computational modelling 
of transition states of lithiation. The synthesis of either enantiomer of these compounds 
by changing one stereocenter in the chiral auxiliary becomes possible. 
The final part will outline the use of products from these reactions to make 
unusual C1-symmetric ligands. Synthesis of cationic iridium complexes using these chiral 
ligands and their use in asymmetric hydrogenation will take the project to the application 
level. The final part of the thesis will discuss the asymmetric hydrogenation of 
recalcitrant 2-substituted quinolines under pressures as low as 5 atm. Finally, attempts 
towards improvements in the enantioselectivity of asymmetric hydrogenation of 
quinolines by incorporation of bidentate ligands will be presented. 
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1. Historical 
1.1. Stereoselective Synthesis of Planar-Chiral Ferrocenes 
1.1.1. Ferrocenes: Synthesis and Applications 
Ferrocene, or bis(cyclopentadienyl)iron (2), was first reported independently by 
two groups. Kealy and Pauson published their contribution in Nature
5
 in 1951 while 
Miller, Tebboth and Tremaine reported preparation of the identical compound in the 
Journal of the Chemical Society.
6
 Both groups postulated the structure of ferrocene as 
having two cyclopentadienyl (Cp) rings individually sigma-bound to the Fe(II) centre 1. 
Soon after publication of these reports, researchers took interest in these compounds and 
the correct ferrocene structure (2) and its aromaticity were published by Woodward & 
Wilkinson
7
 and Fischer & Pfab,
8
 as seen in Figure 1. These proposals were independently 
confirmed by X-ray structural analysis.
9
 For their elegant work on metallocenes, 
Wilkinson and Fischer were awarded Nobel Prize in 1973.  
 
Figure 1. Structure of ferrocene. 
 
Ferrocenes behave as electron-rich aromatics because of the partial negative 
charge of cyclopentadienyl ligands. These compounds undergo electrophilic aromatic 
substitution 3 x 10
6
 times faster than benzene.
10
 The presence of oxidizing electrophiles 
causes decomposition of ferrocene, which prevents their use in electrophilic halogenation 
and nitration. Hence only radical and electrophilic substitution reactions such as Friedel-
Crafts acylation, borylation (under non-oxidizing conditions), mercuration, and lithiation 
4 
 
are used in the synthesis of substituted ferrocenes. Among them, incorporation of a 
heteroatom can be carried out using lithiation and mercuration. 
Lithiation is the most convenient method for the preparation of ferrocene 
derivatives.
11
 Lithiation with n-butyllithium yields mixtures of mono and 1,1'-dilithiated 
species though exclusive formation of dilithioferrocene 3 can be achieved by activating 
n-BuLi with N,N,N',N'-tetramethylethylenediamine (TMEDA) in hexane.
12
 Kagan and 
coworkers carried out investigations on lithiating reagent, reaction time, temperature and 
solvent system to find the best lithiation conditions to get subsequent monosubstituted 
ferrocene derivatives.
13
 By their method, stannane 4 may be prepared on up to 20 g scale 
which only requires distillation for its purification. A more reliable preparation was 
reported by Bildstein whereby monolithioferrocene 5 can be isolated as a pyrophoric 
orange solid by Schlenk filtration and stored under cold conditions and inert 
atmosphere.
14
 Another way of obtaining good conversion to monolithioferrocene is using 
t-BuLi/t-BuOK which allows in situ quench to afford the monosubstituted product 
(Scheme 1).
15
  
 
Scheme 1. Synthesis of mono and dilithioferrocenes.  
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Ferrocene as a ligand backbone offers more degrees of freedom and the different 
conformations of cyclopentadienyls enable the ligand to reduce steric strain. In addition 
to its unique structure, ferrocene has thermal stability and good tolerance to oxygen, 
moisture and many reagents. Owing to these unique properties, ferrocene derivatives 
have been used significantly in academia and industry as ligands for various 
transformations. The most well-known ferrocene ligand, [1,1'-
bis(diphenylphosphino)ferrocene] (dppf) was first described in 1965.
16
 Another well-
known ferrocenyl ligand is the Ir/Xyliphos catalyst 12 used for enantioselective imine 
hydrogenation (Scheme 2a). The intermediate obtained in the synthesis of the herbicide 
(S)-metolachlor is the largest scale known enantioselective catalytic process produced by 
Ciba-Geigy/Syngenta.
17
 The hydrogenation of a tetrasubstituted olefin in presence of 
Josiphos 13 was the key step for the synthesis of biotin by Lonza (Scheme 2b).
17b
 Merck 
chemists reported the hydrogenation of unprotected dehydro β-amino acid intermediate 
for MK-0431 catalyzed by Rh/Josiphos with ee up to 94% (Scheme 2c).
18
 
 
Scheme 2. Important industrial applications of ferrocenyl diphosphine ligands. 
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 In addition to ferrocenyl ligands containing P-donors, N-, S-, O- substituted 
ligands are also used in various metal-catalyzed reactions such as hydrogenation and 
cross-coupling reactions. However, a reliable and versatile route to the synthesis of 
nitrogen substituted directly onto ferrocene cyclopentadienyl ring remains 
underexplored.
19
 This can be understood from the price of 1g of aminoferrocene - more 
than $460!
10
 The lack of a good synthetic method for the synthesis of aminoferrocenes, in 
particular, planar chiral N-substituted ferrocenes has hampered the use of potential N-
donor ferrocenyl ligands in various asymmetric metal-catalyzed reactions. This has 
facilitated the development of several synthetic routes towards the synthesis of 
aminoferrocene over the past 60 years. 
1.1.2. Aminoferrocenes 
 Aminoferrocene (17) was first synthesized by Arimoto
20
 and Nesmeyanov
21
 
independently in 1955. In Nesmeyanov’s initial synthesis, FcLi was treated with O-
benzyl ether of hydroxylamine to give 17, in low yield.  Later on, the same group 
reported two alternative routes towards aminoferrocene starting from bromoferrocene: (i) 
by reduction of azidoferrocene synthesized by treating 14 with sodium azide under 
copper catalysis and (ii) by deprotection of N-ferrocenylphthalimide, 16 synthesized by 
heating bromoferrocene with copper phthalimide as a melt.
21-22
 A modification to the 
latter route was reported by Sato using iodoferrocene, Cu2O and phthalimide to obtain 17 
more conveniently.
23
 On the basis of works from Sato and Nesmeyanov, a high yielding 
synthetic pathway employing iodoferrocene as staring material was reported by 
Bildstein
14
 which was later slightly modified by Heinze.
24
 The synthesis involves 
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coupling of iodoferrocene with copper phthalimide to give ferrocenyl phthalimide which 
was converted to aminoferrocene using the Gabriel synthesis.   
 
Scheme 3. Aminoferrocene synthesis using azide or phthalimide. 
 
Arimoto’s synthesis involved treatment of ferrocenecarboxylic acid with PCl5 in 
benzene followed by NaN3 in acetone to form ferrocenoyl azide 18. Curtius 
rearrangement and subsequent removal of the benzyl formate group gave aminoferrocene. 
A similar strategy was employed by Herberhold and  Butler which involves Curtius 
rearrangement of acyl azide and subsequent cleavage of corresponding amide
25
 or 
carbamate.
26
 Another convenient method for generation of 17 is by quenching 
lithioferrocene by azidostyrene 20 followed by acidic workup to convert intermediate 21 
to aminoferrocene (Scheme 4).
27
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Scheme 4. Preparation of aminoferrocene using acyl azide or azidostyrene. 
 
A direct metal catalyzed coupling of iodoferrocene using liquid ammonia as the 
nitrogen source in presence of CuI/Fe2O3 cocatalyst system in ethanolic solution was 
recently reported, which gave 17 in 65% yield (Scheme 5).
28
 Gasser and coworkers 
employed the same synthetic methodology for the synthesis of aminoruthenocene as well.  
 
Scheme 5. Cu/Fe catalyzed synthesis of aminoferrocene using liquid ammonia. 
 
1.1.3. Planar Chiral Ferrocenes 
 The planar chirality of ferrocenyl compounds substituted with different groups at 
positions 1 and 2 are due to loss of both αv plane of symmetry and inversion axis. The 
absolute configuration is assigned by looking along the C5 axis of ferrocene with the 
more substituted ring directed towards the observer (Figure 2). When R1 > R2, the 
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compound has (R) planar chiral configuration; when R2 > R1, the compound has (S) 
planar chiral configuration.
29
  
 
Figure 2. Assignment of planar chirality in ferrocenes. 
 
 As planar chirality differs from central chirality, the notations used are Rp and Sp 
instead of “(R)” and “(S)”. When ferrocenyl compounds have more than one type of 
chirality, the priority order of elements is central > axial > planar > helicity.
30
 
Soon after Woodward and co-workers classified ferrocene as an aromatic 
compound, researchers applied electrophilic substitution reactions to synthesize planar 
chiral ferrocenes.
31
 The major drawback of this approach was fairly low selectivity 
towards exclusive substitution of either α or β position. Even though the increase in steric 
bulk led to an increase in selectivity of monoacetylation of ethyl ferrocene as observed by 
Rosenblum and Woodward, the isolation of pure product required tedious work up and 
repeated recrystallizations.
32
  
Greater success was achieved by Thompson in 1959 when chemical resolution 
was used and thus the first optically active planar chiral ferrocene compound was 
synthesized. When 25 was treated with (–)-menthydrazide followed by acid mediated 
cleavage of hydrazine 8 mg of (+)-25 was isolated.
33
 The absolute configuration of this 
10 
 
compound was determined by Schlögl and coworkers using Horeau’s method.34 Later in 
1965, the same group reported the synthesis of an (S, Sp) analogue of 25, containing an α-
phenyl group, derived from (S)-α-phenyl-γ-ferrocenylbutyric acid 26 in high 
diastereoselectivity (>95% de) (Scheme 6).
35
 Over the years more effiecient methods 
were developed which allowed easier access to planar chiral ferrocenes. However the 
lithiation-electrophile quench has proven to be an important tool which, in these cases, is 
used almost exclusively.
36
 
 
Scheme 6. Initial studies on the stereoselective synthesis of planar chiral 
ferrocenes. 
 
In principle, the methods for the introduction of planar chirality onto ferrocene 
moiety can be classified into three types: (a) enantioselective lithiation-substitution (b) 
diastereoselective lithiation-substitution and (c) resolution of racemic planar chiral 
ferrocenes by enzymatic or non-enzymatic kinetic resolution. 
1.1.3.1. Enantioselective Synthesis of Planar Chiral Ferrocenes 
 In this method, mono-substituted ferrocenes with achiral directing groups are used 
in presence of chiral alkyllithium or lithium dialkyl amide bases to differentiate between 
the two prochiral ortho-positions on the Cp ring. 
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Scheme 7. Enantioselective lithiation-substitution. 
 
 The initial attempts towards an enantioselective lithiation was reported in 1970 by 
Nozaki, where a (–)-sparteine (34)-mediated lithiation of isopropylferrocene afforded 
mixtures of products in low enantiomeric excess.
37
 In 1995, Simpkins, based on their 
work on (η6-arene) chromium tricarbonyl complexes,38 carried out ortho lithiation using a 
chiral LDA analogue called the Simpkins’ base 29.39 Diphenylphosphine oxide 28 in the 
presence of chiral lithium amide base afforded ortho-substituted trimethylsilyl adduct 30 
in moderate enantioselectivity (Scheme 8). Attempts at subjecting 30 to further 
metallation using alkyllithium bases were fruitless, however, reaction with benzaldehyde 
in presence of CsF gave secondary alcohol 31 as a 1:1 mixture of diastereomers. 
 
Scheme 8. Enatioselective lithiation using Simpkins’ base. 
 
 A breakthrough in this area of chemistry occurred when Snieckus and coworkers 
reported the selective ortho-lithiation of N,N-diisopropyl ferrocenecarboxamide 32 in the 
presence of (–)-sparteine (34) to yield 1,2-disubstituted ferrocene products in excellent 
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enantiomeric excess after electrophile quench (Scheme 9).
40
 This work was based on the 
comprehensive work by Hoppe on the enantioselective synthesis using lithium/(–)-
sparteine carbanion pairs.
41
  
 
Scheme 9. (–)-sparteine-mediated ortho-lithiation using ferrocenyl carboxamide. 
 
Using this method, carbon and heteroatom based substituents could be installed 
with ease and high enantioselectivity. When these products were subjected to subsequent 
lithiation, substitution at the lower Cp ring occurred to give 1,2,1′-trisubstituted product. 
An unprecedented slow racemization of ferrocene was observed during the reaction due 
to a substituted Cp-aryl ligand exchange by an unknown mechanism. Since the 
manipulation of the diisopropyl amide was difficult, enantioselective lithiation was 
extended to N-cumyl-N-ethylferrocenecarboxamide which gave the same yields and 
selectivities as the diisopropyl amide.
42
 
Uemura reported the use of N,N,N′,N′-tetramethyl-(1R,2R)-cyclohexanediamine-
[(R,R)-TMCDA)]-mediated asymmetric lithiation of (dimethylaminomethyl)ferrocene 35 
to give products up to 80% ee (Scheme 10). In this case, use of (–)-sparteine (34) gave 
unexpectedly poor results.
43
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Scheme 10. Enantioselective lithiation of (dimethylaminomethyl)ferrocene. 
 
The first report on the direct synthesis of 2-substituted amino ferrocenes where 
nitrogen is directly attached to the Cp ring was reported by the Metallinos group (Scheme 
11).
44
 The BF3-complexed dimethylaminoferrocene 38 was found to undergo ortho-
lithiation upon treatment with n-BuLi. When the resulting lithioferrocene was quenched 
with various carbon and heteroatom based electrophiles, various 1,2-disubstituted 
products were obtained in 76-94% yield. This included some rare derivatives such as 2-
phosphino-1-aminoferrocenes, which were used as ligands for transition metal catalysis. 
 
Scheme 11. BF3-mediated synthesis of (±)-2-substituted aminoferrocenes. 
 
This work was later extended towards the enantioselective synthesis of 2-
substituted aminoferrocenes using chiral 1,2-diaminocyclohexane-derived additives. 
Specifically, we have shown that enantioselective lithiation of BF3-activated tertiary 
aminoferrocenes is possible in the presence of chiral 1,2-diaminocyclohexane ligands to 
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give a wide range of enantiomerically enriched 2-substituted-1-aminoferrocenes in 90:10 
er (80% ee) (Scheme 12).
45
 Both series of enantiomers can be made.  
 
Scheme 12. Asymmetric lithiation of BF3-activated aminoferrocenes. 
 
By using this method, the synthesis of rare compounds such as aminophosphine 
precursor 46 was achieved, and its iridium complex 47 was used for the asymmetric 
hydrogenation of prochiral alkenes (Scheme 13). Even though this method proves to be 
feasible for the synthesis of 2-substituted aminoferrocenes, the lower enantioselectivity 
(up to 80% ee) and lack of manipulability make this method less desirable.  
 
Scheme 13. Synthesis of Ir(I) complex from aminophosphine 46. 
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1.1.3.2. Diastereoselective Synthesis of Planar Chiral Ferrocenes 
 Among the three methods used for the synthesis of planar chiral ferrocenes, 
diastereoselective-lithiation and substitution is the most widely developed and commonly 
used. In this method, the chiral auxiliary (usually with N- or O- lone pair coordinating 
sites) already present in the molecule coordinates to alkyllithium or lithium dialkylamide 
bases
46
 thereby differentiating the two possible prochiral ortho-positions during 
deprotonation. Thus the lithioferrocene generated is diastereomerically enriched and may 
be trapped with electrophiles to afford planar chiral 1,2-disubstituted ferrocenes.
29
  
 
Scheme 14. Diastereoselective lithiation-substitution. 
 
The very first diastereoselective lithiation-substitution reaction was reported by 
Nozaki and co-workers, making use of a chiral piperidine. After electrophile quench, 49 
was converted to (Rp)-methyl-2-methylferrocene carboxylate by quaternization with 
methyl iodide, and subsequent reduction with sodium amalgam in water and esterification 
with diazomethane. The resulting product was claimed to have formed in 24% yield and 
94% optical purity (Scheme 15),
37, 47
 but doubts regarding the diastereoselectivity in 
lithiation of 48 was reported shortly after.
48
 
 
Scheme 15. Diastereoselective lithiation-substitution by Nozaki. 
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A significant breakthrough in this field of chemistry was the discovery by Ugi that 
N,N-dimethylferrocenylethylamine effects highly diastereoselective ortho-directed 
lithiation.
30b
 Resolution of (±)-51 with (R)-(+)-tartaric acid furnished both isomers in 80-
90% yield. Deprotonation of (R)-51 with n-BuLi in diethyl ether at 27 ºC followed by 
electrophile quench afforded (R, Sp)-53 in 94:6 dr. It has been postulated that the high 
selectivity in the lithiation originates from unfavourable steric interactions between the 
stereogenic α-methyl group and the lower Cp ring (R, Sp-52), as shown in Scheme 16.
49
 
 
Scheme 16. Diastereoselective lithiation-substitution of N, N-
dimethylferrocenylethylamine. 
 Compounds prepared from Ugi’s amine can further undergo a stereospecific SN1 
type reaction of the dimethylamino moiety with retention of configuration. Figure 3 
shows the representative chiral ligands derived from Ugi’s amine possessing a methyl 
group at the stereogenic carbon bonded to C1 (Josiphos 54, BoPhoz 55, Walphos 56, 
Pigiphos 57 and TRAP 58).
16
 For example, Josiphos is prepared from Ugi’s amine by 
SN1 type reaction of the dimethylamino group with secondary phosphines, while 
17 
 
Walphos is prepared by transmetallation of ferrocenyllithium species with ZnBr2 
followed by Negishi coupling with bromoiodobenzene (Figure 3). TRAP ligands are 
synthesized by copper-catalyzed homocoupling of 2-iodo ferrocenylphosphine oxide 
derived from Ugi’s amine. 
 
Figure 3. Ferrocenyl ligands derived from Ugi’s amine. 
 
Kagan and coworkers in 1993 used a chiral dioxolane moiety for the synthesis of 
planar chiral ferrocene derivatives.
50
 Ferrocene carboxaldehyde 59 was converted to 
dimethylacetal 60 using trimethylorthoformate. Transacetalization with (S)-1,2,4-
butanetriol 61 gave the required acetal as the major product along with other isomeric 
acetals. Recrystallization from toluene and subsequent methylation afforded (S,Sp)-64 in 
85% yield. Selective deprotonation of the prochiral R hydrogen of the Cp ring by using t-
BuLi and electrophile quench proceeded with >98% de. Hydrolysis of the acetal in the 
presence of p-TsOH gave solely planar chiral aldehydes (Scheme 17). In this process, the 
temperature of the reaction was found to be crucial since the observed diastereoselectivity 
18 
 
dropped to 80% de at 0 ºC. The diastereoselectivity of ortho-lithiation was not affected 
by the presence of substituents, as shown by the use of pentamethylferrocene derivative 
as substrate.
51
 
 
Scheme 17. Diastereoselective lithiation-functionalization using Kagan’s acetal. 
 
The chiral acetal 62 was utilized for the synthesis of C2-symmetric ferrocenyl 
ligands.
52
 Togni and coworkers utilized Kagan’s acetal to prepare carboxaldehyde 65 
which after oxidation was treated with sodium azide to get acyl azide 67. A curtius 
rearrangement furnished the Cbz-protected nitrogen upon deprotection afforded the 2-
methyl-1-aminoferrocene 69 which was used to make the chiral N-heterocyclic carbene 
ligand (Scheme 18).
52b
 It took seven steps including the use of an acyl azide which can 
potentially be explosive to incorporate nitrogen directly to the Cp ring. Togni stated that 
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the major challenge of their synthesis was the introduction of a nitrogen bond directly 
onto the Cp ring. Later on, the same group reported the preparation of aminoferrocenes in 
five steps starting from Ugi’s amine.52a Even though the number of steps was shortened 
to five, the synthesis still required the preparation of DPPA (diphenyl phosphoryl azide) 
and relies on a diastereoselective nucleophilic addition to the alkene, whose 
stereoselectivity varies with the nucleophile. 
 
Scheme 18. Synthesis of planar chiral ligands using acetal directing group. 
 
The use of chiral sulfoxides for diasteoselective-lithiation and substitution was 
reported initially by Kagan and coworkers in 1993 (Scheme 19).
53
 The key sulfoxide (R)-
71 was synthesized by transmetalation of tributylstannyl ferrocene to lithioferrocene and 
electrophile quench using optically pure menthyl p-toluenesulfinate. Transmetalation was 
necessary since the presence of excess lithioferrocene caused racemization of the 
sulfoxide (R)-71. To avoid this, new methods were developed which included 
enantioselective oxidation of ferrocenyl sulphides
54
 or the use of other chiral sulfinates 
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such as Ellman’s reagent.55 As shown in Scheme 18, the enantiopure t-Bu ferrocenyl 
sulfoxide can be deprotonated with n-BuLi and quenched with iodomethane to afford the 
1,2-disubstituted product (S, Sp)-76 in 98:2 dr. While its p-tolyl congener, up on 
diastereoselective lithiation-electrophile quench, gave (R, Rp)-73 in 99:1 dr.
56
  
 
Scheme 19. Diastereoselective ortho-lithiation of ferrocenyl sulfoxides. 
 
The sulfoxide moiety can be easily converted to other functional groups, giving 
this method a large degree of flexibility.
54
 Sulphur-lithium exchange with PhLi
57
 or t-
BuLi
56
 gave intermediate 78 which can be trapped with various electrophiles to give 
planar chiral 1,2-disubstituted ferrocene compounds (Scheme 20). However, this requires 
that the substituents introduced must be stable to strong bases or be protected. 
 
Scheme 20. The synthesis of planar chiral 1,2-disubstituted ferrocenes. 
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This strategy was utilized for the synthesis of diverse ligands.
29
 The second 
generation Taniaphos was synthesized by ortho-lithiation of (S)-71 with LDA and quench 
with ortho-phosphinyl benzaldehyde to afford alcohol 81 which was methylated (Scheme 
21). Sulfoxide-lithium exchange using t-BuLi followed by electrophile quench using 
chlorodiarylphosphine gave 82.
58
 Similar series of transformations using B(OMe)3 gave 
boronic acid 83, which underwent Suzuki coupling with iodoarenes. Sulfoxide-lithium 
exchange and chlorodiaryl phosphine quench furnished MOPF 84.
59
 
 
Scheme 21. Synthesis of planar chiral ligands using ferrocenyl sulfoxides. 
 
 All the directing groups mentioned so far need to be modified or replaced with P, 
S, or N substituents to make them suitable donor ligands. In the case of chiral oxazolines, 
they act as directing groups as well as excellent N-donor ligands. Ferrocenyl oxazolines 
can be synthesized by using commercially available ferrocene carboxylic acid and 
optically pure amino alcohols. The use of these compounds in diastereoselective-
lithiation was reported independently by Richards,
60
 Sammakia
61
 and Uemura.
62
 When 
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(S)-85 was treated with n-BuLi or s-BuLi in ether at –78 ºC, selective removal of the 
prochiral R hydrogen occurred in up to 39:1 diastereomeric ratio. The diastereoselectivity 
can be further increased to >500:1 by changing the solvent to hexanes and by adding 
TMEDA.
61a
 The high diastereoselectivity in the case of these compounds can be 
attributed to the avoidance of steric interaction between the alkyl group of the 
alkyllithium reagent with the substituent on the oxazoline center (Scheme 22). Upon 
addition of TMEDA, the effective size of alkyllithium reagent increases by chelating to it, 
thereby increasing the steric repulsion between R and R′, hence causing a dramatic 
increase in diastereoselectivity.
29
 
Numerous multidentate ferrocenyl ligands containing chiral oxazolines have been 
reported, and have found applications in Pd- catalyzed allylic alkylation and amination,
63
 
and intermolecular asymmetric Heck reactions.
64
 
 
Scheme 22. Diastereoselective lithiation-substitution of ferrocenyl oxazoline. 
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Previous work in our group used diastereoselective synthesis of planar chiral 
ferrocenes using ferrocenyl phthalimidine as a directing group (Scheme 23).
65
 The 
phthalimidine group was designated to leave nitrogen on the product and its inherent 
lability allowed further transformations. Hence this approach avoided the needs to 
introduce nitrogen at a later stage of synthesis and protection-deprotection sequences and 
rearrangement reactions. N-Ferrocenylphthalimide was prepared from ferrocene 
following the procedures of Bildstein
14
 and Sato.
66
 Thus, iodoferrocene was coupled with 
phthalimide by Cu2O mediated coupling in pyridine. When ferrocenyl phthalimide was 
reduced and protected; ferrocenyl phthalimidine 90 containing a β-ferrocenyl stereocenter 
was obtained. When 90 was subjected to lithiation conditions using LDA and quenched 
with ClSiMe3, gave the 2-silylated product 91 as the major product along with inseparable 
mixture of two aryl-silylated products in less than 5% combined yield (Scheme 23). An 
important observation from this reaction was that 91 was a diastereomerically pure 
compound by 
1
H and 
13
C NMR. This shows that the lithiation occurred in ≥95:5 
diastereoselectivity.  
 
Scheme 23. Diastereoselective substitution of phthalimidines. 
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In addition, the phthalimidine moiety can easily be deprotected and reduced by 
sequential addition of K2CO3 and NaBH4 to give the hydroxyamide 94 which could be 
cleaved to give aminoferrocene and phthalide (Scheme 24).
67
 Hence it can be stated that 
if the phthalimidine starting material was a single stereoisomer, then Cp-silylation 
followed by deprotection of nitrogen to primary amine
68
 would afford product with solely 
planar chirality. 
 
Scheme 24. One-pot deprotection of O-SiR3 phthalimidines. 
1.1.3.3. Nitrogen-Based Chiral Auxiliaries in Lithiation-Substitution Reactions 
 The use of nitrogen-based directing groups is common in arene lithiation and 
metal catalyzed C-H activation reactions, but not well exploited in ferrocene substitution 
reactions. A good chiral auxiliary is one that can be easily attached to a substrate in one 
enantiomeric form to give products in high diastereomeric ratio and can be easily cleaved 
from the product.  
Metallinos and coworkers have reported a directing group that would facilitate 
diastereo- as well as enantioselective lithiation reactions using readily available and 
inexpensive L-proline as a starting material (Scheme 25).
69
 The required starting 
materials were prepared from t-Bu amide 97, which was obtained from Cbz-protected L-
proline.  
25 
 
 
Scheme 25. Preparation of starting materials. 
 
The chiral urea 98 underwent selective deprotonation of the pro-S hydrogen using 
s-BuLi, followed by electrophile quench to afford products in >95:5 diastereoselectivity. 
When the achiral imidazolones were used, asymmetric lithiation using i-PrLi in presence 
of (−)-sparteine occurred which up on electrophile quench afforded products in up to 99:1 
er. The resulting products were successfully converted to ligand precursors and 
organocatalysts.  
 
Scheme 26. Diastereo/enantioselective lithiation-substitution of urea. 
 
The difficulty in removing the t-Bu group initiated a further improvement of this 
strategy. Hoppe and coworkers have shown that when N-silyl protected O-aryl 
carbamates were subjected to ortho-lithiation, a broad range of ortho-substituted products 
26 
 
105 were obtained.
70
 The removal of the carbamate moiety under basic conditions 
furnished ortho-substituted phenols.  
 
Scheme 27. ortho-lithiation by N-silyl O-aryl carbamates. 
 
Hence we decided to use N-silyl protected L-proline hydantoin moiety as a 
directing group to achieve diastereoselective lithiation-substitution of 108 (Scheme 28).
71
 
Similar selectivity was observed for 108, as was seen in the case of 98. Deprotection of 
the silyl group under acidic conditions furnished 102, which was utilized for the synthesis 
of organocatalysts (chiral guanidines) and metal complexes. Thus the L-proline hydantoin 
derived chiral auxiliary proved to be less expensive and required fewer synthetic steps 
compared to N-Cbz protected prolinamide 97.  
 
Scheme 28. Diastereoselective lithiation-substitution using N-silyl protected 108. 
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1.2. Asymmetric Hydrogenation of 2-Substituted Quinolines 
1.2.1. Applications of Tetrahydroquinolines 
The tetrahydroquinoline ring systems form a common structural motif found in a 
number of pharmaceutical agents and are found as the core structure of a number of 
natural products.
72
 For example, (S)-flumequine 109 is an antibacterial agent.
73
 Some of 
the simple 2-substituted 1,2,3,4-tetrahydroquinoline alkaloids isolated from the trunk 
bark of a Venezuelan shrubby tree Galipea ofﬁcinalis Hancock, is known in folk 
medicine for its many healing properties (Figure 4).
74
 Apart from the broad applications 
in pharmaceutical and agrochemical synthesis, these compounds have been used as 
coordination ligands as well.
75
 
 
Figure 4. Selected bioactive compounds and alkaloids derived from chiral 1,2,3,4-
tetrahydroquinoline derivatives. 
1.2.2. Hydrogenation of Quinolines 
The partial hydrogenation of polynuclear heteroaromatics using H2 was first 
reported by Fish and coworkers in 1982 using a ruthenium catalyst.
76
 Later on, various 
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methods such as the use of transition metals, metals in acids (Sn/HCl, Zn/HCOOH, 
Zn/CH3COOH), cobalt or Raney nickel catalyzed hydrogenations, as well as acid 
catalyzed transfer hydrogenation in presence of Hantzsch ester were developed for the 
reduction of quinoline derivatives (Scheme 29).
72a, 77
  
 
 
Scheme 29. Organocatalytic hydrogenation of quinolines. 
 
1.2.3. Asymmetric Hydrogenation of Quinolines 
The asymmetric hydrogenation of heteroarenes is rather difficult compared to 
other prochiral unsaturated compounds, such as olefins, ketones, and imines. The high 
stability of aromatic compounds, the presence of a heteroatom that can potentially 
deactivate the catalyst, and the lack of secondary coordinating groups make it difficult to 
get high activity and/or enantioselectivity.
78
 Among them, bicyclic heteroaromatic 
compounds are easy to hydrogenate compared to the corresponding single ring systems as 
one of the rings is reserved for hydrogenation process.  
1.2.3.1. Brønsted Acid-Catalyzed Asymmetric Hydrogenation  
 The use of chiral phosphoric acids in the chiral Brønsted acid-catalyzed 
asymmetric transfer hydrogenation
79
 of quinolines was first reported by Rueping.
80
 The 
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chiral acid 119 was found to be ideal for the asymmetric hydrogenation of 2-phenyl 
quinoline (Scheme 30). The scope of the reaction was tested on a variety of 2-substituted 
quinolines to deliver products in high enantioselectivities and good conversions. 
Subsequently, the methodology was used to synthesize biologically active 
tetrahydroquinoline alkaloids such as galipinine 111 (91% ee), cuspareine 110 (90% ee), 
and angustureine 112 (90% ee).
80c
  
 
Scheme 30. Rueping’s chiral Brønsted acid-catalyzed transfer hydrogenation. 
 
 The proposed mechanism of the reaction involves protonation of quinoline by the 
catalyst to generate iminium intermediate A followed by the first hydride transfer from 
dihydropyridine to the generated enamine B and pyridinium salt C (Scheme 31). The 
latter then undergoes a proton transfer to regenerate the catalyst and Hantzsch pyridine 
115. The former then reacts with the catalyst in a second cycle to produce an iminium 
species D followed by second hydride transfer to give the tetrahydroquinoline product 
118. Subsequent proton transfer regenerates the catalyst.
80c
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 The key step in this mechanism varies with the position of substituents. For 2-
substituted quinolines, the stereodetermining step was the Brønsted acid-catalyzed 1,2-
hydride addition. However, in the case of 3-substituted quinolines, isomerization of B 
promoted by Brønsted acid to give D was the key step. Rueping used this methodology 
for the asymmetric transfer hydrogenation of 3- and 2,3-substituted quinolines via an 
enantioselective protonation process as well.
80b
  
 
Scheme 31. Proposed mechanism for asymmetric hydrogenation of quinolines. 
31 
 
 
   Rueping’s method was also applied to 2- and 2,9- octahydrophenanthrolines by 
the Metallinos group and it was observed that the transformations of phenanthrolines 
were difficult compared to analogous quinolines.
81
 The enantioselectivity and conversion 
were found to be dependent on the steric bulk of the substituents in R
1
 position. For 
smaller substituents, reduction products were obtained in yieldwith 90:10 er as 
diamine products (Scheme 32). Conversion to corresponding ureas 122 allowed the 
measurement of enantioselectivity using chiral HPLC. The introduction of bulkier groups 
led to an erosion in the yields and enantioselectivities (R
1 
= i-Pr, 28% yield, 70:30 er). 
Surprisingly, 2-phenyl phenanthroline was reduced in low yield, but with excellent er 
(97:3), while 2,9-diphenylphenanthroline underwent reduction of only one pyridyl ring in 
high yield and lower er (62:38). A secondary interaction such as π-stacking was 
suggested for this anomalous behaviour.  
 
Scheme 32. Organocatalytic reduction of 2- and 2,9- disubstituted phenanthrolines. 
 
Very recently, Zhou and coworkers reported asymmetric transfer hydrogenation 
of 3-nitroquinolines with high enantio- and distereoselectivities (Scheme 33).
82
 The 
original experiment using [Ir]/(S)-MeO-Biphep 139/I2 [(S)-MeO-Biphep = (S)-(2,2´-
dimethoxybiphenyl-6,6´-dilyl)bis(diphenyl phosphine)] afforded the desired product only 
in 16% yield and 19% ee, presumably due to the increased aromaticity arising from the 
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presence of the nitro group and its interaction with the catalyst. Using chiral acid (S)-126 
and Hantzsch ester 125, enantiomerically enriched cyclic nitro compounds with two 
continuous stereocenters were synthesized (Scheme 33).  
 
Scheme 33. Organocatalytic reduction of 3-nitroquinolines. 
 
1.2.3.2. Ruthenium and Rhodium-Catalyzed Asymmetric Hydrogenation 
 Even though iridium is the most widely used metal, other transition metals such as 
ruthenium and rhodium are also used in the asymmetric hydrogenation of quinolines in 
the presence of chiral ligands. An air stable Ru/Ts-DPEN catalyst in ionic liquid was 
found to be excellent for asymmetric hydrogenation of quinolines with quantitative 
conversions and enantioselectivities up to 99%.
83
 This catalyst system introduced by 
Chan and Fan was found to proceed smoothly in MeOH and ionic liquid [bmim]PF6 
(Scheme 34) and was found to be selective towards C=N (quinoline) over C=O (ketone) 
bonds. By using a thin film of ionic liquid supported on silica gel, the reusability of 
catalyst up to sixth run by simple filtration was achieved.  
 Other notable works in this area included the use of solvent-free or highly 
concentrated systems which gave high conversion and selectivity,
84
 and the use of 
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tethered Ru(II) complex in a solution of formic acid/triethylamine/methanol which gave 
moderate enantioselectivities with good conversion in contrast to Ru/TsDPEN system.
85
 
 
Scheme 34. Ruthenium catalyzed asymmetric hydrogenation of quinolines. 
 
  An asymmetric transfer hydrogenation of quinolines were carried out by Xiao 
and coworkers, using a [Cp*RhCl/Ts-dpen] catalyst system (Ts-dpen = N-(p-
toluenesulfonyl)-1,2-diphenylethylenediamine, Noyori ligand)
86
 in aqueous media.
87
  
 
Scheme 35. Rh-catalyzed asymmetric transfer hydrogenation of quinolines. 
 
The reaction rate was found to be sensitive to the pH of the reaction medium and 
on the concentration of both formate and protonated quinolines. This supported the 
proposed ionic mechanism. The best reactivity and selectivity were observed with 4-tert-
butylphenyl-substituted ligand (Scheme 35). A broad range of substrates, 2-alkyl, 2- aryl, 
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2,3-disubstituted and 2,6-disubstituted quinolines gave desired products in good 
conversions and high enantioselectivities.  
 A diastereoselective hydrogenation using a chiral auxiliary-substituted quinolines 
was carried out by Glorius and coworkers (Scheme 36).
88
 The usual homogenous 
asymmetric hydrogenation involves formation of 1,2,3,4 tetrahydroquinolines with a 
newly formed stereocenter at 2- and/or 3- positions. This reaction stands out from others 
as it gave 5,6,7,8 tetrahydroquinolines. The reaction was carried out with two consecutive 
heterogeneous hydrogenations. In the first step, PtO2 and trifluoroacetic acid were found 
to be the optimal combination to give 5,6,7,8 tetrahydroquinolines in good yield and dr 
up to 89:11. These were then taken to the next step, where catalytic hydrogenation and 
Rh/C with acetic acid as solvent gave decahydroquinolines with four newly formed 
stereocenters with enatioselectivities up to 99% ee, which also enabled complete removal 
of the auxiliary. The cis-stereochemistry was controlled by the chiral auxiliary rather than 
the methyl group present. 
 
 
Scheme 36. Diastereoselective hydrogenation of quinolines to decahydroquinolines. 
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1.2.3.3. Iridium-Catalyzed Asymmetric Hydrogenation 
Iridium catalyzed asymmetric hydrogenation
89
 of quinolines has proven to be the 
mostly widely used method to access enantiopure 1,2,3,4 tetrahydroquinolines. A vast 
number of studies have been done in this area mostly focusing on finding effective 
ligands to get high activity and selectivity. A variety of bidentate phosphorus ligands 
such as atropisomeric biaryl diphosphine ligands, diphosphonite ligands and phosphine-
phosphoramidite ligands and some monodentate as well as phosphorus containing ligands 
such as N,P-ligands and S,P-ligands, have been used. Additives such as iodine, 
chloroformates, Brønsted acids and triphenyl phosphine were needed in some cases.
72a
 
1.2.3.4. Atropisomeric Biaryl Diphosphine Ligands 
A significant lead in this field was a highly effective Ir-catalyzed asymmetric 
hydrogenation of 2,6-substituted quinolines reported by Zhou and co-workers in 2003 
using (R)-MeO-Biphep 139 as the ligand in the presence of iodide.
90
  
 
Scheme 37. Ir-catalyzed asymmetric hydrogenation of quinolines. 
 
Their initial studies on the hydrogenation of 2- methyl quinoline as a model 
substrate and [Ir(COD)Cl]2/(R)-MeO-BiPhep 139 as the catalyst system in CH2Cl2 
provided product with low enantioselectivity. Screening of different additives showed 
that the addition of iodine increased both activity and selectivity. The reaction was found 
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to be strongly solvent dependant, and toluene provided the best reaction media. Under the 
optimal conditions, different 2- and 2,6-substituted quinolines were hydrogenated with 
high conversions (83-94% yield) and enantioselectivities (72-96% ee). Using this catalyst 
system, alkyl, aryl, benzylic and 2,3- substituted quinolines were hydrogenated.
91
 This 
catalyst had good functional group tolerance as well. Various functional groups such as 
hydroxyl, ketone, ester, amide benzenesulfonyl substituted quinolines were hydrogenated 
using benzene as solvent media. 
The methodology was extended towards the synthesis of natural products 
cuspareine 110, galipinine 111, augustureine 112 and the first enantioselective total 
synthesis of naturally occurring alkaloid (–)-galipeine 113.74b  
 The studies on the mechanism and on the role of iodine were conducted by 
experimental and computational studies by Zhou et al. (Scheme 38).
91
 The reaction 
proceeded via two catalytic cycles and an inner sphere mechanism was postulated. In the 
presence of I2, the Ir(I) species A, is oxidized to generate an Ir(III) species and subsequent 
heterolytic cleavage of H2 gives the Ir(III)-H species B with the release of HI. The 
coordination of quinoline to B generates C and a 1,4-hydride transfer provides 
intermediate D. Heterolytic cleavage of another molecule of H2 gives enamine F and 
regenerates the Ir(III)-H catalytic species B. Isomerization of F in presence of HI forms 
imine G, which then enters a second catalytic cycle where it is coordinated to the active 
catalytic species B to give intermediate H. This is the stereo-determining step where 
insertion of Ir-H to the C=N generates the chiral center which further undergoes a σ-bond 
metathesis with hydrogen to generate tetrahydroquinoline and regenerates the catalyst, 
thus completing the cycle. 
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Scheme 38. Postulated mechanism for Ir-catalyzed hydrogenation of quinolines. 
 
In the case of 2,3-disubstituted quinolines, the stereodetermining step is the 
isomerization of F to G, followed by hydrogenation to provide product by a kinetic 
resolution process. For high enantioselectivity, the rate of isomerization (kiso) should be 
faster than rate of hydrogenation (khy) (Scheme 39). Hence to accelerate isomerization 
and decelerate the hydrogenation high temperature and low hydrogen pressure should be 
employed.
91
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Scheme 39. Mechanism for hydrogenation of 2,3-disubstituted quinolines. 
 
In 2005, Chan and coworkers reported the use of P-Phos 143a for asymmetric 
hydrogenation of quinolines and up to 92% ee was obtained. The catalyst was found to be 
air stable and subsequently its recyclability was tested in DMPEG-500/hexane. The 
catalyst retained its activity and enantioselectivity up to eight cycles and only a simple 
filtration was necessary to isolate the products. Further studies showed that the efficiency 
of this catalyst can further be increased if used with degassed solvent in a glovebox. Its 
catalyst activity increased with a decrease in the amount of iodine, which reduced catalyst 
loadings to S/C ratio 2000-50000 as well. Under these conditions, products were obtained 
in excellent yields and up to 96% ee with up to 4000 h
-1
 TOF and 43000 TON.
78, 92
  
Following this report a series of C2-symmetric diphosphine ligands were 
synthesized by Chan and coworkers using atropdiastereoselective Ullmann coupling and 
ring-closure reactions, which were subsequently tested for asymmetric hydrogenation of 
quinolines, looking for air stable and recyclable ligands (Figure 5).
93
 The reactions 
proceeded well in DMPEG-500/hexane while poor conversion and enantioselectivity 
were obtained when carried out in ionic liquids. Iridium catalysts of P-Phos 143a, Xyl-P-
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Phos 143b and Cl-MeO-Biphep 144 were found to be air stable, however catalysts 
derived from SynPhos 145 and Difluorphos 146 ligands were sensitive to air. By using 2-
methyl quinoline as substrate, the catalyst reproducibility was tested in DMPEG/hexane 
system and found that Ir-MeO-Biphep 139, Ir-Cl-MeO-Biphep 144 and Ir-SynPhos 145 
were suitable for catalyst recovery and reuse.
93a
 The commercially available DifluorPhos 
146 with [Ir(COD)Cl]2  in THF forms a very efficient catalyst with TON up to 43000 and 
TOF up to 3510 h
-1
.
78
  
 
Figure 5. Atropisomeric diphosphine ligands for asymmetric hydrogenation. 
 
A major drawback for most of these catalytic systems for quinoline hydrogenation 
was low catalyst activity; to achieve good results, a low substrate/catalyst ratio of 100 
was needed. This is because of catalyst deactivation that arises from the formation of 
dimers and trimers through hydride bridged bonds under hydrogen atmosphere.
94
 To 
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prevent this, modifications were done to ligands, either by using dendrimers to 
encapsulate the iridium complex or through the introduction of bulky substituents 147.
95
  
1.2.3.5. Diphosphinite and Diphosphonite Ligands 
 The use of chiral diphosphinite ligands in asymmetric hydrogenation of 
quinolines were investigated by Chan’s group (Figure 6).96 Comparing BINAPO 148a 
and H8-BINAPO 148b, the latter gave better results resulting from its rigid structure with 
up to 96% ee was obtained when reaction was carried out in THF and even better results 
in DMPEG-500/hexane.  
 
Figure 6. Diphosphinite and diphosphonite ligands. 
 
The iridium catalyst was prone to deactivation in this system, its activity and 
enantioselectivity dropped after two runs. The rigidity of the spirobiindane system to 
facilitate chirality transfer and prevent catalytically inactive species was utilized by Chan 
and coworkers (Figure 6); their SpiroPO ligand 149 showed superior activity and 
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selectivity with S/C ratio of 5000. However, the recyclability of this catalyst system in 
DMPEG-500/hexane biphasic system showed a sharp drop in conversion.
97
 A BINOL-
derived diphosphinite ligand 150 with an achiral diphenyl ether link was used by Reetz 
and coworkers. To further improve the enantioselectivity, achiral monodentate P-ligands 
were used as additive for some substrates.
98
  
1.2.3.6. Other Phosphine-Containing Ligands 
 Franciò and Leitner et al. developed a set of phosphine-phosphoramidite 
ligands 151, which possesses two elements of chirality and were found to be effective in 
Rh-, Ru- and Ir- catalyzed asymmetric hydrogenation reactions (Figure 7). Hence these 
fall into the category of privileged ligands. In the Ir-catalyzed hydrogenation of 
quinolines, up to 97% ee was obtained.  
 
Figure 7. Phosphine-phosphoramidite and phosphine-phosphite ligands. 
 
Another similar kind of ligand, PipPhos 152 showed enhanced stereoselectivity 
when chloride salts and achiral phosphine ligands were used as additives.
99
 A phosphine-
phosphite ligand 153 was developed by Pizzano and Vidal-Ferran group in 2010. 
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Phosphoric acid as additive was necessary to improve activity and enantioselectivity, 
while iodine had no effect on them.
100
 Bolm and coworkers synthesized naphthalene-
bridged P,N-type sulfoximines 154 and when applied to the asymmetric hydrogenation of 
quinolines, products were obtained in up to 90:10 er.
101
 Iodine, the common additive, had 
negative effect on this catalyst system leading to low conversions and selectivities. 
 Most of the ligands used in Ir-catalyzed hydrogenation have been phosphine 
based. An exception to this was Fan’s diamine based ligand 155 which was found to react 
smoothly without any inert gas protection (Scheme 40).
102
 The products were formed in 
high yield with up to 99% ee at catalyst loading of 0.2 mol%. 
 
 
Scheme 40. Asymmetric hydrogenation of quinolines using diamine ligands. 
 
1.2.3.7. Other Additives 
Chloroformates were also employed as additives in place of iodine. It offers a 
number of advantages: it can reduce the aromaticity of the ring by electron withdrawal, 
prevent catalyst poisoning and can act as a secondary coordination group between 
substrate and catalyst. The use of [Ir(COD)Cl]2/(S)-SegPhos 157/ClCO2Bn/Li2CO3 
catalytic system gave products with 88-90% ee (Scheme 41).
103
 To avoid the additional 
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deprotection needed for these reactions, Brønsted acids were employed instead, where 
piperidine triflic acid gave the best results.
104
 
 
Scheme 41. Chloroformate activated asymmetric hydrogenation of quinolines. 
 
Using 2-aryl and 2-alkyl substituted quinolinium salts as substrates and cationic 
dinuclear triply halogen bridged iridium (III) complex 159 with axially chiral 
diphosphine ligand as catalytic species; asymmetric hydrogenation was carried out by 
Mashima and Genet et al. In the presence of iodine and using DifluorPhos as the ligand, 
2-substituted tetrahydroquinolines were obtained up to 95% ee (Scheme 42). An 
unexpected preference for chloro- and bromo-iridium catalyst over iodo-iridium catalyst 
was observed in this case.
105
  
 
Scheme 42. Asymmetric hydrogenation of quinolinium salts. 
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1.2.3.8. Ferrocene-Based Ligands in Asymmetric Hydrogenation 
The use of planar chiral 2-phosphino-1-aminoferrocene ligands and their 
Ir(COD)BAr
F
 complexes in asymmetric hydrogenation of several prochiral alkenes were 
reported by the Metallinos group with enantioselectivities up to 92% (Scheme 43).
106
 The 
iridium complex 47, was found to catalyze asymmetric hydrogenation of cinnamate esters 
in up to 96:4 er. 
 
Scheme 43. Asymmetric hydrogenation of alkenes with catalyst 47. 
 
The ferrocenyloxazoline-derived P,N ligand 162 was used in the iridium catalyzed 
asymmetric hydrogenation of 2-substituted quinolines and gave up to 92% ee with 
substrate/catalyst ratio up to 1000 (Scheme 44).
107
 It was found that central chirality 
dominates the absolute configuration of products. Further improvement of the catalytic 
activity was achieved by introducing bulky functional groups on the phosphorus atom.
95a
 
 
Scheme 44. Iridium catalyzed asymmetric hydrogenation of substituted quinolines using 
ferrocenyl P,N ligand. 
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1.2.3.8. Iridium Catalyzed Hydrogenation of Quinolines Under Mild Conditions 
 The first report on catalytic systems using N-heterocyclic carbenes was reported 
by Crabtree et al.
108
 They synthesized six different ionic complexes, Figure 8, either 
through base-assisted metalation
109
 from an imidazolium salt and [Ir(COD)Cl]2 or by 
transmetalation from a silver complex,
110
 followed by the addition of a neutral ligand in 
the presence of a noncoordinating anion PF6‾ or BAr
F‾. The benzimidazole and imidazole 
complexes with various wingtip substitutions thus synthesized were found to be air stable 
both in the solid state and in solution (Figure 8).
111
 The geometry around iridium in 163a 
was found to be square planar as shown by single crystal X-ray analysis. 
 
Figure 8. Iridium precursor complexes screened for catalysis. 
 
The initial screening was done at high hydrogen pressures (70 atm) using 163a 
and 2-methyl quinoline as a substrate, only trace amount of 2-methyl 1,2,3,4-
tetrahydroquinoline was obtained. Upon addition of triphenylphosphine, the activity 
improved considerably while stoichiometric amounts of iodide did not make any change. 
The reaction was found to be solvent-dependant; high conversions were obtained in 
toluene. On catalyst screening, 163a was found to be the best catalyst, while sterically 
hindered 164a-c gave poor to no conversion. Good conversions were obtained even at 1 
atm of H2 at reasonable times (<24 h) with 1 mol % of catalyst at 35 ºC.  
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Using the above optimized conditions, a number of 2-, 6-, 8- substituted 
quinolines were hydrogenated in high yields. Some sterically demanding substrates 
required higher hydrogen pressures (5 atm). The imine underwent hydrogenation while 
acetophenone was found to be completely unreactive. 
 To understand the mechanism of the reaction, some reactive intermediates were 
isolated. When 163a was treated with PPh3 and H2 in presence of a noncoordinating base 
DBU, neutral meridional iridium trihydride species 165 was obtained (Scheme 45). The 
structure was confirmed by 
1
H and 
31
P NMR shifts and coupling constants. The triplet of 
doublet at δ –11.08 ppm ( Ha, JPH = 17.6 Hz, JHH = 4.4 Hz) and triplet of triplets at δ –
13.86 ppm ( Hb, JPH = 19.3 Hz, JHH = 4.4 Hz) were assigned to two types of hydrides. The 
small coupling constants indicated that these hydrides were cis to the phosphines and 
were mutually trans. The single peak in the 
31
P NMR spectrum further proved that the 
phosphines were trans to each other.  
 
Scheme 45. Generation of iridium trihydride and dihydrogen complex. 
 
On addition of [H(Et2O)2][BAr
F
4] to 165, cationic species 166a was formed which 
showed a single broad hydride resonance at δ –7.71 ppm corresponding to 4H per Ir 
(Scheme 45). Possible structures include a fluxional classical iridium(V) tetrahydride and 
a fluxional nonclassical iridium (III) dihydrogen dihydride. Variable temperature NMR 
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studies showed T1 (min) value for complex 166a was 30 ms at 233K (CD2Cl2) while 
complex 165 exhibited T1 (min) value 350 ms at 253K (CD2Cl2) at 500 MHz. A 
nonclassical hydride signal typically exhibits a T1(min) value no larger than 35 ms at 250 
MHz which corresponds to 70 ms at 500 MHz.
112
 The broad signal was assigned to the 
coalescence of both classical and non-classical hydrides due to rapid fluxional exchange 
combined with anomalous broadening. 
A different hydride 167 was isolated from 163a, PPh3 and hydrogen without using 
a base. The reaction showed characteristic color changes during its formation: in the 
presence of hydrogen, the initial orange-red solution became colorless and a white solid 
precipitated; its color reappeared upon applying a vaccum (resulting in loss of hydrogen). 
This color change was found to be reversible; treatment of 167 with 1 atm H2 gave 166b 
the PF6‾ analogue of 166a (Scheme 46). From X-ray crystallography and 
1
H NMR data, 
the ionic iridium hydride 167 was found to have cis hydride geometry. Using variable 
temperature NMR experiments it was confirmed that 167 was a classical iridium 
dihydride complex.  
 
Scheme 46. Generation of iridium dihydride and dihydrogen species. 
 
 Having isolated the iridium hydride species, studies were done to establish the 
potential reactive intermediates in the catalytic cycle. Complex 165 by itself failed to 
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hydrogenate 2-methyl quinoline, under optimized conditions but on addition of 
[H(Et2O)2][BAr
F
4], the protonated substrate allowed hydride delivery from complex 165. 
However, dihydride complex 167 was capable of delivering quinoline hydrogenation 
even without the acid. Hence it can be inferred that a dihydrogen complex analogous to 
166 was formed in situ and that this acidic species then carried out stepwise proton 
delivery and hydride delivery to substrate.  
 Based on experimental studies (vide supra) and DFT calculations, a sequential 
proton and hydride transfer by invoking an outer sphere mechanism has been postulated 
for this reaction (Scheme 47). The cationic iridium H2 complex (166) activates the 
substrate by protonation of quinoline nitrogen. Subsequent hydride transfer from the 
catalyst to the 4-position of substrate gives the enamine species (170). Isomerization of 
the 1,4-dihydroquinoline gives the 3,4-isomer (171) which enters another cycle of 
protonation and 1,2-hydride transfer to give tetrahydroquinoline. 
 
Scheme 47. Mechanism for the hydrogenation of quinolines. 
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Although 163a was capable of hydrogenating a range of quinolines, it had 
restricted solvent scope. In search of a more efficient catalyst, Crabtree and coworkers 
synthesized a cyclometalated benzoquinoline complex of Ir(III)
113
 which was shown to 
add H2 readily to give a dihydrogen complex 175, which was shown to enter into a 
reversible protonation in equilibrium  with 176, similar to 166 (Scheme 48).
114
  
 
Scheme 48. Generation of dihydrogen species from 174. 
 
 
Scheme 49. Reduction and reductive alkylation using 168a. 
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 Catalyst screening showed that 174a gave full conversion of quinaldine 168 with 
1 mol % of catalyst under 1 atm H2 at room temperature in a wide array of solvents 
including THF, 1,4-dioxane and cyclopentyl methyl ether. Further substrate scope was 
investigated with benzylic aldehydes. In presence of stoichiometric amounts of Hünig’s 
base, various 2- and 4- substituted benzaldehydes were hydrogenated under 1 atm H2 at 
80 ºC to afford products in high yields. Ketones and aliphatic aldehydes were unreactive 
under these conditions.  
Crabtree and coworkers extended their studies towards one-pot, tandem reduction 
of quinaldine with excess benzylic aldehydes to give N-alkylated tetrahydroquinaldine 
products. The reductive alkylation was tolerant of aldehydes substituted at the 4-position 
with mildly electron donating and withdrawing groups. However, acetophenone and N-
benzylidenemethylamine were unreactive to alkylation. The mechanism of the reaction 
involves the formation of hydrogenated heterocycle 173 which reacts with aldehyde to 
give hemiaminal 182. In the presence of an acidic catalyst, a highly activated iminium 
species 183 is generated which then undergoes reduction to afford the product 184. 
 
Scheme 50. Mechanism of reductive alkylation. 
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2. Objectives 
The aim of the current work is to develop a direct method for the synthesis of 2-
substituted planar chiral ferrocenes. Since lithiation-substitution has proved to be an 
efficient method for the selective synthesis of ferrocenes, this approach was chosen. The 
advancement of this methodology would require the development of a practical N-based 
chiral auxiliary for planar chiral induction in ferrocenes.  
A practical chiral auxiliary must have the following features:  
a) It must be available in large quantities from inexpensive starting materials  
b) It must be stable to the strong bases used in lithiation  
c) It must provide products in high diastereomeric ratio  
d) It should provide a means to synthesize both enantiomers of planar chiral 
products  
e) It must be readily converted to other functional groups, including primary 
amines.  
Previous work in the Metallinos group has shown that BF3 activated 
aminoferrocenes underwent enantioselective lithiation in presence of chiral cyclohexane 
diamine ligands to afford 2-substituted aminoferrocenes (Scheme 12).
45
 Even though this 
approach proves to be feasible for the synthesis of planar chiral ferrocenes; lower 
enantioselectivity (up to 80% ee) and lack of manipulability make this method less 
desirable.   
Hence a new approach was chosen, which included the use of ferrocenyl 
phthalimidine as a chiral auxiliary (Scheme 23).
65
 When ferrocenyl phthalimidine was 
subjected to lithiation conditions using LDA and quenched with ClSiMe3, 2-silylated 
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product was obtained as a diastereomerically pure compound along with inseparable 
mixture of two aryl-silylated products. Hence it can be stated that if the phthalimidine 
starting material was a single stereoisomer, then Cp-silylation followed by deprotection 
of nitrogen to primary amine would afford product with solely planar chirality. This 
directing group also had the advantage of ease of manipulability using simple 
transformations. 
The use of a chiral auxiliary derived from readily available and inexpensive L-
proline was found to facilitate diastereo- as well as enantioselective lithiation reactions 
(Scheme 26, 27).
69, 71
 The products formed were easily converted to several other 
functionalities such as ligand precursors and chiral guanidines. Hence a chiral directing 
group derived from L-proline which satisfies the above-mentioned features of a practical 
chiral auxiliary would be apt for the development of a practical method for the synthesis 
of planar chiral ferrocenes.  
With this global objective in mind, the sub-objectives of this work are: 
1. To investigate the utility of a chiral directing group prepared from the inexpensive 
L-proline hydantoin 107, based on the work done on ferrocenyl phthalimidines and 
the demonstrated utility of proline hydantoin in diastereo- and enantiolithiation 
chemistry. The ferrocenyl hydantoin 185 may be synthesized by copper mediated 
coupling of iodoferrocene 22 and 107
66
 and can be reduced to corresponding 
hemiaminal which may require protection as N-silyloxy moiety to fix the 
stereochemistry of hemiaminal ether (Scheme 51).  
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Scheme 51. Proposed use of L-proline hydantoin as a removable/manipulable, N-based 
directing group. 
2. To study the stereoselectivity induced by these epimers in the diastereoselective 
lithiation-substitution reaction. Investigate conditions that will allow manipulation 
of the auxiliary into other functionalities including but not limited to primary 
amines.  
 
Scheme 52. Proposed diastereoselective lithiation-substitution and manipulation of chiral 
auxiliary. 
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3. To explore the utility of these compounds to act as ligand precursors to make metal 
complexes. These complexes will be used as catalysts for various asymmetric 
transformations. 
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3. Results and Discussion 
3.1. Diastereoselective Synthesis of Planar Chiral N-Substituted Ferrocenes 
There are several different methods reported in the literature for the synthesis of 
iodoferrocene, one of the required bulk starting material for this project. Among the 
methods known, Kagan’s procedure using t-BuLi and electrophile quench with n-
Bu3SnCl at 0 ºC affords a crude mixture of 1-monosubstituted and 1,1' disubstituted 
stannyl ferrocenes. It requires distillation for the isolation of monosubstituted product 
which was then treated with molecular iodine to get iodoferrocene (Scheme 1).
13a
 
Alternatively, iodoferrocene may be prepared by isolation of pyrophoric lithioferrocene 
which may be quenched with elemental iodine. To simplify the preparation of this key 
compound, a procedure reported by Mueller-Westerhoff, used to prepare formylferrocene 
from ferrocene devoid of 1,1’-diformylferrocene, was adapted.15 Thus, in the presence of 
substoichiometric amounts of KOt-Bu, lithioferrocene 5 was generated by t-BuLi 
lithiation. Subsequent quench with iodine gives iodoferrocene 22 in 80% yield (Scheme 
53).  
To couple iodoferrocene with L-proline hydantoin, Bildstein
14
 and Sato’s 
procedure
66
 [used for the synthesis of ferrocenyl phthalimide 88 (Scheme 23)], involving 
Cu2O-mediated coupling, was used. This procedure afforded product 185 in good yield, 
but the product was found to have undergone partial racemization (scalemic, 52% ee). On 
screening different solvents for this reaction, CH3CN and DMSO were found to give 
product in high enantiomeric purity (as measured by chiral HPLC). To minimize the 
reaction time, a solvent with a higher boiling point, DMSO was chosen which afforded 
product 185 in 53% yield.  
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The N-ferrocenyl hydantion 185 thus obtained was then reduced using Schwartz’s 
reagent.
115
 Schwartz’s reagent has been used primarly to reduce amides to aldehydes.116 It 
was felt that reduction of hydantoin 185 with this reagent would be chemoselective in 
that the amide carbonyl would be reduced in preference to the urea. In addition, the 
purported stability of the initial aminoalkoxide intermediate offered the possibility that 
the silyl-protected aminal ether would be produced as a single stereoisomer if the initial 
hydride addition was selective. Indeed, reduction of 185 with Schwartz’s reagent 
proceeded diastereoselectively and the product was O-silylated in situ by using 
chlorotriethylsilane to afford a 10:1 mixture of syn/anti epimers, that was recrystallized to 
give syn-187 in 80% yield (Scheme 53). The methine hydrogen signal at δ 5.44 ppm, α to 
silyloxy group, was found to be a doublet with a coupling constant of 6.3 Hz, typical for 
syn stereochemistry. The hydride addition must be stereoselective and the intermediate 
seems to have configurational stability because when the intermediate hemiaminal was 
isolated, a 1:1 mixture of epimers were obtained. 
 
Scheme 53. Synthesis of compound syn-187. 
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 The ability of syn-187 in the diastereoselective-lithiation substitution was tested in 
reactions with lithium amide bases using in situ electrophiles. When syn-187 was treated 
with 2.2 equivalents of LDA with a mixture of either TMSCl or B(O-i-Pr)3 in THF at –78 
°C,  products 188a-b were isolated in good yields. The products were found to be single 
diastereomers by 
1
H and 
13
C NMR, showing that the selectivity in deprotonation of the 
ortho Cp hydrogen was at least 95:5.
117
 This selectivity is comparable to what is obtained 
using other chiral directing groups such as Ugi’s amine30b and oxazolines.60b, 61b, 62a This 
reaction also represents the first diastereoselective lithiation and substitution reaction 
using a chiral directing group which contains the challenging nitrogen-ferrocene bond 
already installed by design.
52b
 Similar results were obtained with stannane using LiTMP 
and in situ Bu3SnCl under analogous conditions.  
 
Scheme 54. Diastereoselective lithiation of syn-187 with lithium amide bases. 
 
Further proof to the selective deprotonation by LDA and formation of S-planar 
chiral (Sp) boronic acid was obtained by single crystal X-ray diffraction of 188b (Figure 
9). The compound crystallizes in the trigonal P32 space group as two independent 
molecules. The dihedral angle between the methine hydrogen α to silyloxy group and the 
methine of pyrrolidine ring was found to be 11.6º which is consistent with the observed 
6.3 Hz coupling constant observed in the syn-diastereomer 187. The cyclopentadienyl 
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rings were found to be slightly staggered with a torsion angle of 1.6º. Solution using the 
Sp enantiomer model [Flack parameter = 0.010(13)] confirmed the S-planar chirality of 
188b as expected.  
 
Figure 9. ORTEP depiction of 188b with 30% probability ellipsoids (hydrogens omitted 
for clarity). 
Encouraged by these results, the scope of the reaction was tested with 
alkyllithiums by using sequential diastereoselective lithiation-electrophile quench of syn-
187 (Table 1). In this way, electrophiles that are unstable to in situ deprotonation with 
lithium amide bases may be used. Thus lithiation of syn-187 with 2.2 equivalents of t-
BuLi at –78 °C for 30 min. in THF, followed by quench with MeI, gave the methyl 
adduct in 91% yield and >95:5 dr as determined by 
1
H NMR. Attempts to lithiate syn-187 
using n-BuLi or i-PrLi gave methyl adduct 188d as a single diastereomer, but with poor 
yield. Hence by using the optimized reaction conditions; various planar chiral products 
188a-h were obtained in good to excellent yields. With the exception of aldehyde (74:4 
59 
 
dr), all products were formed with 95:5 dr. The TMS, B(OH)2 and SnBu3 adducts were 
found to be optically and spectroscopically indistinguishable from the products obtained 
by deprotonation using lithium amide bases. Additionally, transmetalation of LiTMP-
derived stannane with n-BuLi at –78 °C, followed by MeI or B(OEt)3 quench afforded 
products identical to those obtained by deprotonation of syn-187 with either t-BuLi or 
LDA. Moreover, the selective deprotonation of pro-Sp hydrogen using LDA was 
confirmed by the X-ray structure of boronic acid 188b. The boronic acid 188b obtained 
either by using t-BuLi or by transmetalation from the stannane 188c was found to be 
optically and spectroscopically identical to the one obtained using LDA. This result 
shows that the lithiation stereochemistry of syn-187 did not change upon switching from 
lithium amide base to t-BuLi. All products 188a-h are formed via selective deprotonation 
of pro-Sp hydrogen irrespective of the base used. Hence by using this method, a variety of 
carbon as well as hetero-atom substituents could be installed selectively on the ferrocene 
ring.  
Many of these heteroatom substituted products such as the iodide, stannane or 
boronic acid, may be useful for further transformations such as cross-coupling and metal-
halogen exchange reactions. Unfortunately, attempts to introduce a phosphino substituent 
using chlorodiphenylphosphine as electrophile resulted in decomposition of the product 
along with partial recovery of the starting material. 
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Table 1. Substrate scope for lithiation of syn-187. 
 
Having established the lithiation-substitution method, our next focus was to 
exploit the inherent designed lability of the O-silyl aminal ether in the new directing 
group. When syn-187 was treated with p-TsOH, and heated to reflux for 30 minutes, 
rapid elimination occurred to provide ferrocenyl imidazolone 192a; repeating the same 
reaction conditions with 188d-f, Table 1, generated solely planar chiral imidazolones 
(Scheme 55). Chiral HPLC measurement of compounds 192b-d against the 
corresponding racemic standards were found to be 100:1 er (98% ee); showing that the 
overall synthetic sequence gives planar chiral ferrocenyl compounds in high enantiomeric 
purity. Similar chiral N-t-Bu-imidazolones were shown to act as precursors to C1-
symmetric NHCs via their chloroimidazolium salts, thus showing future applications of 
these compounds in catalysis.
69
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 When syn-187 was treated with a base instead of acid (K2CO3 in refluxing MeOH), 
O-desilylation occurred to give the hemiaminal, which was reduced with NaBH4 in 
EtOH.
68
 The ring opened urea thus obtained was reduced with LiAlH4
118
 in refluxing 
THF to afford N-methyl aminoferrocene 189e. Hydrolysis of 191a with 50% NaOH in 
MeOH provided aminoferrocene 189a in 58% yield. Ultimately, this procedure was 
carried out on three derivatives 191b-d to afford planar chiral 2-substituted 
aminoferrocenes 189b-d in 31-67% yield.  
 
Scheme 55. Manipulation and hydrolysis of chiral auxiliary. 
 
Initial attempt to hydrolyze urea 191d with the aforementioned procedure provided 2-
trimethylsilyl aminoferrocene 189d only in 22% yield. Lipshutz  and co-workers have 
shown effective hydrolysis of urea with KOH in dioxane/water.
119
 In our hand, a 
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modified procedure of Lipshutz’s protocol (KOH in dioxane), provided clean product 
189d resulting in 65% yield. Even though products were obtained only in moderate 
yields, the majority of unreacted urea could be recovered in all three cases (191b-20% , 
191c-52% and 191d-15%). The absolute configuration of 189b was assigned to be Sp, by 
comparing its specific rotation ([α]D
20
 –39.3) to that of known Rp enantiomer ([α]D
20
 
+40).
52b, 120
 This result was expected based on the X-ray structure of the boronic acid 
adduct 188b. 
When the benzophenone adduct was subjected to the same deprotection-reduction  
sequence (Scheme 56), urea 191e was obtained which upon hydrolysis gave the 
corresponding oxazin-2-one 193. 
 
Scheme 56. Formation of oxazinone from benzophenone adduct. 
 
3.2. On the Origin of Stereoselectivity 
From the work on ferrocenyl phthalimidines, it is clear that the β-silyloxy moiety 
plays a vital role in determining the stereoselectivity (Scheme 23). Hence it was of 
interest to study the origin of stereoselectivity of syn-187. The origin of stereoselectivity 
in diastereoselective lithiation of ferrocenes with other chiral directing groups may be 
classified as one of the two cases: (a) Cp ring controlled or, (b) base controlled. In other 
words, lithiation selectivity is controlled primarily by the avoidance of steric interactions 
from either the directing group and the ferrocene core, or the directing group and the base 
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used for deprotonation.
121
 For example, in the case of Ugi’s amine, lithiation is directed 
towards pro-Rp position selectively because the alternate conformation is disfavored by 
collision of the α-methyl group with the lower unsubstituted cyclopentadienyl (Cp) ring. 
In the case of oxazolines, deprotonation of the pro-Rp hydrogen is preferred since the 
alternate orientation of the directing group produces pronounced steric interactions with 
the base (Scheme 57). 
 
Scheme 57. The origin of stereochemistry of Ugi’s amine and oxazolines. 
 
In general, directing groups with stereogenic centers α to the ferrocene core 
appear to undergo Cp ring controlled lithiation (Ugi’s amine or sulfoxides). Directing 
groups with more distant γ-ferrocenyl stereocenters (oxazolines) undergo base controlled 
lithiation. The directing group, syn-187 has β,γ-stereogenic centers and its lithiation 
selectivity was found to be insensitive to the size of the base used for deprotonation 
(LDA, LiTMP, n-BuLi, i-PrLi or t-BuLi).
122
 Furthermore, the high diastereoselectivity 
observed for lithiation of racemic phthalimidine 90, which has only a β-chiral 
stereocenter; suggest that the β position in the syn-187 is more important to the reaction 
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outcome. In that case, it is the proximal and relatively bulky β-silyloxy moiety that plays 
a predominant role in the selective abstraction of pro-Sp proton compared to the γ-
stereocenter of the pyrrolidine ring. To have a better insight into this, the β-epimer of syn-
187 (anti-187) was synthesized to determine whether it will induce the pro-Rp, rather than 
pro-Sp lithiation. 
The synthesis of anti-187 involved the isolation of a 1:1 mixture of hemiaminals 
186, after reduction with Schwartz’s reagent. The epimers thus obtained were treated 
with n-BuLi at 0 ºC to generate aminoalkoxides which were O-silylated with TESCl 
(Scheme 58). It was important to take the hemiaminals into the next step within an hour 
since more time resulted in the predominant formation of a syn diastereomer. The syn and 
anti diastereomers were separated via flash column chromatography followed by 
recrystallization to give anti-187 and syn-187 in 42% and 44% yield respectively. In the 
1
H NMR spectrum of anti-187, the methine proton at δ 5.39, α to silyloxy group, was 
found to be a singlet showing that it may be orthogonal to the methine hydrogen of the 
pyrrolidine ring. 
 
Scheme 58. Synthesis of compound anti-187. 
 
The same lithiation conditions used for syn-187 were applied for anti-187 to 
determine the lithiation selectivity. Thus with 2.2 equivalents of t-BuLi in THF at –78 ºC 
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and quenching with iodomethane gave 190a as a single diastereomer by 
1
H and 
13
C NMR 
data (Scheme 59).  
 
Scheme 59. Diastereoselective lithiation of compound anti-187. 
The proof that anti-187 had directed lithiation of the pro-Rp hydrogen was 
provided by X-ray analysis of the methyl-substituted product 190a (Figure 10). The 
compound crystallizes in the orthorhombic P212121 space group. The dihedral angle 
between the methine hydrogen α to silyloxy group and the methine hydrogen of the 
pyrrolidine ring was found to be 96º which is consistent with the observed singlet in the 
anti-diastereomer 187. The cyclopentadienyl rings were found to be staggered with a 
torsion angle of 24º. Solution using the Rp enantiomer model [Flack parameter = 
0.021(7)] confirmed the R-planar chirality of 190a as expected. 
The reaction was repeated with iodoethane and dimethyl disulphide as 
electrophiles, and in all cases, the products were formed in >95:5 diastereomeric ratio. 
When i-PrLi or n-BuLi were used instead, the degree of diastereoselectivity remained the 
same, but there was a decrease in conversion.  
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Figure 10. ORTEP depiction of (1S,7S,Rp)-190a at 30% probability. All hydrogens 
except H11 and H12 are omitted for clarity. 
Further confirmation to the extent of planar chiral induction was obtained by 
synthesis of 2-substituted imidazolones by acid-induced elimination of 190a-c. When 
these compounds were treated with p-toluenesulfonic acid in CHCl3 at reflux for 30 min., 
the imidazolones 192a-c were formed in high yields ranging from 85-95%. The products 
thus obtained were found to be the antipodes of the imidazolones derived from syn 188a-
c as observed from specific rotation and chiral stationary phase HPLC analysis. From all 
these observations described above, it is clear that it is the configuration of silyloxy-
containing β-ferrocenyl stereogenic center of each substrate that determines the sense of 
planar chiral induction. 
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Table 2. Comparison of imidazolone antipodes. 
 
3.2.1. Spectroscopic Analysis of syn/anti-187 and Their Deuterated Congeners. 
 From the experimental results, it may be inferred that the β-silyloxy stereocenter 
in each substrate exerts a conformational bias making the urea carbonyl to point towards 
either the pro-Sp or pro-Rp hydrogens. Hence it is reasonable to assume that the lithiation 
occurred via coordination of the base to the more electron rich urea oxygen rather than 
the bulkier silyloxy moeity of the directing group. Further evidence of the preferred 
orientation of the urea carbonyl moiety was obtained by nOe difference spectra acquired 
by selective irradiation of the respective β-silyloxy methine hydrogens in syn- and anti- 
187. In the case of syn-187, irradiation of methine doublet at δ 5.44 produced a 1.7% nOe 
for the neighbouring pyrrolidine methine at δ 3.93, along with a 1.0% nOe for a Cp ring 
hydrogen at δ 4.30 (Figure 11). Among the other three Cp hydrogens, the most 
deshielded hydrogen at δ 4.80 was tentatively assigned as the pro-Sp hydrogen. 
Similarly, in the case of anti-187, irradiation of the β-silyloxy methine at δ 5.41 
produced 1.4% nOe for the Cp ring hydrogen at δ 4.46 along with a 0.6% nOe for the Cp 
ring proton at δ 4.97 ppm (Figure 11). The most deshielded Cp ring hydrogen at δ 4.97 
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having smaller nOe from the β-silyloxy methine at δ 5.41 was tentatively assigned as the 
pro-Rp hydrogen.  
 
Figure 11. Relationship of key nOe’s to observed sites of lithiation–deuteration for syn- 
and anti-187. 
 
To support the above assignments, lithiation-deuteration experiments were carried 
out on syn- and anti- 187. In the case of syn-187, it was expected that the signal assigned 
as the pro-Rp ortho Cp hydrogen at δ 4.30 ppm should remain as such and the signal at δ 
4.80 assigned as the pro-Sp hydrogen should disappear. In accordance with these, 
lithiation of syn-187 under standard conditions followed by addition of excess methanol-
d4 afforded a 
1
H NMR spectrum of syn-188i in which the signal at δ 4.80 disappeared 
(Scheme 60). The integral ratio to the signal at δ 4.80 versus δ 4.30 was found to be 
0.08:1. The lithiation-deuteration experiment on anti-187 showed disappearance of the 
signal at δ 4.97 ppm with a resulting integral ratio of 0.02:1 versus the peak at δ 4.46 
ppm. Subjecting these compounds to elimination conditions, imidazolones (192d, ent-
192d) with solely planar chirality due to the presence of a deuterium as a substituent were 
obtained. 
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Scheme 60. Synthesis of deuterated antipodes. 
 
3.2.2. Computational Modeling of syn/anti Lithiation.    
 When syn-187 and anti-187 were subjected to variable temperature 
1
H-NMR (300 
MHz) in DMSO-d6 at 130 ºC, neither epimer showed any signs of signal coalescence in 
their respective 
1
H-NMR spectra, even for Cp hydrogens ortho to the directing group. 
Additionally, the fact that both epimers showed significant nOe for ortho-Cp protons by 
irradiation of their β-silyloxy methine hydrogens suggested a large rotational barrier, or at 
least a conformational preference about the Cp-nitrogen bond for each substrate. To get 
more information about their conformational behaviour, global minima were calculated 
for both epimers at the B3LYP
123
/6-31G(d,p) level of theory using Gaussian '09.
124
 The 
lowest energy minima obtained by this process for each epimer are given in Figure 12. 
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     syn-181                              anti-181   
             Figure 12. Calculated ground states for syn- and anti-187. 
 
In both calculated global minima, the triethylsilyloxy moiety was placed well 
above the plane of the top Cp ring, to minimize steric interactions with the ferrocene core. 
The carbonyl group in the case of syn-187 was found to produce a dihedral angle 
(carbonyl-nitrogen-Cp(ipso)-Cp(ortho)) of 30.0º below the plane of the substituted (top) Cp 
ring, i.e., pointing towards the pro-Sp Cp hydrogen. The contact distance between urea 
oxygen and pro-Sp Cp hydrogen was found to be 2.58 Å. Likewise for anti-187, the urea 
carbonyl points in the direction of the pro-Rp hydrogen producing a dihedral angle of 
25.8º. The contact distance between the urea and the pro-Rp hydrogen was 2.59 Å. More 
information about the rotational barriers of both epimers about their Cp(ipso)-N bonds was 
obtained by performing optimizations constrained about the carbonyl-nitrogen-Cp(ipso)-
Cp(ortho) dihedral at 10° increments over a complete range of 360º. From these 
calculations, the overall approximate rotational barrier was found to be 16 and 10 
kcal/mol for syn- and anti-187, respectively. From spectroscopic observations, it 
appeared that the real rotational barriers for each epimer may be >20.9 kcal/mol.
125
 The 
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calculated values for rotational barriers may be an underestimation since the 
minimizations were done in 10º increments. 
Calculations of the transition states for lithiation were done at the MP2/6-
31G(d,p)//B3LYP/6-31G(d,p) level of theory using the above-mentioned conformational 
minima, syn- and anti-187, as a starting point. The transition state model predicted that 
the lithium of the t-BuLi base coordinates to the urea oxygen in such a way that the 
incoming carbanion is essentially coplanar with the prochiral C-H bonds of each 
compound (Figure 13 of syn-187). The carbonyl-nitrogen-Cp(ipso)-Cp(ortho) dihedral angle 
is tilted 45.3º below the plane of the top Cp ring to accommodate the base, an increase of 
15.3º from the calculated ground state. In the case of TS-anti-187, the carbonyl group lies 
41.5º below the plane of the top Cp ring with an increase of 15.7º from anti-187 (Figure 
13). For both epimers, the transition states of lithiation seems to avoid any significant 
steric interactions between the base and any parts of the directing group, which supports 
the hypothesis of a Cp ring controlled lithiation. The activation energies for TS-syn-187 
and TS-anti-187 (8.8 and 6.7 kcal/mol respectively) were found to be lower than the 
computationally approximated rotational barriers. It may be concluded that a 
conformational preference, determined primarily by the β-silyloxy moiety, is responsible 
for the observed lithiation selectivity. Since it affects the position of urea carbonyl to 
point towards one of the two ortho-Cp hydrogens. Hence, a strong conformational 
preference appears to have significant influence on the stereoselectivity in these cases 
compared to energetically less demanding activation barriers. 
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                              TS-syn-187                                          TS-anti-187 
Figure 13. Single-point MP2/6-31G(d,p)//B3LYP/6-31G(d,p) calculated transition states 
for t-BuLi-mediated lithiation of syn- and anti-187 with t-BuLi. 
 
3.3. Synthesis of an Annulated Chiral N-Ferrocenyl Imidazolium Salt and its Ir(I) 
Complexes  
Having established a new method for the synthesis of planar chiral N-substituted 
ferrocenes, attention turned to potential applications of any derived ligands in catalytic 
asymmetric reactions. A potential entry into such systems was found when alcohol 188g 
underwent cyclization to give products anti- and syn-194 (4:1 ratio) rather than 
elimination to the imidazolones. Repetition of this experiment on a larger scale (1.2 g) 
offered only anti-194, presumably because of the reversibility of the reaction by virtue of 
an iminium intermediate. 
 
Scheme 61. Synthesis of annulated ureas from benzophenone adduct. 
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As before, the assignment of relative stereochemistry was obtained by nOe 
difference spectra by selective irradiation of the respective methine hydrogens α to 
oxygen and by coupling constants. In the case of syn-194, the methine signal at δ 4.93 
ppm was found to be a doublet with coupling constant of 7.5 Hz close to other products 
with established syn-stereochemistry (eg. 188b). Irradiation of methine doublet of syn-
194 at δ 4.88 introduced a 4.4% nOe for the neighbouring pyrrolidine methine at δ 3.97, 
along with a 1.4% nOe for a phenyl ring hydrogen at δ 7.18 (Figure 14).  
In the case of anti-194, the methine signal at δ 5.46 was found to be a singlet 
similar to other products with established anti-stereochemistry (eg. 190a) indicating 90º 
dihedral angle. Irradiation of the methine singlet of anti-194 at δ 5.48 produced 1.3% nOe 
for the neighbouring pyrrolidine methine at δ 3.90 along with a 1.9% nOe for the Cp ring 
proton at δ 3.72 ppm, 2.2% nOe at the methylene hydrogen at δ 1.57, and 3.2% nOe for 
one of phenyl ring protons at δ 7.76 ppm (Figure 14).  
 
Figure 14. Key nOes of syn and anti-194 ureas. 
 
When anti-194 was treated with four equivalents of DIBAL-H, aminal 195 was 
obtained (Scheme 62). The aminal was found to be isolable and indefinitely stable in a 
freezer at −20 ºC under inert atmosphere. Subsequent oxidation of 195 with tritylium 
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tetrafluoroborate gave imidazolinium salt 196 which was not isolated due to its 
instability. Deprotonation of the imidazolinium salt with KOt-Bu generated the 
imidazolylidene, which was trapped with [Ir(COD)Cl]2 to give 197 as a mixture of major 
and minor coordination isomers. It was found that stirring a mixture of these isomers at 
room temperature for 16 h led to the conversion of the minor isomer to the major isomer.  
 
 
Scheme 62. Synthesis of an annulated chiral N-ferrocenyl imidazolinium salt and 
complexation to Ir(I). 
Evidence for the coordination of ligand to iridium metal was obtained initially by 
13
C NMR where a characteristic ylidene carbon signal was found at δ 206 ppm. Further 
confirmation on the structure was obtained by single crystal X-ray structure of 197 
(Figure 15). Thus by treating a solution of 197 in CH2Cl2 containing one equivalent of 
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PPh3 gave the cationic Ir(I) complex 198 isolated as PF6‾ salt. This compound showed 
two peaks in its 
31
P NMR spectrum, a singlet at 16 ppm corresponding to the phosphine 
and a septet at –144.2 ppm corresponding to PF6‾salt. 
 
 
Figure 15. ORTEP depiction of 197 with 30% probability ellipsoids 
(all hydrogens except H6a, H5a, H4a, H3a and H2a are omitted for clarity).  
 
The complex crystallized in the triclinic P1 space group as two independent 
molecules. The first molecule was found to have disorder in the pyrrolidine ring and the 
other had disorder in cyclooctadiene, which were modelled. The crystal structure shows 
the anti-stereochemisrty of 197 at the C6a and C5a positions. The complex was found to 
be four coordinate with square-planar geometry at iridium, with a bond distance of 2.00Å 
between carbenoid carbon and iridium. The cyclopentadienyl rings were found to be 
eclipsed and the dihedral angle between N2a-C1a-Ir1a-Cl1a was found to be 98.6(3)º 
avoiding steric interaction of ligand with cyclooctadiene.
126
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The same synthetic pathway was used for the synthesis of an Ir(I) complex 202, 
prepared from anti-187 as the starting material. Diastereoselective lithiation followed by 
benzophenone quench gave 190e as a single diastereomer that, on acid-mediated 
cyclization, gave a mixture of syn-199 and anti-199 ureas which were separated by 
column chromatography (Scheme 63).  
 
Scheme 63. Synthesis of annulated ureas using compound 190e. 
 
The stereochemical assignment was obtained by the nOe difference spectroscopy 
acquired by selective irradiation of the respective methine hydrogen α to oxygen and 3J 
coupling constants. In the case of syn-199, the methine signal at δ 5.58 was found to be a 
doublet with a coupling constant of 6.6 Hz. This observation is in accordance with the 
coupling constant value seen in the case of boronic acid with syn stereochemistry, 188b. 
For futher support, nOe experiments were carried out.  
 
Figure 16. Key nOes of syn-199 and anti-199 ureas. 
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Irradiation of methine doublet at δ 5.60 introduced a 3.8% nOe for the 
neighbouring pyrrolidine methine at δ 4.21, along with a 2.9% nOe for a phenyl ring 
hydrogen at δ 7.75 and a 1.4% nOe for one of Cp ring hydrogens at 3.77 ppm (Figure 16). 
Similarly, in the case of anti-199, the methine signal at δ 4.60 was found to be a doublet 
with a coupling constant of 1.5 Hz. This is typical for a compound with anti 
stereochemistry (eg. anti-190a). For further evidence, irradiation of the methine singlet α 
to oxygen at δ 4.64 was carried out. It produced a 0.9% nOe for the neighbouring 
pyrrolidine methine at δ 4.01, along with a 0.7% nOe for one of phenyl ring protons at δ 
7.21 ppm and a 1.9% nOe for one of methylene hydrogens of pyrrolidine ring. (Figure 
16).   
Reduction of syn- and anti-199 gave syn-200 (78%) and anti-200 (60%), 
respectively. Among the aminals, only syn-200 underwent oxidation and was trapped as 
an iridium complex 201. This neutral iridium complex was converted to Ir(I) complex 
202 by treating its CH2Cl2 solution with PPh3 followed by anionic exchange (Scheme 64). 
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Scheme 64. Synthesis of Ir(I) complex derived from anti-187. 
3.3.1. Asymmetric Hydrogenation of Quinolines 
Based on the work by Crabtree and coworkers, where N-heterocyclic carbenes 
(NHCs) were employed as ancillary ligands for the first time in quinoline 
hydrogenations,
108
 the reactivity of complexes (198 and 202) in carrying out asymmetric 
hydrogenation being tested with 2-methyl quinoline.  
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Table 3. Screening of iridium precursors for asymmetric hydrogenation. 
 
Initial screens at high hydrogen pressures (45 atm) in toluene at room temperature 
(Table 3) using 1 mol% of catalyst 198 and 1 mol% PPh3 as an additive gave full 
conversion in 40% ee. When reaction was repeated at 5 atm of hydrogen, full conversion 
to 2-methyl tetrahydroquinoline 203a was observed in 79:21 er (58% ee). Surprisingly, 
lower selectivity (46% ee) and slower conversion was observed when the reaction was 
carried out in 1 atm of H2 due to prolonged reaction time which can lead to decrease in 
selectivity due to racemization. Complex 202, derived from anti-187, was found to 
inactive at 5 atm of hydrogen. By increasing hydrogen pressure to 45 atm, 2-methyl 
80 
 
tetrahydroquinoline was obtained with 84% conversion and 36% ee. The versatility of 
complex 198 allowed us to perform more optimization studies using this catalyst. 
The reaction was found to be solvent dependant, with full conversion being 
observed in toluene (94%), and fairly good conversion in THF (86%) (Table 4). Methanol 
and dichloromethane were found to be poor solvents for this reaction. Without additive, 
the conversion and enantioselectivity dropped considerably. In contrast to the case with 
some other catalysts that are expected to operate by inner sphere mechanisms,
90, 93b
 the 
use of iodine as an additive afforded only trace amounts of product. On addition of 1 
mol% of triphenylphosphine, the intermediate iridium hydride complexes which are 
responsible for catalysis were formed. The dihydride remains coordinately unsaturated in 
the presence of non-coordinating PF6 anion allowing the hydride species to react with 
free hydrogen. The use of triphenylphosphine as an additive can be considered as an 
advantage over iodine since halides which may inhibit the formation of the active catalyst 
by competing for a coordination site. In this sense, the new chiral catalyst system seems 
to behave similarly to Crabtree’s complex. To study the effects of other phosphines as 
additives, P(o-tol)3 and P(2-fur)3 were used.  The use of P(o-tol)3  gave good conversion 
(90%) but only with low ee (35%), and it required longer reaction time (18 h). When P(2-
fur)3 was used as additive, very low conversion (53%) was observed with very poor 
selectivity (4%). One notable feature of using P(2-fur)3 as an additive was that the (R) 
enantiomer was formed in excess, while in all other cases, (S) enantiomer was the major 
product. This might be due to the presence of oxygen atoms participating in the transition 
state of enantiomer determining step by coordination. 
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Table 4. Optimization of the hydrogenation of 2-methyl quinoline.   
Based on these observations, a proposed mechanism of the reaction considering 
an outer sphere mechanistic pathway, is given in Scheme 65.  
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Scheme 65. Proposed mechanism for the hydrogenation 2-methyl quinoline. 
  Assuming that similar reactive intermediates as that of Crabtree’s 
mechanistic pathway are formed (Scheme 47); the enantioselectivity of this reaction can 
be explained by considering the following transition state (Figure 17). The generation of 
lower energy transition state formed due to CH/π attraction between phenyl group of 
dihydroquinoline and the η5-Cp ring can give rise to lower energy TS-si than TS-re. CH/π 
interaction was realized by Noyori and co-workers in rationalizing the asymmetric 
reduction of ketones.
83b
 Accurate explanation to mechanistic pathway and 
stereoselectivity requires DFT study of mechanism and origin of stereoselectivity. 
 
 
Figure 17. Proposed transition state for origin of enantioselectivity. 
 
3.3.2. Substrate Scope for the Hydrogenation Precatalyst 
 After the initial catalyst screening, several substituted quinolines were subjected 
to hydrogenation using catalyst 198. Among them, 2-methyl quinoline and 6-fluoro 2-
methyl quinoline went to full conversion within 10 h, with 203b giving the highest 
enantioselectivity of the series; 90:10 er (80% ee). (S)-6-Fluoro 2-methyl 
tetrahydroquinoline 203b is the key intermediate in the synthesis of antibacterial agent 
(S)-flumequine 109.
73
 This result supports the possibility that this catalytic system 
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operates by outer sphere mechanism. In outer sphere mechanism, protonation at several 
substitutions on the quinoline are permitted, including functionalities in 2, 6- positions. 
The reaction selectivity was found to be sensitive to the presence of a phenyl group 203e 
in 2-position. However, in all cases, the hydrogen pressure used is far lower than those 
typical for this type of asymmetric hydrogenation. Ketimine (N-(1-
phenylethylidene)aniline), 2,9-dimethyl phenanthroline, 1-methyl isoquinoline and 3-
methyl isoquinoline were found to be reluctant to hydrogenation under given conditions. 
The substrate scope for this reaction seems to be limited, depending on the pKa of the 
heteroaromatic compound. By ligand modifications, the acidity of the reactive hydride 
species can be increased, thereby enabling protonation heteroaromatic compounds with 
lower pKas. 
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Table 5. Substrate scope for the iridium catalyzed asymmetric hydrogenation. 
  
Encouraged by the results shown by catalyst 198 in asymmetric hydrogenation of 
quinolines where the reactivity of the catalyst 198 was similar to that exhibited by 
Crabtreeʼs catalyst, our next attempt was to improve the enantioselectivity of reaction. 
For that, a few different catalyst systems were envisioned. Under an analogous procedure 
used previously to prepare 198, complex 208 was prepared by using diastereoselective 
lithiation-benzaldehyde quench on syn-187. Acid mediated cyclization followed by 
reduction gave the aminal 205 with an additional chiral center (Scheme 65). The Ir(I) 
complex 208 was synthesized using the same method employed for complexes 198 and 
202. The asymmetric hydrogenation of 2-methyl quinoline using complex 208 under 
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optimized conditions gave good conversion (88%) at low pressures (5 atm) with very low 
enantioselectivity (18% ee). 
 
Scheme 66. Sythesis of Ir(I) complex using benzaldehyde adduct (188j). 
 
Our next attempt was to make complexes where these groups are restricted to 
freely rotate. Using the same lithiation conditions and employing xanthone as an 
electrophile gave 209 after cyclization. Synthesis of compound 209 was on the 
assumption that this ring system may accentuate the anti-stereochemistry of ligand 
backbone because of the spirocyclic quartenary center, in addition to the steric influence. 
Unfortunately, the aminal 210 was found to be sensitive to oxidation and thus precluding 
the synthesis of an iridium complex (Scheme 66).  
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Scheme 67. Synthesis of Ir(I) complex using xanthone adduct. 
 
Hence the reaction pathway was repeated using fluorenone as the electrophile 
which was taken to a neutral iridium complex (Scheme 67). Attempts to make its cationic 
complex were unfruitful. When asymmetric hydrogenation of 2-methyl quinoline was 
carried out using catalyst 214 along with 1.1 equiv. of PPh3 under optimized conditions, 
no conversion was observed. 
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Scheme 68. Synthesis of Ir(I) complex using fluorenone adduct. 
 
 Attempts to see the effects of alkyl substituents instead of diphenyl groups on the 
complex were unsuccessful as well. The annulated ureas (215, 218), where the former 
was synthesized using acetone as the electrophile and the latter by reduction of 
corresponding aldehyde 188h, underwent over reduction on treatment with DIBAL-H to 
give 216 and 219, respectively (Scheme 68). 
 
Scheme 69. Attempts towards synthesis of Ir(I) complex with alkyl substituents. 
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3.4. Attempts Towards Synthesis of Bidentate Ligands and Their Ir(I) Complexes 
The asymmetric hydrogenation of 2-substituted quinolines using Ir(I) complex 
198 gave the corresponding products in good yields with up to 80% ee. This might be 
attributed to the presence of metal center far from the planar chirality, thereby decreasing 
the extent of chiral induction. In addition to that, the use of different phosphines as 
additives showed changes in yield and enantioselectivity. To improve enantioselectivity, 
attempts were made to synthesize bidentate ligand systems with phosphine directly 
attached to the Cp ring. When anti-194 was subjected to lithiation conditions using t-
BuLi in presence of TMEDA, and quenched with chlorophosphines,
127
 220a and 220b 
were formed in moderate yields (Scheme 69). The phoshines with electron withdrawing 
groups (4-trifluoromethyl and 3,5-bis-trifluoromethyl benzene) were used as electrophiles 
since the use of cholorodiphenylphosphine as electrophile gave poor conversion (>20% 
yield), as an inseparable mixture of product and starting material. This result corroborates 
the expectation that urea carbonyl forms the site for base coordination for t-BuLi as seen 
from the studies on origin of stereoselectivity (Section 3.2). Subjecting these compounds 
to reduction using DIBAL-H at room temperature resulted in recovery of the starting 
material; when carried out at higher temperature, the material underwent decomposition. 
 
Scheme 70. Synthesis of phosphine compounds 220a,b. 
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 In order to avoid the possible coordination of aluminium salts to phosphine which 
may prevent reduction of urea 220, the iodo compound 221 was synthesized.  When the 
iodourea was treated with DIBAL-H, aminal 222 was obtained. Lithium-halogen 
exchange using n-BuLi, followed by quenching with chlorodiphenylphosphine gave 223 
in 63% yield. Oxidation with tritylium tetrafluoroborate was unsuccessful, as the 
compound seemed to undergo coordination of trityl cation via phosphine 224, which was 
isolated and characterized (Scheme 70). Hence, 223 was converted to the corresponding 
phosphine sulfide 225, which when subjected to oxidation resulted in the recovery of 
starting material. The starting material was found to decompose under these conditions at 
elevated temparatures (Scheme 71). 
 
Scheme 71. Attempts towards synthesis of diphenyl phosphine containing bidentate 
ligands. 
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Scheme 72. Synthesis of phosphine sulfide 225. 
 
3.5. Synthesis of a Rhodium Complex Using an Annulated NHC ligand  
A rhodium (I) complex 226 was synthesized by following the same synthetic 
procedure used to prepare the Ir(I) complex 197 (Scheme 72). Asimple way to evaluate 
the basicity of a carbene ligand is to compare the IR data of carbonyl ligands in 
corresponding carbene carbonyl complexes. The wavenumber of CO stretching frequency 
is directly proportional to the back donation from the metal center. A very basic ligand 
should give a relatively smaller wavenumber due to strong σ donation of the carbon atom 
to the metal and little π back donation from the metal center to the ligand.128 The IR data 
of metal carbonyl complexes have been widely used to assess the overall donor strength 
of a bound carbene ligand. The stretching frequency (ν) of trans-CO moiety enables the 
most rigorous assessment of the electronic properties of the ligand because it is least 
influenced by any steric effects. To study the electron releasing capacity of the ferrocenyl 
substituted ligand, (NHC)RhCl(CO)2 was synthesized and determined the stretching 
frequency of trans-CO ligand at ν = 2007 cm-1. This is indicative of an electron-releasing 
capacity close to that of a dimesityl imidazol-2-ylidene (IMes) ligand (2006 cm
-1
).
129
 The 
use of this complex in catalytic asymmetric hydroformylation reaction is being persued in 
the Metallinos group. 
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Scheme 73. Synthesis of rhodium complexes 226 and 227. 
 
3.6. Attempts Towards Non-annulated Bidentate Ligands and Their Ir(I) Complexes 
 A saturated urea 229 can be synthesized from syn-187 by treating with sodium 
cyanoborohydride and acetic acid (Scheme 73).  
 
 
Scheme 74. Synthesis of neutral iridium complex 230. 
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When syn-187 was treated with 6 equivalents of DIBAL-H, it caused reduction of 
the urea moiety and removal of silyloxy group to give aminal 228. When this aminal was 
subjected to oxidation, the imidazolinium salt was formed, which was taken to the next 
step as a crude mixture. Deprotonation of the imidazolinium salt followed by trapping 
with iridium gave the neutral iridium complex 230. This observation encouraged us to 
develop a synthetic route towards the synthesis of bidentate ligands and their Ir(I) 
complexes.  
 Previous attempts to make a diphenylphosphino derivative of syn-187 were 
unsuccessful possibly due to the presence of excess base. Previous result in the group has 
shown that the use of an additive, 2-dimethyl aminoethanol (DMAE) in the lithiation of 
BF3-activated tertiary aminoferrocenes has shown to give high enantioselectivity.
45
 To 
study the effect of an additive in lithiation of syn-187, different additives such as DMAE, 
LiCl and tetramethylethylenediamine (TMEDA) were used with 2.2 equivalents of t-BuLi 
and by using methyl iodide or tributyltin chloride as electrophiles. In all cases, the 
products were formed in lower yields (up to 65% for methyl substituted compound, 
188d) than the reaction done without additive.
127d
 Hence we expected that the use of 
chlorophosphines containing electron withdrawing groups on phenyl ring would impart 
stability to the resulting phosphine substituent. Thus the 3,5-bis-trifluoromethyl and 4-
trifluoromethyl phosphines were prepared which on treatment with DIBAL-H were 
resistant to reduction. Hence the phophine 231a or b was heated to reflux with BH3∙THF 
which facilitated the coordination of borane to phosphine and removal of the silyloxy 
group to get urea 232 which then underwent reduction easily to give corresponding 
aminals in good yields (Scheme 74). 
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Scheme 75. Synthesis of borane-phosphine aminals. 
 
 The aminals were found to be resistent to oxidation at room temperature and on 
heating at higher temperature, decomposition of starting material was observed (Scheme 
75).  
 
Scheme 76. Attempts towards oxidation of aminal 233. 
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The oxidation was therefore carried out on free phosphine 234 using tritylium 
tetrafluoroborate which resulted in the coordination of trityl cation to phosphine (vide 
supra). Hence the phosphine was converted to phosphine sulphide 235 by heating a 
benzene solution of 234 with sulphur. Unfortunately, 235 was resistant to oxidation as 
well presumably due to the steric hindrance from sulphur. 
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4. Conclusions and Future Work 
A feasible method for the stereoselective synthesis of planar chiral ferrocenes has been 
developed. The chiral auxiliary used for the synthesis was found to satisfy all the 
requirements of a practical chiral auxiliary. The key starting material was prepared by 
coupling of readily available L-proline hydantoin to iodoferrocene followed by 
stereoselective hydrosilylation. Upon lithiation and electrophile quench, this chiral 
auxiliary was found to deliver ortho-substitured products in ˃95:5 diastereoselectivity. It 
also provides a direct route to ortho-substituted planar chiral hydrolysis products by 
making use of a labile silyoxy moiety. The studies on the origin of stereochemistry 
showed that the epimeric substrate, anti-187, induced lithiation of pro-Rp rather than pro-
Sp position of the ferrocene core in >95:5 dr. This reversal of stereochemistry was 
confirmed by X-ray analysis and by comparison solely planar chiral imidazolones derived 
from both syn- and anti-187 epimers. The data were further supported by the 
spectroscopic studies including 1-D nOe experiments, base effects, and selective 
lithiation-deuteration of both epimers showing that the lithiation process is Cp ring 
controlled as in the case of Ugi’s amine. Additional support was obtained by ground and 
transition state modeling of syn- and anti-187 epimers.  
Our studies towards the synthesis of advanced derivatives resulted in the preparation 
of an iridium complex. The cationic iridium complex prepared was used for the 
asymmetric hydrogenation of 2-substituted quinolines in pressures as low as 5 atm in up 
to 80% ee. Attempts to improve the hydrogenation stereoselectivity by synthesizing 
bidentate ligand systems were found to be unsuccessful. An alternative route towards the 
synthesis of bidentate ligand system is to make use of an ortho-substituted imidazolone. 
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Imidazolones can be converted to imidazolylidines, which can act as ligand precursors.
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Thus by treating 192c with phosphoryl oxychloride or oxalyl chloride can give 
corresponding chloroimidazolium salt. On treatment with base such as t-BuLi, carbene 
will be generated which can be trapped with a metal complex. The susceptibility of 
phosphines towards oxidation or decomposition can be ruled out by introducing the 
phosphino group at a later stage by metal-halogen exchange.  
 
Scheme 77. Alternative route to bidentate metal complexes. 
 
Acyclic diaminocarbenes possess some advantages over NHCs. They have donor 
ability in comparison with NHCs and hence displays an increased electronic density on a 
metal center. This property of these compounds facilitates the oxidative addition of an 
organic substrate to the metal center which is a key step in transition metal catalyzed 
organic reactions. Additionally, acyclic diaminocarbene ligands possess wider N-C-N 
bond angles compared to related N-heterocyclic carbenes, and, consequently, occupy 
more space next to a metal center. Acyclic diaminocarbenes provides greater steric 
control which on the one hand, increases the stability of the corresponding metal 
complexes and on the other hand, facilitates reductive elimination which is the final stage 
of cross-coupling catalytic cycle. In an attempt to make acyclic diaminocarbenes as 
alternative to NHCs as ligands,
130
 190a was treated with POCl3 at room temperature, and 
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underwent cyclization to give oxazol-ylidene amine 237 (Scheme 77). This can be solved 
by protecting the amide nitrogen and hydroxyl and then converting it to corresponding 
ylidene by treatment with phosphoryl oxychloride or oxalyl chloride. The carbene 
precursor thus generated can be treated with a base and trapped as a metal complex. By 
introducing a phophino group by diastereoselective lithiation and substitution, and by 
using the same strategy, synthesis of bidentate metal complexes can be achieved as well. 
 
Scheme 78. Formation of oxazol-ylidene amine 237. 
 
 
Scheme 79. Synthesis acyclic diaminocarbenes. 
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5. Experimental Procedures 
General Experimental. All reagents were purchased from Aldrich, Fisher Scientific, 
Acros, Strem or Oakwood chemicals and used as received unless otherwise indicated. 
Tetrahydrofuran, diethyl ether and 1,4-dioxane were freshly distilled from 
sodium/benzophenone ketyl under an atmosphere of nitrogen. Toluene was freshly 
distilled from sodium under an atmosphere of nitrogen. Dichloromethane and dimethyl 
sulfoxide were distilled from CaH2 under an atmosphere of nitrogen. Methanol was 
distilled from magnesium methoxide under argon. All alkyllithium and lithium amide 
bases were titrated against N-benzylbenzamide
131
 to a blue endpoint. All reactions were 
performed under argon in flame- or oven-dried glassware using syringe-septum cap 
techniques unless otherwise indicated. TLC was performed on silica gel unless otherwise 
stated. Column chromatography was performed on silica gel 60 (70-230 mesh). 
Schwartz’s reagent was prepared according to a literature procedure.115 NMR spectra 
were obtained on a Bruker Avance 300, 400 or 600 MHz instrument and are referenced to 
the residual proton signal of the deuterated solvent for 
1
H spectra, and to the carbon 
multiplet of the deuterated solvent for 
13
C spectra according to published values.
41
 
Spectroscopic data are reported as follows: (multiplicity, number of protons, coupling 
constant), where s = singlet, d = doublet, t = triplet, q = quartet and dd = doublet of 
doublets. Enantiomeric ratios were determined on an Agilent 1100 series HPLC system at 
λ = 254 nm on a Chiralcel OD-H column. Except for hydrogenation products, all 
compounds were compared against racemic material. It should be noted for HPLC 
measurements that response factors were not obtained for each enantiomer in all the cases 
and the reported enantiomeric ratios are not calibrated. FT-IR spectra were obtained on 
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an ATI Mattson Research Series spectrometer as KBr pellets for solids or on KBr discs 
for liquids and on Bruker ALPHA platinum ATR spectrometer as neat material. Optical 
rotations were measured on a Rudolph Research Autopol III automatic polarimeter. Mass 
spectra were obtained on an MSI/Kratos Concept 1S Mass Spectrometer. Combustion 
analyses were performed by Atlantic Microlab Inc., Norcross, GA, USA. Melting points 
were determined on a Kofler hot-stage apparatus and are uncorrected. Crystallographic 
data for the structures reported in this thesis have been deposited with the Cambridge 
Crystallographic Data Centre as corresponding supplementary publication number. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif. 
Iodoferrocene (22).
132
 
Following a literature procedure adapted from the synthesis of 
formylferrocene;
15
 ferrocene (30.0 g, 0.16 mol) and potassium t-butoxide (2.2 
g, 0.02 mol) were dissolved in 1.6 L of dry THF and the solution was cooled to 
−74 ºC using a dry ice/acetone bath. Over a period of 35 min., t-BuLi (310 mL, 1.04 M in 
pentane, 0.32 mol) was added keeping the internal reaction temperature below −70 ºC. 
After 1 h, iodine (96.0 g, 0.38 mol) was added in one portion by increasing the flow of 
argon, to the reddish orange solution. The reaction mixture was then allowed to warm to 
−40 ºC over a period of 20 min, followed by addition of water. The combined organic 
extract was washed with sat. aq. Na2S2O3, water, brine, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, hexanes) afforded 22 (40 g, 0.13 mol, 80%) as an orange-brown oil which 
solidified on standing. mp 43-45 °C [lit.
132
 mp. 44-45 °C]; IR (neat) νmax
 
3091, 2919, 
100 
 
2852, 1405, 1377, 1337, 1104, 814 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 4.40 (t, 2H, J = 
1.5 Hz), 4.18 (s, 5H), 4.14 (t, 2H, J = 1.8 Hz). 
If a mixture of iodoferrocene and ferrocene was obtained, the yield of iodoferrocene was 
calculated as follows: 
From 
1
H NMR, FcI:Fc was found to be 5:1 (see selected spectra). 
Mtotal = MFcI + MFc 
          = nFcI x MWFcI + nFc x MWFc 
          = nFc (5 MWFcI + MWFc) 
nFc = Mtotal/(5 MWFcI + MWFc) 
Mtotal = 19.88 g 
Therefore, nFc = 0.01 moles 
Amount of Fc present = 0.01 moles x 186.04 g/mol = 1.86 g 
Amount of FcI present = 19.88 g – 1.86 g = 18.02 g. 
Yield = 67%  
(–)-(R)-Tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione (107).133 
According to literature procedures,
134
 to a solution of L-proline 106 (50.0 g, 
0.43 mol) in water (150 mL) was added potassium cyanate (43.0 g, 0.53 
mol) and the reaction mixture was heated at 70 °C for 1 h to give a clear 
solution. The reaction mixture was allowed to cool to room temperature and 6M HCl 
(150 mL) was added slowly, which resulted in the evolution of gas and formation of a 
white precipitate. The reaction mixture was then heated to reflux for 2 h, producing a 
clear, slightly yellow solution. After cooling to room temperature, the reaction mixture 
was placed in a refrigerator for 24 h. Colorless crystals formed were filtered and washed 
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with ice-cold water to give 107 (60 g, 0.43 mol, 50%) as rod-like crystals. mp 161-162 °C 
(H2O) [lit
134d
 mp 165-167 °C (H2O)]; [α]D
18
  –124 (c 1.0, MeOH); IR (neat) νmax 3171, 
3062, 2987, 2961, 2734, 1753, 1702, 1395, 1112 cm
–1
; 
1
H NMR (400 MHz, CDCl3) δ 
8.40 (bs, 1H), 4.13 (dd, 1H, J = 7.6, 1.6 Hz), 3.69 (dt, 1H, J = 15.2, 7.6 Hz), 3.21 (dq, 1H, 
J = 12.8, 4.8 Hz),  2.28-2.20 (m, 1H), 2.16-2.01 (m, 2H), 1.83-1.73 (m, 1H). 
(–)-2-Ferrocenyl-7aS-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione (185). 
 A mixture of iodoferrocene (6.70 g, 21.60 mmol), 107 (4.50 g, 32.40 
mmol) and Cu2O (2.50 g, 17.30 mmol) in DMSO (22 mL) were heated 
at 120 °C for 43 h. After cooling to room temperature, the reaction 
mixture was diluted with ether and washed with water (2 ×) and brine, dried over 
anhydrous Na2SO4 and the volatiles were removed under reduced pressure. Purification 
by flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.22) afforded 185 
(3.9 g) as an orange solid that was recrystallized from CH2Cl2/hexanes to give (3.7 g, 
0.01 mol, 53%) orange blocks; mp 112-113 °C (CH2Cl2/hexanes); [α]D
20
   –128 (c 1.1, 
CHCl3); CSP HPLC analysis (Chiralcel OD-H; eluent: 90:10 hexanes/i-PrOH, 1.0 
mL/min) determined >99:1 er, >98% ee [tR(minor) = 16.22 min, tR(major) = 19.65 min]; 
IR (KBr) νmax 3136, 3080, 2983, 2904, 1771, 1707, 1482, 1387, 1373 cm
–1
; 
1
H NMR 
(600 MHz, CDCl3) δ 4.95 (s, 1H), 4.92 (s, 1H), 4.20 (s, 5H), 4.13-4.10 (m, 3H), 3.78-3.74 
(m, 1H), 3.33-3.29 (m, 1H), 2.33-2.28 (m, 1H), 2.16-2.10 (m, 2H), 1.79-1.72 (m, 1H); 
13
C NMR (150.9 MHz, CDCl3) δ 172.2, 159.2, 89.0, 69.5, 65.4, 65.3, 62.8, 62.7, 62.5, 
45.9, 27.9, 26.8; EIMS [m/z (%)] 324 (M
+
, 64), 227 (100), 121 (19), 56 (26); HRMS (EI) 
calcd for C16H16N2O2
56
Fe: 324.0561; found 324.0563. Anal. calcd for C16H16N2O2Fe: C, 
59.28; H, 4.98. Found: C, 59.38; H, 5.13. 
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(+)-2-Ferrocenyl-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-c]imidazol-3-one 
(syn-187). 
Hydantoin 185 (2.00 g, 6.17 mmol) and Schwartz’s reagent (2.10 g, 
8.02 mmol) were suspended in THF (15 mL) and stirred at room 
temperature. After 10 min., the mixture became homogenous indicating 
consumption of starting material. At this point, solid imidazole (1.0 g, 14.2 mmol) and 
DMAP (68.0 mg, 0.56 mmol) were added, followed by TESCl (1.40 mL, 8.02 mmol), 
and the mixture was stirred at room temperature for a further 5 h. The reaction mixture 
was diluted diethyl ether (50 mL) and worked up with water (2 mL). The organic phase 
was washed with 10% CuSO4 solution (2 × 25 mL), sat. aq. NaHCO3 and water. The 
resulting precipitate was removed by filtration through a pad of Celite and the filtrate was 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.42) afforded 
crystalline orange solid, as a 10:1 mixture of reduction epimers. Recrystallization of this 
mixture from EtOH-water afforded syn-187 (2.2 g, 5.0 mmol, 80%) in two crops as a 
diastereomerically enriched crystalline orange solid. mp 97- 98 °C (EtOH/water); [α]D
20
 
 +111 (c 1.0, CHCl3); CSP HPLC analysis (Chiralcel OD-H; eluent: 97:3 hexanes/i-
PrOH, 1.0 mL/min) determined >99:1 er, >98% ee [tR(minor) = 8.73 min, tR(major) = 
14.37 min]; IR (KBr) νmax 3083, 2953, 2910, 2876, 1693, 1501, 1411, 1085, 1006 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 5.44 (d, 1H, J = 6.3 Hz), 4.80 (s, 1H), 4.29 (s, 1H), 4.18 
(s, 5H), 4.04 (s, 1H), 3.95-3.93 (m, 2H), 3.65-3.61 (m, 1H), 3.13-3.09 (m, 1H), 1.98-1.91 
(m, 3H), 1.75-1.72 (m, 1H), 0.90 (t, 9H, J = 7.8 Hz), 0.61-0.51 (m, 6H); 
13
C NMR (150.9 
MHz, CDCl3) δ 159.2, 96.3, 82.6, 69.0, 65.1, 63.6, 62.0, 61.7, 61.5, 45.8, 26.5, 25.3, 6.8, 
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5.0; EIMS [m/z (%)] 440 (M
+
, 40), 308 (66), 243 (100), 227 (39), 103 (86), 75 (68); 
HRMS (EI) calcd for C22H32N2O2Si
56
Fe: 440.1582; found 440.1587. Anal. calcd for 
C22H32N2O2SiFe: C, 59.99; H, 7.32. Found: C, 60.17; H, 7.59. 
(+)-2-[(2Rp-Trimethylsilyl)ferrocenyl]-1R-triethylsilyloxy7aS-hexahydropyrrolo[1,2-
c]imidazol-3-one) (188a) using LDA. 
A solution of LDA (0.36 mL, 1.37 M in THF, 0.50 mmol) was added 
dropwise to a solution of syn-187 (100 mg, 0.23 mmol) and TMSCl 
(0.07 mL, 0.57 mmol) in THF (3 mL) at –78 °C and the mixture was 
stirred at that temperature for 2 h. The reaction mixture was worked up by addition of 
water (0.5 mL) and warmed to room temperature and extracted with diethyl ether (2 × 10 
mL). The combined organic extract was washed with water, brine, dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.57) afforded 188a (93 mg, 0.18 
mmol, 80%), as a diastereomerically enriched orange oil; [α]D
20
 +111 (c 1.2, CHCl3); IR 
(KBr, neat) νmax 3092, 2954, 2879, 1715, 1461, 1410, 1243 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 5.39 (d, 1H, J = 6.3 Hz), 4.31-4.30, (m, 1H), 4.24 (s, 5H), 4.13 (t, 1H, J = 2.4 
Hz), 4.05-4.04 (m, 1H), 3.93-3.86 (m, 1H), 3.60-3.56 (m, 1H), 3.16-3.12 (m, 1H), 1.92-
1.84 (m, 3H), 1.73-1.69 (m, 1H), 0.83 (t, 9H, J = 7.8 Hz), 0.48 (q, 6H, J = 7.8 Hz), 0.22 
(s, 9H); 
13
C NMR (75.5 MHz, CDCl3) δ 159.2, 98.7, 84.7, 72.1, 69.4, 69.2, 67.1, 66.8, 
61.7, 46.0, 26.5, 25.3, 6.6, 4.8, 0.5; EIMS [m/z(%)] 512 (M
+
, 80), 497 (100), 482 (37), 
380 (18), 365 (38), 299 (57), 103 (48), 75 (43); HRMS (EI) calcd for C25H40N2O2Si2
56
Fe: 
512.1977; found 512.1972. 
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(+)-2-(Ferrocene-2Sp-boronic acid)-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-
c]imidazol-3-one) (188b) using LDA. 
A solution of LDA (0.36 mL, 1.37 M in THF, 0.50 mmol) was added 
dropwise to a solution of syn-187 (100 mg, 0.23 mmol) and B(Oi-Pr)3 
(0.13 mL, 0.57 mmol) in THF (3 mL) at –78 °C and the mixture was 
stirred at that temperature for 2 h. The reaction mixture was worked up by addition of 
water (0.5 mL), warmed to room temperature and extracted with diethyl ether (2 × 10 
mL). The combined organic extract was washed with water, brine, dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Gradient flash column chromatography 
(silica gel, 3:7 EtOAc/hexanes, Rf = 0.30, then 98:2 EtOAc/MeOH) afforded 188b (80 
mg, 0.16 mmol, 73%), as a diastereomerically enriched orange solid that was 
recrystallized from EtOAc/hexanes to give rod-like crystals; mp 122-124 °C 
(EtOAc/hexanes); [α]D
20
 +82 (c 1.0, CHCl3); X-Ray diffractometry was performed on an 
orange rod (0 × 0 × 0 mm
3
): C22H33FeBN2O4Si: M = 484.25 g/mol, trigonal, P32, a = 
19.() Å, b = 19.() Å, c = 13.() Å, V = 997.6(6) Å
3
, α = 90 °, β = 90 °, γ = 120 °, Z = 8, Dc 
=  g/cm
3
, F(000) = , T = 298(2) K; X data were collected. The structure was solved by 
Direct Methods (SHELXTL) and refined by full-matrix least squares on F
2
 resulting in 
final R, Rw and GOF [for X data with F > 2σ(F)] of 0.0328, 0.0646 and 1.01, 
respectively, for solution using the Sp enantiomer model [Flack parameter = 0.010(13)] 
[CCDC 845195 contains the crystallographic data for 188b]; IR (KBr) νmax 3354, 3097, 
3083, 2956, 2877, 1650, 1468, 1399, 1377, 1331 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 
6.91 (s, 2H), 5.28 (d, 1H, J = 6.6 Hz), 4.43-4.42 (m, 1H), 4.36-4.35 (m, 1H), 4.29 (s, 5H), 
4.27-4.26 (m, 1H), 4.02-3.98 (m, 1H), 3.63-3.59 (m, 1H), 3.21-3.15 (m, 1H), 2.02-1.91 
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(m, 3H), 1,75-1.69 (m, 1H). 0.77 (t, 9H, J = 8.1 Hz), 0.40-0.25 (m, 6H); 
13
C NMR (75.5 
MHz, CDCl3) δ 161.0, 97.7, 85.6, 72.0, 70.9, 70.0, 69.8, 68.0, 61.8, 46.0, 26.8, 24.7, 6.6, 
4.5; EIMS [m/z (%)] 484 (M
+
, 12), 466 (33), 86 (65), 84 (100), 57 (46), 43 (50); HRMS 
(EI) calcd for C22H33BN2O4Si
56
Fe: 484.1652; found 484.1631; Anal. calcd for 
C22H33N2O4SiFe: C, 54.57; H, 6.87. Found: C, 54.50; H, 6.87.  
(+)-2-[(+)-2-[(Rp-Tributylstannyl)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydro 
pyrrolo[1,2-c]imidazol-3-one (188c) using LiTMP. 
A solution of LiTMP (0.70 mL, 0.72 M in THF, 0.50 mmol) was 
added dropwise to a solution of syn-187 (100 mg, 0.23 mmol) and 
Bu3SnCl (0.15 mL, 0.57 mmol) in THF (3 mL) at –78 °C and the 
mixture was stirred at that temperature for 2 h. The reaction mixture was worked up by 
addition of water (0.5 mL), warmed to room temperature and extracted with diethyl ether 
(2 × 10 mL). The combined organic extract was washed with water, brine, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.62) afforded 188c (70 mg, 0.10 
mmol, 45%), as a diastereomerically enriched orange oil; [α]D
20
 +164 (c 1.3, CHCl3); IR 
(KBr, neat) νmax 3093, 2954, 2920, 2876, 1706, 1462, 1410 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 5.40 (d, 1H, J = 6.3 Hz), 4.39-4.38, (m, 1H), 4.20 (s, 5H), 4.10 (t, 1H, J = 2.4 
Hz), 3.99-3.92 (m, 2H), 3.62-3.56 (m, 1H), 3.16-3.09 (m, 1H), 2.03-1.81 (m, 3H), 1.77-
1.69 (m, 1H), 1.57-1.47 (m, 6H), 1.40-1.25 (m, 6H), 1.09-0.96 (m, 6H), 0.90 (t, 9H, J = 
7.2 Hz), 0.82 (t, 9H, J = 7.8 Hz), 0.46 (q, 6H, J = 7.8 Hz); 
13
C NMR (75.5 MHz, CDCl3) 
δ 159.2, 99.7, 83.7, 72.7, 68.9, 67.6, 66.2, 66.0, 61.7, 45.9, 29.3, 27.7, 26.8, 25.2, 13.8, 
106 
 
11.4, 6.7, 4.8; EIMS [m/z(%)] 673 (M-C4H9, 96), 635 (26), 503 (29), 243 (33), 103 (100), 
75 (80); HRMS (EI) calcd for C30H49N2O2Si
120
Sn
56
Fe: 673.1934; found 673.1944. 
(+)-2-[(2Sp-Methyl)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-c] 
imidazol-3-one (188d). 
To a solution of syn-187 (100 mg, 0.23 mmol) in THF (3 mL) at –78 °C 
was added t-BuLi (0.32 mL, 1.58 M in pentane, 0.51 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with MeI (0.04 mL, 0.57 mmol) and stirred for 
30 min. at that temperature. Workup was conducted by addition of water (0.5 mL) and, 
after warming to room temperature, the reaction mixture was extracted with diethyl ether 
(2 × 10 mL). The combined organic extract was washed with water, brine, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Gradient purification by 
flash column chromatography (silica gel, 2:8 EtOAc/hexanes, then 3:7 EtOAc/hexanes, 
Rf = 0.51) afforded 188d (94 mg, 0.21 mmol, 91%) as a diastereomerically enriched 
orange oil which solidified on standing; mp 64-65 °C; [α]D
20
 +133 (c 1.0, CHCl3); IR 
(KBr) νmax 3095, 3080, 2955, 2876, 1696, 1490, 1402, 1084, 1003 cm
–1
; 
1
H NMR (300 
MHz, CDCl3) δ 5.24 (d, 1H, J = 6.3 Hz), 4.20 (s, 5H), 4.06 (m, 1H), 4.01 (m, 1H), 3.94 
(q, 1H, J = 6.6 Hz), 3.87 (t, 1H, J = 2.7 Hz), 3.62-3.52 (m, 1H), 3.16-3.08 (m, 1H), 1.99-
1.84 (m, 3H), 1.91 (s, 3H), 1.75-1.67 (m, 1H), 0.81 (t, 9H, J = 7.8 Hz), 0.46-0.30 (m, 6H); 
13
C NMR (75.5 MHz, CDCl3) δ 159.0, 93.2, 85.2, 80.6, 69.8, 67.5, 65.2, 62.9, 61.5, 46.0, 
26.7, 25.2, 12.9, 6.6, 4.6; EIMS [m/z (%)] 454 (M
+
, 53), 322 (86), 257 (90), 241 (50), 103 
(100), 75 (78); HRMS (EI) calcd for C23H34N2O2Si
56
Fe: 454.1739; found 454.1737. 
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(+)-2-[(2Rp-Iodo)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-c] 
imidazol-3-one (188e). 
To a solution of syn-187 (100 mg, 0.23 mmol) in THF (3 mL) at –78 
°C was added t-BuLi (0.32 mL, 1.58 M in pentane, 0.51 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with a solution of ICH2CH2I (161 mg, 0.57 
mmol) in THF (3 mL) and stirred for 30 min. at that temperature. Workup was conducted 
by addition of water (0.5 mL) and, after warming to room temperature, the reaction 
mixture was extracted with diethyl ether (2 × 10 mL). The combined organic extract was 
washed with sat. aq. Na2S2O3, water, brine, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 3:7 EtOAc/hexanes, Rf = 0.44) afforded 188e (118 mg, 0.21 mmol, 91%) as a 
diastereomerically enriched orange oil; [α]D
20
 +196 (c 0.4, CHCl3); IR (KBr) νmax 3094, 
2954, 2911, 2877, 1721, 1471, 1402, 1118, 1004 cm
–1
; 
1
H NMR (600 MHz, CDCl3) δ 
5.28 (d, 1H, J = 6.6 Hz), 4.45 (m, 1H), 4.37 (s, 5H), 4.22 (m, 1H), 4.15 (t, 1H, J = 2.4 
Hz), 3.93 (q, 1H, J = 6.6 Hz), 3.73-3.69 (m, 1H), 3.19-3.15 (m, 1H), 2.04-1.99 (m, 2H), 
1.94-1.86 (m, 1H), 1.76-1.70 (m, 1H), 0.85 (t, 9H, J = 7.8 Hz), 0.45-0.38 (m, 6H); 
13
C 
NMR (150.9 MHz, CDCl3) δ 158.6, 95.3, 85.0, 73.2, 72.4, 66.3, 66.2, 61.7, 46.5, 42.2, 
26.4, 25.4, 6.8, 4.7; EIMS [m/z (%)] 566 (M
+
, 25), 434 (24), 308 (28), 243 (31), 103 
(100), 75 (86), 43 (98); HRMS (EI) calcd for C22H31N2O2SiI
56
Fe: 566.0549; found 
566.0544. 
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(+)-2-[(2Rp-Thiomethyl)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-
c]imidazol-3-one (188f). 
To a solution of syn-187 (300 mg, 0.68 mmol) in THF (7 mL) at –78 °C 
was added t-BuLi (1.06 mL, 1.41 M in pentane, 1.50 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with (MeS)2 (0.15 mL, 1.70 mmol) and stirred 
for 30 min. at that temperature. Workup was conducted by addition of water (0.5 mL) 
and, after warming to room temperature, the reaction mixture was extracted with diethyl 
ether (2 × 25 mL). The combined organic extract was washed with water, brine, dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash 
column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.30) afforded 188f (311 
mg, 0.64 mmol, 94%) as a diastereomerically enriched orange glass; [α]D
20
 +187 (c 1.3, 
CHCl3); IR (KBr, neat) νmax 3093, 2954, 2917, 2878, 1721, 1475, 1406 cm
–1
; 
1
H NMR 
(300 MHz, CDCl3) δ 5.41 (d, 1H, J = 6.6 Hz), 4.34 (m, 1H), 4.31 (s, 5H), 4.22 (m, 1H), 
4.10 (t, 1H, J = 2.4 Hz), 3.95 (q, 1H, J = 6.6 Hz), 3.69-3.65 (m, 1H), 3.20-3.14 (m, 1H), 
2.24 (s, 3H), 2.02-1.87 (m, 3H), 1.75-1.71 (m, 1H), 0.87 (t, 9H, J = 8.1 Hz), 0.54 (q, 6H, 
J = 8.1 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 158.9, 95.0, 84.8, 80.8, 70.6, 69.8, 65.6, 
64.8, 62.0, 46.1, 26.4, 25.4, 19.8, 6.7, 4.9; EIMS [m/z (%)] 486 (M
+
, 39), 354 (78), 103 
(100), 75 (77); HRMS (EI) calcd for C23H34N2O2SSi
56
Fe: 486.1459; found 486.1461. 
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(+)-2-[2Sp-(Diphenylhydroxymethyl)ferrocenyl]-1R-triethylsilyloxy-7aS 
hexahydropyrrolo[1,2-c]imidazol-3-one (188g). 
To a solution of syn-187 (300 mg, 0.68 mmol) in THF (7 mL) at –78 
°C was added t-BuLi (1.03 mL, 1.45 M in pentane, 1.50 mmol). 
After stirring for 30 min, a distinct color change from orange to 
orange-red was observed. The solution was quenched a solution of Ph2CO (311 mg, 1.70 
mmol) in THF (2.5 mL) and stirred for 30 min. at that temperature. Workup was 
conducted by addition of water (0.5 mL) and, after warming to room temperature, the 
reaction mixture was extracted with diethyl ether (2 × 25 mL). The combined organic 
extract was washed with water, brine, dried over anhydrous Na2SO4 and concentrated 
under reduced pressure. Purification by flash column chromatography (silica gel, 2:8 
EtOAc/hexanes, Rf = 0.40) afforded 188g (369 mg, 0.59 mmol, 87%) as a 
diastereomerically enriched orange solid; mp 65-66 ºC; [α]D
20
 +137 (c 0.7, CHCl3); IR 
(KBr) νmax 3247, 3087, 3058, 2957, 2878, 1682, 1469, 1410 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 8.14 (s, 1H), 7.54-7.51 (m, 2H), 7.33-7.09 (m, 8H), 5.49 (d, 1H, J = 7.2 Hz), 
4.45 (s, 5H), 4.27 (m, 1H), 3.94 (t, 1H, J = 2.7 Hz), 3.52-3.41 (m, 2H), 3.38 (m, 1H), 
2.98-2.89 (m, 1H), 1.62-1.33 (m, 3H), 1.29-1.22 (m, 1H), 0.92 (t, 9H, J = 7.8 Hz), 0.61 
(q, 6H, J = 7.8 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 160.7, 147.1, 146.1, 128.1, 127.3, 
127.2, 127.0, 126.3, 126.0, 92.0, 90.2, 81.6, 75.7, 72.0, 70.0, 65.9, 62.5, 62.2, 47.3, 24.0, 
23.9, 6.8, 4.7; EIMS [m/z (%)] 622 (M
+
, 1), 490 (57), 103 (61), 84 (100), 43 (55); HRMS 
(EI) calcd for C35H42N2O3Si
56
Fe: 622.2314; found 622.2308. Anal. calcd for 
C35H42N2O3SiFe: C, 67.51; H, 6.80. Found: C, 67.61; H, 6.81. 
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(+)-2-[(2Sp-Formyl)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-c] 
imidazol-3-one) (188h). 
To a solution of syn-187 (100 mg, 0.23 mmol) in THF (3 mL) at –78 °C 
was added t-BuLi (0.35 mL, 1.45 M in pentane, 0.51 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with DMF (0.04 mL, 0.57 mmol) and stirred 
for 30 min. at that temperature. Workup was conducted by addition of water (0.5 mL) 
and, after warming to room temperature, the reaction mixture was extracted with diethyl 
ether (2 × 10 mL). The combined organic extract was washed with water, brine, dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash 
column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.27) afforded the major 
diastereomer, Sp-188h (74 mg, 0.16 mmol, 70%), just after the minor diastereomer, Rp-
188h (4 mg, 0.01 mmol, 4%); Data for Sp-188h, a red-orange oil, are as follows: [α]D
20
 
+720 (c 0.2, CHCl3); IR (KBr, neat) νmax 3097, 2956, 2913, 2878, 1710, 1671, 1472, 
1442, 1401 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 10.09 (s, 1H), 5.26 (d, 1H, J = 6.3 Hz), 
4.80-4.79 (m, 1H), 4.53-4.52 (m, 1H), 4.46-4.44 (m, 1H), 4.38 (s, 5H), 3.94 (q, 1H, 6.6 
Hz), 3.63-3.55 (m, 1H), 3.18-3.10 (m, 1H), 1.99-1.86 (m, 3H), 1.75-1.71 (m, 1H), 0.77 (t, 
9H, J = 7.8 Hz), 0.45-0.28 (m, 6H); 
13
C NMR (75.5 MHz, CDCl3) δ 195.6, 159.1, 96.2, 
84.7, 73.9, 71.2, 70.3, 68.6, 65.0, 61.7, 45.9, 26.4, 25.0, 6.6, 4.5; EIMS [m/z (%)] 468 
(M
+
, 14), 336 (31), 243 (40), 103 (97), 75 (100), 57 (65), 43 (81); HRMS (EI) calcd for 
C23H32N2O3Si
56
Fe: 468.1531; found 468.1533. 
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(+)-2-[(2Rp-Trimethylsilyl)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydropyrrolo 
[1,2-c]imidazol-3-one) (188a) using t-BuLi. 
To a solution of syn-187 (100 mg, 0.23 mmol) in THF (3 mL) at –78 °C 
was added t-BuLi (0.32 mL, 1.58 M in pentane, 0.51 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with TMSCl (0.07 mL, 0.57 mmol) and stirred 
for 30 min. at that temperature. Workup was conducted by addition of water (0.5 mL) 
and, after warming to room temperature, the reaction mixture was extracted with diethyl 
ether (2 × 10 mL). The combined organic extract was washed with water, brine, dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash 
column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.57) afforded 188a (98 mg, 
0.19 mmol, 84%) as a diastereomerically enriched orange oil; [α]D
20
 +109 (c 1.7, CHCl3). 
All spectroscopic data matched LDA-derived 188a above. 
(+)-2-(Ferrocene-2Spboronicacid)-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-
c]imidazol-3-one) (188b) using t-BuLi. 
To a solution of syn-187 (100 mg, 0.23 mmol) in THF (3 mL) at –78 
°C was added t-BuLi (0.42 mL, 1.20 M in pentane, 0.51 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with B(OEt)3 (0.01 mL, 0.57 mmol) and stirred 
for 30 min. at that temperature. Workup was conducted by addition of water (0.5 mL) 
and, after warming to room temperature, the reaction mixture was extracted with diethyl 
ether (2 × 10 mL). The combined organic extract was washed with water, brine, dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash 
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column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.30, then 98:2 
EtOAc/MeOH) afforded 188b (89 mg, 0.18 mmol, 80%), as a diastereomerically 
enriched orange solid that was recrystallized from EtOAc/hexanes to give rod like 
crystals; mp 122-124 °C (EtOAc/hexanes); [α]D
20
 +80 (c 1.0, CHCl3). All spectroscopic 
data and mp matched LDA-derived 188b above. 
(+)-2-[(Rp-Tributylstannyl)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydropyrrolo 
[1,2-c]imidazol-3-one (188c) using t-BuLi. 
To a solution of syn-187 (80.0 mg, 0.18 mmol) in THF (2 mL) at –78 
°C was added t-BuLi (0.31 mL, 1.30 M in pentane, 0.40 mmol). After 
stirring for 30 min, a distinct colour change from orange to orange-
red was observed. The solution was quenched with Bu3SnCl (0.12 mL, 0.45 mmol) and 
stirred for 30 min. at that temperature. Workup was conducted by addition of water (0.5 
mL) and, after warming to room temperature, the reaction mixture was extracted with 
diethyl ether (2 × 10 mL). The combined organic extract was washed with water, brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.62) afforded 188c 
(116 mg, 0.17 mmol, 87%) as a diastereomerically enriched orange oil; [α]D
20
 +170 (c 
0.8, CHCl3); All spectroscopic data matched LiTMP-derived 188c above. 
Transmetalation of stannane 188c to make methyl adduct 188d. 
A solution of 188c (60.0 mg, 0.08 mmol) in THF (2 mL) was cooled to –78 °C, treated 
with n-BuLi (0.04 mL, 2.39 M in hexanes, 0.089 mmol) and stirred for 30 min. The 
solution was quenched with MeI (7.0 μL, 0.12 mmol) and stirred for another 30 min. at 
that temperature. Workup was conducted by addition of water (1 mL) and, after warming 
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to room temperature, the reaction mixture was extracted with Et2O (3 × 10 mL). The 
combined organic phase was washed with brine, dried over anhydrous Na2SO4, filtered 
and concentrated under reduced pressure. Flash column chromatography (silica gel, 3:7 
EtOAc/hexanes, Rf = 0.51) afforded 188d (31 mg, 0.07 mmol, 86%) as a 
diastereomerically enriched orange oil which solidifies on standing; mp 64-65 °C; [α]D
20
 
+135 (c 0.8, CHCl3). Spectroscopic data matched that reported for t-BuLi derived 188d 
above. 
Transmetalation of stannane 188c to make boronic acid 188b. 
A solution of 188c (38.0 mg, 0.05 mmol) in THF (1 mL) was cooled to –78 °C, treated 
with n-BuLi (0.02 mL, 2.39 M in hexanes, 0.06 mmol) and stirred for 30 min. The 
solution was quenched with B(OEt)3 (13.0 μL, 0.08 mmol) and stirred for another 30 min. 
at that temperature. Workup was conducted by addition of water (5 mL) and, after 
warming to room temperature, the reaction mixture was extracted with Et2O (3 × 10 mL). 
The combined organic phase was washed with brine, dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure. The crude product was purified by 
column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.30) to give 188b (23 mg, 
0.05 mmol, 92%) as a diastereomerically enriched orange solid that was recrystallized 
from EtOAc/hexanes to give rod like crystals; mp 124-126 °C; [α]D
20
 +79 (c 1.13, 
CHCl3). Spectroscopic data and mp matched that reported for LDA or t-BuLi derived 
188b above. 
Ferrocenyl-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one (192a). 
A solution of syn-187 (140 mg, 0.43 mmol) and p-toluenesulfonic acid monohydrate (326 
mg, 1.72 mmol) in CHCl3 (5 mL) was heated to reflux for 30 min.. The solution was 
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cooled to room temperature, diluted with chloroform (20 mL) and 
was washed sequentially with sat. aq. NaHCO3, H2O, brine, dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, EtOAc, Rf = 0.20) afforded 192a 
(124 mg, 0.40 mmol, 94%) as orange solid; mp 193-194 ºC; IR (KBr) νmax 3095, 2991, 
2961, 2922, 1678, 1638, 1507, 1413 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 6.13 (s, 1H), 
4.68 (t, 2H, J = 1.5 Hz), 4.18 (s, 5H), 4.05 (t, 2H, J = 1.5 Hz), 3.71 (t, 2H, J = 6.9 Hz), 
2.73 (t, 2H, J = 6.6 Hz), 2.46-2.39 (m, 2H, J = 7.2 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 
149.1, 127.0, 101.7, 95.1, 69.1, 64.9, 61.0, 42.2, 27.9, 22.8; EIMS [m/z (%)] 308 (M
+
, 
100), 243 (53), 73 (21); HRMS (EI) calcd for C16H16N2O
56
Fe: 308.0612; found 308.0579. 
(–)-2-[(2Sp-Methyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one 
(192b). 
A solution of 188d (100 mg, 0.22 mmol) and p-toluenesulfonic acid 
monohydrate (168 mg, 0.88 mmol) in CHCl3 (2 mL) was heated to 
reflux for 30 min.. The solution was cooled to room temperature, diluted 
with chloroform (10 mL) and was washed sequentially with sat. aq. NaHCO3, H2O, brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
flash column chromatography (silica gel, EtOAc, Rf = 0.32) afforded 192b (65 mg, 0.20 
mmol, 91%) as orange solid; mp 137-138 ºC; [α]D
20
 –29 (c 1.0, CHCl3); CSP HPLC 
analysis (Chiralcel OD-H; eluent: 50:50 hexanes/i-PrOH, 1.0 mL/min) determined 100:1 
er, 98% ee [tR(minor) = 6.21 min, tR(major) = 8.35 min]; IR (KBr) νmax 3123, 3087, 2961, 
2921, 1682, 1637, 1493, 1410 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 6.31 (s, 1H), 4.33 (m, 
1H), 4.16 (s, 5H), 4.06 (m, 1H), 3.98 (t, 1H, J = 2.4 Hz), 3.70 (t, 2H, J = 6.9 Hz), 2.74 (t, 
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2H, J =  6.9 Hz), 2.40 (quin, 2H, J = 6.9 Hz), 2.04 (s, 3H); 
13
C NMR (75.5 MHz, CDCl3) 
δ 150.0, 125.8, 104.9, 93.8, 79.8, 69.6, 67.3, 64.3, 63.8, 42.2, 27.9, 22.8, 13.3; EIMS [m/z 
(%)] 322 (M
+
, 100), 257 (89), 84 (50); HRMS (EI) calcd for C17H18N2O
56
Fe: 322.0768; 
found 322.0760. 
(–)-2-[2Rp-(Iodo)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one (192c). 
A solution of 188e (98.0 mg, 0.17 mmol) and p-toluene sulfonic acid 
monohydrate (131 mg, 0.69 mmol) in CHCl3 (5 mL), heated to reflux 
for 30 min.. The solution was cooled to room temperature, diluted 
with chloroform (10 mL) and was washed sequentially with sat. aq. NaHCO3, water, 
brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, EtOAc, Rf = 0.23) afforded 192c 
(67 mg, 0.15 mmol, 90%) as orange glass; [α]D
20
 –59 (c 0.8, CHCl3); IR (KBr, neat) νmax 
3153, 3093, 2958, 2927, 1690, 1638, 1487, 1409 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 
6.55 (s, 1H), 4.78 (m, 1H), 4.40 (m, 1H), 4.25 (s, 5H), 4.24 (m, 1H), 3.72 (t, 2H, J = 6.9 
Hz), 2.78 (t, 2H, J = 6.9 Hz), 2.42 (quin, 2H, J = 6.9 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 
150.1, 125.7, 104.8, 95.2, 72.6, 72.0, 67.1, 66.4, 42.3, 37.1, 27.9, 22.8; EIMS [m/z (%)] 
434 (M
+
, 57), 308 (39), 243 (40), 84 (100); HRMS (EI) calcd for C16H15N2OI
56
Fe: 
433.9578; found 433.9571. 
 
(–)-2-[2Rp-(Thiomethyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one 
(192d). 
A solution of 188f (237 mg, 0.49 mmol) and p-toluenesulfonic acid monohydrate (371 
mg, 1.95 mmol) in CHCl3 (5 mL), heated to reflux for 30 min.. The solution was cooled 
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to room temperature, diluted with chloroform (10 mL), and was 
washed sequentially with sat. aq. NaHCO3, H2O, brine, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, EtOAc, Rf = 0.20) afforded 
188d (163 mg, 0.46 mmol, 93%) as orange glass; [α]D
20
 –98 (c 1.4, CHCl3); IR (KBr, 
neat) νmax 3152, 3092, 2976, 2918, 1682, 1636, 1486, 1408 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 6.76 (s, 1H), 4.91 (m, 1H), 4.27 (m, 1H), 4.24 (s, 5H), 4.19 (t, 1H, J = 2.7 Hz), 
3.72 (t, 2H, J = 7.2 Hz), 2.78 (t, 2H, J = 7.2 Hz), 2.43 (quin, 2H, J = 7.2 Hz), 2.16 (s, 
3H); 
13
C NMR (75.5 MHz, CDCl3) δ 150.2, 125.7, 104.7, 95.6, 74.9, 70.5, 70.4, 67.4, 
65.6, 42.3, 27.9, 22.9, 20.5; EIMS [m/z (%)] 354 (M
+
, 100), 339 (17), 289 (18), 274 (29); 
HRMS (EI) calcd for C17H18N2OS
56
Fe: 354.0489; found 354.0492. 
 (–)-2S-Hydroxymethylpyrrolidine-1-carbox-(ferrocenyl)-amide (191a). 
A mixture of syn-187 (100 mg, 0.23 mmol) and K2CO3 (190 mg, 1.38 
mmol) in MeOH (4 mL) was heated to reflux for 30 min.. After cooling 
to room temperature, the mixture was passed through Celite, rinsed well 
with CH2Cl2 and concentrated under reduced pressure. The crude hemiaminal was 
redissolved in abs. EtOH (5 mL), treated with NaBH4 (52.0 mg, 1.38 mmol) and heated 
to reflux for another 30 min.. After cooling to 0 °C, workup was performed by careful 
addition of sat. aq. NH4Cl (2 mL). The excess EtOH was evaporated under reduced 
pressure and the mixture was extracted with CH2Cl2 (2 × 20 mL), washed with H2O, 
brine, dried over anhydrous Na2SO4 and was concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 96:4 EtOAc/Et3N, Rf = 0.20) 
afforded 191a (70 mg, 0.18 mmol, 93%) as orange solid; mp 208-210 °C 
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(EtOAc/hexanes); [α]D
18
 –3 (c 1.0, CHCl3); IR (KBr) νmax 3364, 3299, 3093, 2953, 2925, 
2872, 1716, 1641, 1552, 1492, 1457 cm
–1
; 
1
H NMR (300 MHz, CDCl3, rotameric) δ 5.04 
(b, 1H), 4.51 (b, 1H), 4.43 (b, 1H), 4.13 (s, 5H), 3.94 (m, 3 H),  3.63-3.60 (m, 1H), 3.54-
3.47 (m, 2H), 3.31-3.30 (m, 1H), 2.03-1.93 (m, 1H), 1.86-1.80 (m, 2H), 1.58-1.52 (m, 
1H); 
13
C NMR (75.5 MHz, CDCl3, rotameric) δ 157.1, 98.2, 69.3, 67.4, 64.6, 64.5, 61.5, 
60.2, 53.5, 47.1, 47.0, 28.7, 23.9; EIMS [m/z (%)] 400 (M
+
, 12), 300 (23), 299 (100), 121 
(23), 70 (47); HRMS (EI) calcd for C19H28N2O2Si
56
Fe: 400.1269; found 400.1263. 
(–)-2S-Hydroxymethylpyrrolidine-1-carbox-[2Sp-(methyl)ferrocenyl]-amide (191b). 
A mixture of 188d (200 mg, 0.44 mmol) and K2CO3 (365 mg, 2.64 
mmol) in MeOH (5 mL) was heated to reflux for 30 min.. After cooling 
to room temperature, the mixture was passed through Celite, rinsed well 
with CH2Cl2 and concentrated under reduced pressure. The crude hemiaminal was 
redissolved in abs. EtOH (5 mL), treated with NaBH4 (100 mg, 2.64 mmol), and heated 
to reflux for another 30 min.. After cooling to 0 °C, workup was performed by careful 
addition of sat. aq. NH4Cl (5 mL). The excess EtOH was evaporated under reduced 
pressure and the mixture was extracted with CH2Cl2 (2 × 20 mL), washed with H2O, 
brine, dried over anhydrous Na2SO4 and was concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 96:4 EtOAc/Et3N, Rf = 0.33) 
afforded 191b (137 mg, 0.40 mmol, 91%) as an orange solid; mp 139-140 °C; [α]D
20
 –
181 (c 1.59, CHCl3); IR (KBr) νmax 3340, 3094, 3008, 2974, 2931, 2875, 1638, 1537, 
1455 cm
–1
; 
1
H NMR (600 MHz, CD3OD) δ 4.38 (s, 1H), 4.08 (s, 5H), 4.02-3.98 (m, 1H), 
3.97 (s, 1H), 3.88 (s, 1H), 3.72 (dd, 1H, J = 10.8, 1.5 Hz), 3.67-3.59 (m, 2H), 3.39-3.34 
(m, 1H), 2.16-2.09 (m, 1H), 1.99 (s, 3H), 1.93-1.85 (m, 2H), 1.78-1.74 (m, 1H); 
13
C 
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NMR (150.9 MHz, CD3OD) δ 158.8, 93.5, 78.2, 69.2, 66.0, 65.8, 64.7, 62.5, 60.2, 46.9, 
28.6, 23.3, 11.4; EIMS [m/z(%)] 342 (M
+
, 11), 241 (100); HRMS (EI) calcd for 
C17H22N2O2
56
Fe: 342.1030; found 342.1030. 
(–)-2S-Hydroxymethylpyrrolidine-1-carbox-[2Rp-(thiomethyl)ferrocenyl]-amide 
(191c). 
A mixture of 188f (232 mg, 0.48 mmol) and K2CO3 (396 mg, 2.86 
mmol) in MeOH (6 mL) was heated to reflux for 30 min.. After cooling 
to room temperature, the mixture was passed through Celite, rinsed well 
with CH2Cl2 and concentrated under reduced pressure. The crude hemiaminal was 
redissolved in abs. EtOH (6 mL), treated with NaBH4 (108 mg, 2.86 mmol), and heated 
to reflux for another 30 min.. After cooling to 0 °C, workup was performed by careful 
addition of sat. aq. NH4Cl (5 mL). The excess EtOH was evaporated under reduced 
pressure and the mixture was extracted with CH2Cl2 (2 × 20 mL), washed with H2O, 
brine, dried over anhydrous Na2SO4 and was concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 96:4 EtOAc/Et3N, Rf = 0.33) 
afforded 191c (164 mg, 0.44 mmol, 92%) as an orange glass; [α]D
20
 –344 (c 1.4, CHCl3); 
IR (KBr) νmax 3351, 3092, 3008, 2954, 2920, 2873, 1628, 1542, 1492, 1429 cm
–1
; 
1
H 
NMR (300 MHz, CDCl3, rotameric) δ 5.12 (b, 0.5 H), 5.07 (b, 0.5H), 4.18 (b, 2H), 4.11 
(s, 5H), 4.05 (t, 1H, J = 2.4 Hz), 3.71-3.44 (m, 5H), 2.15 (s, 1.5H), 2.14 (s, 1.5H), 2.09-
1.94 (m, 3H), 1.68-1.64 (m, 1H); 
13
C NMR (75.5 MHz, CDCl3, rotameric) δ 156.5, 156.2, 
98.8, 71.0, 70.2, 68.7, 67.5, 64.5, 62.0, 60.6, 47.0, 28.6, 28.5, 24.21, 24.17, 20.85, 20.79; 
EIMS [m/z(%)] 374 (M
+
, 7), 273 (95), 230 (35), 84 (100), 70 (37); HRMS (EI) calcd for 
C17H22N2O2S
56
Fe: 374.0751; found 374.0749. 
119 
 
 
(–)-2S-Hydroxymethylpyrrolidine-1-carbox-[2Rp-(trimethylsilyl)ferrocenyl]-amide 
(191d). 
A mixture of 188a (237 mg, 0.46 mmol) and K2CO3 (384 mg, 2.77 
mmol) in MeOH (5 mL), heated to reflux for 30 min.. After cooling to 
room temperature, the mixture was passed through Celite, rinsed well 
with CH2Cl2 and concentrated under reduced pressure. The crude hemiaminal was 
redissolved in abs. EtOH (5 mL), treated with NaBH4 (105 mg, 2.77 mmol) and heated to 
reflux for another 30 min.. After cooling to 0 °C, workup was performed by careful 
addition of sat. aq. NH4Cl (5 mL). The excess EtOH was evaporated under reduced 
pressure and the mixture was extracted with CH2Cl2 (2 × 20 mL), washed with H2O, 
brine, dried over anhydrous Na2SO4 and was concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 96:4 EtOAc/Et3N, Rf = 0.57) 
afforded 191d (164 mg, 0.41 mmol, 89%) as orange solid; mp 208-210 °C 
(EtOAc/hexanes); [α]D
20
 –214 (c 1.4, CHCl3); IR (KBr) νmax 3406, 3333, 3091, 2919, 
2852, 1716, 1602, 1484, 1435 cm
–1
; 
1
H NMR (300 MHz, CDCl3, rotameric) δ 6.17 (b, 
1H), 5.06 (b, 1H), 4.86 (m, 0.5 H), 4.79 (m, 0.5H) 4.18-4.16 (m, 1H), 4.12 (s, 5H), 4.09-
4.04 (m, 1H), 3.89-3.85 (m, 1H), 3.62-3.52 (m, 2H), 3.53-3.37 (m, 2H), 2.05-1.85 (m, 
3H), 1.64-1.53 (m, 1H), 0.29 (s, 9H); 
13
C NMR (75.5 MHz, CDCl3, rotameric) δ 157.5, 
157.3, 99.5, 98.9, 70.4, 70.0, 68.1, 67.8, 67.7, 67.5, 66.9, 65.9, 65.1, 60.5, 47.0, 46.9, 
28.6, 28.5, 24.2, 24.1, 0.06, 0.01; EIMS [m/z (%)] 400 (M
+
, 12), 300 (23), 299 (100), 121 
(23), 70 (47); HRMS (EI) calcd for C19H28N2O2Si
56
Fe: 400.1269; found 400.1263. 
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 Aminoferrocene (CAS #1273-82-1) (189a).
25
 
A solution of 191a (20.0 mg, 0.06 mmol) and aq. 6M KOH (0.5 mL) in 1,4-
dioxane (0.5 mL) was heated at reflux for 22 h. After cooling to room 
temperature, 1,4-dioxane was removed under reduced pressure, and the aqueous phase 
was diluted with brine, extracted with dichloromethane (2 × 2 mL). The combined 
organic extract was dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure. Purification by flash column chromatography (silica gel, 50:45:5 
EtOAc/hexanes/Et3N, Rf = 0.43) afforded 189a (7 mg, 0.03 mmol, 58%) as orange glass; 
IR (KBr) νmax 3389, 3323, 3207, 3277, 2923, 1612, 1496, 1405 cm
–1
; 
1
H NMR (300 
MHz, CDCl3) δ 4.10 (s, 5H), 3.99 (s, 2H), 3.84 (s, 2H), 2.59 (b, 2H). All other 
spectroscopic data were found to be in agreement with published data.
25
 
(–)-2Sp-Methyl-1-aminoferrocene (189b). 
A solution of 191b (20.0 mg, 0.06 mmol) and 50% (w/w) aq. NaOH (0.2 
mL) in MeOH (0.6 mL) was heated at reflux for 20 h. After cooling to 
room temperature, the methanol was removed under reduced pressure, and the aqueous 
phase was diluted with brine, extracted with dichloromethane (2 × 2 mL). The combined 
organic extract was dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure. Purification by flash column chromatography (silica gel, 50:45:5 
EtOAc/hexanes/Et3N, Rf = 0.43) afforded sequentially 189b as orange solid (8 mg, 0.04 
mmol, 67%), and recovered 191b (4 mg, 0.01 mmol, 20%); [α]D
20
 –39 (c 0.2, abs. EtOH) 
[lit.
120
 [α]D
20
 +41 (c 0.2, abs. EtOH) for Rp-enantiomer]; IR (KBr) νmax 3406, 3333, 3091, 
2919, 2852, 1716, 1601, 1484 cm
–1
; 
1
H NMR (600 MHz, C6D6) δ 3.90 (s, 5H), 3.75-3.72 
(m, 2H), 3.66 (s, 1H), 1.86 (b, 2H), 1.71 (s, 3H); 
13
C NMR (150.9 MHz, C6D6) δ 105.1, 
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71.8, 69.8, 65.5, 60.8, 58.0, 30.2, 12.3; EIMS [m/z (%)] 215 (M
+
, 100), 149 (11), 93 (20), 
56 (12); HRMS (EI) calcd for C11H13N
56
Fe: 215.0397; found 215.0399. 
(–)-2Rp-Thiomethyl-1-aminoferrocene (189c). 
A solution of 191c (48.0 mg, 0.13 mmol) and 50% (w/w) aq. NaOH (0.5 
mL) in MeOH (1.5 mL) was heated at reflux for 20 h. After cooling to 
room temperature, the methanol was removed under reduced pressure, and 
the aqueous layer was diluted with brine, extracted with dichloromethane (2 × 2 mL), 
dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 50:45:5 EtOAc/hexanes/Et3N, Rf 
= 0.50) afforded sequentially 189c (10 mg, 0.04 mmol, 31%) as an orange glass, and 
recovered 191c (25 mg, 0.07 mmol, 52%); [α]D
20
 –83 (c 0.5, abs. EtOH); IR (KBr, neat) 
νmax 3390, 3292, 3196, 2905, 2855, 1618, 1495, 1475 cm
–1
; 
1
H NMR (600 MHz, C6D6) δ 
4.08 (s, 1H), 3.98 (m, 5H), 3.74-3.70 (m, 2H), 2.46 (b, 2H), 1.94 (s, 3H); 
13
C NMR 
(150.9 MHz, C6D6 from HSQC & HMBC spectra) δ 109.3, 71.2, 70.3, 68.4, 62.9, 56.9, 
19.7; EIMS [m/z(%)] 247 (M
+
, 100), 232 (31), 166 (62), 56 (12); HRMS (EI) calcd for 
C11H13SN
56
Fe: 247.0118; found 247.0120. 
(–)-2Rp-Trimethylsilyl-1-aminoferrocene (189d). 
A solution of 191d (20.0 mg, 0.05 mmol) and aq. 6M KOH (0.5 mL) in 
1,4-dioxane (0.5 mL) was heated at reflux for 22 h. After cooling to room 
temperature, dioxane was removed under reduced pressure, and the aqueous phase was 
diluted with brine, extracted with dichloromethane (2 × 2 mL). The combined organic 
extract was dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. Purification by flash column chromatography (silica gel, 50:45:5 
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EtOAc/hexanes/Et3N, Rf = 0.65) afforded sequentially 189d (9 mg, 0.03 mmol, 65%) and 
an orange glass and recovered 191d (3 mg, 0.01 mmol, 15%). [α]D
20
 –44 (c 0.2, abs. 
EtOH); IR (KBr) νmax 3423, 3350, 3216, 3093, 2953, 2895, 1613, 1463, 1431 cm
–1
; 
1
H 
NMR (300 MHz, CDCl3) δ 4.14 (s, 1H), 4.07 (s, 5H), 4.00 (s, 1H), 3.77 (s, 1H), 2.60 (b, 
2H), 0.32 (s, 9H); 
13
C NMR (75.5 MHz, CDCl3) δ 110.4, 69.0, 68.9, 65.6, 61.5, 59.7, 
0.01; EIMS [m/z (%)] 273 (M
+
, 100); HRMS (EI) calcd for C13H19NSi
56
Fe: 273.0636; 
found 273.0639. 
N-Methyl aminoferrocene (189e). 
To a solution of 191a (108 mg, 0.33 mmol) in THF (5 mL) was added 
LiAlH4 (62.0 mg, 1.64 mmol) at 0 °C and was then heated to reflux for 
16 h. After cooling to 0 °C, work up was carried out using Fieser’s method and the 
volatiles were concentrated and purified using flash column chromatography (silica gel, 
50:46:4 EtOAc/hexanes/Et3N, Rf = 0.50) afforded 189e (36 mg, 0.17 mmol, 51%) as an 
orange solid; mp 51-52 °C; IR (neat) νmax 3364, 3348, 3326, 3086, 2920, 2804, 1503, 
1443 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 4.16 (s, 5H), 3.89 (s, 4H), 2.73 (s, 3H), 2.31 (b, 
1H); 
13
C NMR (75.5 MHz, CDCl3) δ 112.1, 67.8, 63.0,55.4, 33.8; EIMS [m/z(%)] 215 
(M
+
, 100), 200 (24), 121 (37), 93 (17), 66 (11); HRMS (EI) calcd for C11H13N
56
Fe: 
215.0392; found 215.1391. 
(–)-2S-Hydroxymethylpyrrolidine-1-carbox-[2Rp-(iodo)ferrocenyl]-amide (191e). 
A mixture of 188g (233 mg, 0.38 mmol) and K2CO3 (311 mg, 2.25 
mmol) in MeOH (5 mL) was heated to reflux for 30 min.. After 
cooling to room temperature, the mixture was passed through Celite, 
rinsed well with CH2Cl2 and concentrated under reduced pressure. The crude hemiaminal 
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was redissolved in abs. EtOH (5 mL), treated with NaBH4 (85.0 mg, 2.25 mmol), and 
heated to reflux for another 30 min.. After cooling to 0 °C, workup was performed by 
careful addition of sat. aq. NH4Cl (2 mL). The excess EtOH was evaporated under 
reduced pressure and the mixture was extracted with CH2Cl2 (2 × 20 mL), washed with 
H2O, brine, dried over anhydrous Na2SO4 and was concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 50:46:4 EtOAc/hexanes/Et3N, Rf 
= 0.18) afforded 191e (175 mg, 0.34 mmol, 92%) as orange glass; [α]D
20
 –255 (c 1.1, 
CHCl3); IR (KBr) νmax 3317, 3084, 2951, 2926, 2872, 1632, 1547, 1491, 1393 cm
–1
; 
1
H 
NMR (300 MHz, CD3OD, rotameric) δ 7.49-7.46 (d, 2H, J = 7.2 Hz), 7.37-7.28 (m, 3H), 
7.23-7.19 (m, 3H), 7.13-7.10 (m, 2H), 5.09 (s, 1H), 4.16 (s, 5H), 4.00 (s, 1H), 3.77-3.53 
(m, 1H), 3.52-3.48 (m, 1H), 3.40-3.30 (m, 2H), 3.26-3.22 (m, 1H), 3.10-3.09 (m, 1H), 
1.91-1.79 (m, 4H); 
13
C NMR (75.5 MHz, CD3OD, rotameric) δ 157.3, 148.0, 147.6, 
128.7, 128.7, 128.5, 128.2, 128.1, 87.1, 80.3, 70.8, 67.3, 67.2, 64.9, 64.7, 64.4, 63.9, 63.8, 
60.2, 47.5, 28.9, 28.7, 24.5, 24.4; EIMS [m/z (%)] 510 (M
+
, 1.2), 393 (19), 367 (17), 365 
(28), 363 (32); HRMS (EI) calcd for C29H30N2O3Fe: 510.1605; found 510.1599. 
 (+)-2Rp-4,4-Diphenyl-ferrocenyl[1,3]oxazin-2-one (193). 
 A solution of 190e (66.0 mg, 0.03 mmol) and aq. 50% w/w NaOH (1.0 mL) 
in MeOH (0.5 mL) was heated at reflux for 6 h. After cooling to room 
temperature, 1,4-dioxane was removed under reduced pressure, and the 
aqueous phase was diluted with brine, extracted with dichloromethane (2 × 2 mL). The 
combined organic extract was dried over anhydrous Na2SO4, filtered and concentrated 
under reduced pressure. Purification by flash column chromatography (silica gel, 50:45:5 
EtOAc/hexanes/Et3N, Rf = 0.40) afforded 193 (17 mg, 0.04 mmol, 32%) as an orange 
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glassy solid; [α]D
20
 +584 (c 0.4, CHCl3); IR (CHCl3) νmax 3437, 3065, 3032, 3011, 2960, 
2933, 1709, 1625, 1494 cm
–1
; 
1
H NMR (600 MHz, C6D6) δ 8.33-8.30 (bs, 1H), 7.60 (d, 
2H, J = 7.2 Hz), 7.29 (d, 2H, J = 6.6 Hz), 7.16-7.12 (m, 2H), 7.05 (t, 1H, J = 7.8 Hz), 
6.91 (m, 3H), 4.04 (m, 1H), 3.97 (s, 5H), 3.75-3.74 (m, 1H), 3.65 (t, 1H, J = 7.8 Hz); 
13
C 
NMR (75.5 MHz, CDCl3) δ 153.0, 142.8, 142.4, 128.4, 128.1, 127.9, 127.4, 127.3, 125.4, 
94.2, 87.3, 77.4, 70.0, 63.3, 62.4, 56.2; EIMS [m/z (%)] 409 (M
+
, 8), 245 (29), 244 (100), 
120 (18), 83 (86); HRMS (EI) calcd for C24H19NO2
56
Fe: 409.0765; found 409.0760. 
(–)-2-Ferrocenyl-1S-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-c]imidazol-3-one 
(anti-187). 
Hydantoin 185
 (3.00 g, 9.25 mmol) and Schwartz’s reagent (3.10 g, 
12.03 mmol) were suspended in THF (70 mL) and stirred at room 
temperature. After 10 min., TLC (3:7 EtOAc/hexanes, Rf = 0.06) 
indicated consumption of starting material. The reaction mixture was worked up with 
saturated aqueous NaHCO3 solution followed by water (10 mL). The reaction mixture 
was filtered through Celite using copious CH2Cl2 and concentrated under reduced 
pressure to afford a mixture of hemiaminals (3.02 g) that should be protected within 2 h. 
A solution of the hemiaminals (186, 3.02 g) in THF (70 mL) was cooled to 0 °C and 
treated with n-BuLi (4.01 mL, 2.31 M in hexanes, 9.27 mmol). A distinct color change 
from orange to red-orange was observed. After 3 min., TESCl (2.02 mL, 12.05 mmol) 
was added drop-wise and the mixture was stirred for an additional 5 min., wherein a 
distinct color change from red-orange to orange was observed. After 10 min., the reaction 
mixture was removed from the ice bath, allowed to warm to room temperature before 
being diluted with diethyl ether (20 mL), and worked up with water (5 mL). After 
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extraction of the reaction mixture with diethyl ether (3 × 10 mL), the combined organic 
extract was dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure to give 187 (3.2 g, 7.3 mmol, 92%) as a 0.95:1 mixture of anti/syn epimers. 
Purification by flash column chromatography (silica gel, 1:9 EtOAc/hexanes, Rf (syn) = 
0.16, Rf (anti) = 0.20) separated anti-187 and syn-187. Recrystallization of the 
chromatographed anti epimer from EtOH-water afforded anti-187 (1.5 g, 3.4 mmol, 42%) 
in two crops as a diastereomerically enriched crystalline orange solid. Recrystallization of 
the chromatographed syn epimer from EtOH-water afforded syn-187 (1.6 g, 3.6 mmol, 
44%) as a diastereomerically enriched crystalline orange solid for an overall yield of 86% 
(3 g). The following data were obtained for anti-187: mp 80-81 °C (EtOH/water); [α]D
20
 
–67 (c 1.0, CHCl3); CSP HPLC analysis (Chiralcel OD-H; eluent: 97:3 hexanes/i-PrOH, 
1.0 mL/min) determined >99:1 er, >98% ee [tR(major) = 7.94 min, tR(minor) = 14.92 
min]; IR (KBr) νmax 3091, 3081, 2954, 2897, 2873, 1693, 1504, 1417, 1092 cm
–1
; 
1
H 
NMR (300 MHz, CDCl3) δ 5.39 (s, 1H), 4.95 (s, 1H), 4.43 (s, 1H), 4.17 (s, 5H), 4.02 (s, 
1H), 3.96 (s, 1H), 3.79-3.70 (m, 1H), 3.44-3.39 (m, 1H), 3.15-3.07 (m, 1H), 2.10-1.84 
(m, 3H), 1.31-1.22 (m, 1H), 1.00 (t, 9H, J = 7.8 Hz), 0.69 (q, 6H, J = 7.8 Hz); 
13
C NMR 
(150.9 MHz, CDCl3) δ 160.6, 96.7, 84.5, 68.8, 66.8, 64.4, 63.9, 61.2, 59.1, 45.5, 28.6, 
24.8, 6.8, 5.2; EIMS [m/z (%)] 440 (M
+
, 18), 308 (57), 243 (90), 103 (100), 75 (81), 47 
(20); HRMS (EI) calcd for C22H32N2O2Si
56
Fe: 440.1582; found 440.1575; Anal. calcd for 
C22H32N2O2SiFe: C, 59.99; H, 7.32. Found: C, 60.17; H, 7.21. 
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(–)-2-[(2Rp-Methyl)ferrocenyl]-1S-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-
c]imidazol-3-one (190a). 
A solution of anti-187 (100 mg, 0.22 mmol) in THF (2 mL) at –78 °C 
was exposed to t-BuLi (0.49 mL, 1.01 M in pentane, 0.50 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with MeI (0.03 mL, 0.57 mmol) and stirred for 
10 min. at that temperature. Workup was conducted by addition of water (0.5 mL), brine 
(5 mL) and, after warming to room temperature, the reaction mixture was extracted with 
diethyl ether (3 × 10 mL). The combined organic extract was dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.44) afforded 190a (92 mg, 0.20 
mmol, 89%) as a diastereomerically enriched orange solid (>95:5 dr by NMR); mp 128-
129 °C (EtOH/H2O); [α]D
20
 –132 (c 1.0, CHCl3); X-Ray diffractometry was performed on 
an orange plate (0.12 × 0.12 × 0.04 mm
3
): C23H34N2O2SiFe: M = 454.46 g/mol, 
orthorhombic, P212121, a = 7.4514(2)  Å, b = 15.7850(5) Å, c = 19.2930(7) Å, V = 
2269.25(13) Å
3
, α = 90 °, β = 90 °, γ = 90 °, Z = 4, Dc = 1.330 g/cm
3
, F(000) = 968, T = 
147(2) K; 13733 reflections were collected. The structure was solved by Direct Methods 
(SHELXTL) and refined by full-matrix least squares on F
2
 resulting in final R, Rw and 
GOF [for 3738 data with F > 2σ(F)] of 0.0492, 0.1354 and 1.040, respectively, for 
solution using the Rp enantiomer model [Flack parameter = 0.021(7)] [Crystallographic 
data (excluding structure factors) for 190a has been deposited with the Cambridge 
Crystallographic Data Centre as supplementary publication no. CCDC 915630]; IR (KBr) 
νmax 2956, 2918, 2875, 1714, 1487, 1392, 1190, 1072, 1009 cm
–1
; 
1
H NMR (300 MHz, 
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CDCl3) δ 5.32 (s, 1H), 4.17 (s, 5H), 4.05 (m, 2H), 3.91 (t, 1H, J = 2.4 Hz), 3.76-3.70 (m, 
1H), 3.43-3.38 (m, 1H), 3.14-3.08 (m, 1H), 2.07-1.92 (m, 2H), 1.92 (s, 3H), 1.93-1.83 
(m, 1H), 1.43-1.36 (m, 1H), 0.93 (t, 9H, J = 7.8 Hz), 0.62-0.54 (m, 6H); 
13
C NMR (150.9 
MHz, CDCl3) δ 161.1, 93.7, 86.7, 81.3, 69.6, 67.2, 66.7, 63.9, 63.3, 45.8, 27.8, 24.9, 13.4, 
6.8, 5.1; EIMS [m/z (%)] 454 (M
+
, 18), 322 (81), 257 (100), 241 (21), 121 (32), 103 (99), 
75 (92), 56 (34); HRMS (EI) calcd for C23H34N2O2Si
56
Fe: 454.1739; found 454.1735; 
Anal. calcd for C23H34N2O2SiFe: C, 60.79; H, 7.54. Found: C, 60.81; H, 7.46. 
(–)-2-[(2Sp-Thiomethyl)ferrocenyl]-1S-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-
c]imidazol-3-one (190b). 
A solution of anti-187 (100 mg, 0.22 mmol) in THF (2 mL) at –78 °C 
was exposed to t-BuLi (0.36 mL, 1.40 M in pentane, 0.50 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with (MeS)2 (0.05 mL, 0.57 mmol) and stirred 
for 30 min. at that temperature. Workup was conducted by addition of water (0.5 mL), 
brine (5 mL) and, after warming to room temperature, the reaction mixture was extracted 
with diethyl ether (3 × 10 mL). The combined organic extract was dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 10:86:4 EtOAc/hexanes/Et3N, Rf = 0.45) afforded 190b (105 
mg, 0.22 mmol, 95%) as a diastereomerically enriched dark-orange oil; [α]D
20
 –216 (c 
1.1, CHCl3); IR (KBr, neat) νmax 3090, 2953, 2921, 2876, 1720, 1479, 1401, 1066 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 5.56 (s, 1H), 4.37-4.36 (m, 1H), 4.29 (s, 5H), 4.28-4.26 
(m, 1H), 4.18 (t, 1H, J = 2.7 Hz), 3.75-3.69 (m, 1H), 3.48-3.43 (m, 1H), 3.11-3.05 (m, 
1H), 2.19 (s, 3H), 2.05-1.99 (m, 2H), 1.90-1.75 (m, 1H), 1.70-1.60 (m, 1H), 0.97 (t, 9H, J 
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= 7.8 Hz), 0.67 (q, 6H, J = 7.8 Hz); 
13
C NMR (150.9 MHz, CDCl3) δ 162.6, 95.8, 88.1, 
80.0, 70.8, 70.5, 67.5, 66.6, 65.9, 46.0, 28.2, 24.8, 20.3, 6.9, 5.6; EIMS [m/z(%)] 486 
(M
+
, 100), 454 (70), 289 (21), 273 (74), 103 (68), 75 (57); HRMS (EI) calcd for 
C23H34N2O2SSi
56
Fe: 486.1459; found 486.1457. 
(–)-2-[(2Sp-Iodo)ferrocenyl]-1S-triethylsilyloxy-7aS-hexahydro-pyrrolo[1,2-
c]imidazol-3-one (190c). 
A solution of anti-187 (100 mg, 0.22 mmol) in THF (2 mL) at –78 °C 
was exposed to t-BuLi (0.36 mL, 1.40 M in pentane, 0.50 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with a solution of ICH2CH2I (160 mg, 0.57 
mmol) in THF (3 mL) and stirred for 45 min. at that temperature. Workup was conducted 
by addition of water (0.5 mL), brine (5 mL) and, after warming to room temperature, the 
reaction mixture was extracted with diethyl ether (3 × 10 mL). The combined organic 
extract was dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.45) 
afforded 190c (120 mg, 0.21 mmol, 93%) as a diastereomerically enriched dark-orange 
oil; [α]D
20
 –135 (c 1.3, CHCl3); IR (KBr, neat) νmax 3091, 2954, 2910, 2875, 1722, 1475, 
1398, 1072, 1005 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 5.43 (s, 1H), 4.45 (t, 1H, J = 2.1 
Hz), 4.30 (s, 5H), 4.20 (m, 2H), 3.79-3.72 (m, 1H), 3.50-3.42 (m, 1H), 3.13-3.06 (m, 1H), 
2.08-2.00 (m, 2H), 1.89-1.86 (m, 1H), 1.67-1.59 (m, 1H), 0.96 (t, 9H, J = Hz), 0.63 (q, 
6H, J = 7.8 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 161.4 95.4, 87.3, 72.6, 72.2, 67.0, 66.5, 
66.3, 45.8, 42.1, 28.2, 24.9, 6.9, 5.4; EIMS [m/z(%)] 566 (M
+
, 58), 434 (19), 252 (36), 
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149 (100), 103 (67), 75 (57), 57 (29); HRMS (EI) calcd for C22H31IN2O2Si
56
Fe: 
566.0549; found 566.0534. 
(+)-2-[(2Rp-Methyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]-imidazol-3-one (ent-
192a). 
A solution of 190a (39.0 mg, 0.09 mmol) and p-toluenesulfonic acid 
monohydrate (65.0 mg, 0.34 mmol) in CHCl3 (1 mL) was heated to 
reflux for 40 min.. The solution was cooled to room temperature, diluted 
with chloroform (10 mL) and was washed sequentially with sat. aq. NaHCO3, H2O, brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
flash column chromatography (silica gel, EtOAc, Rf = 0.32) afforded ent-192a (26 mg, 
0.08 mmol, 95%) as an enantiomerically enriched orange solid that could be 
recrystallized from EtOH/water; mp 135-136 °C (EtOH/water); [α]D
20
 +31.0 (c 1.3, 
CHCl3) [Sp enantiomer [α]D
20
 –29 (c 1.0, CHCl3)]; CSP HPLC analysis (Chiralcel OD-H; 
eluent: 50:50 hexanes/i-PrOH, 1.0 mL/min) determined 97:3 er, 94% ee [tR(minor) = 6.39 
min, tR(major) = 8.58 min]; Spectroscopic data matched that for antipode 192a: IR (KBr) 
νmax 3126, 3077, 2954, 2883, 2852, 1678, 1630, 1493, 1408 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 6.33 (s, 1H), 4.38 (m, 1H), 4.20 (s, 5H), 4.11 (m, 1H), 4.02 (m, 1H), 3.76 (b, 
2H), 2.79 (bt, 2H), 2.43 (m, 2H), 2.03 (s, 3H). 
(+)-2-[2Sp-(Thiomethyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one 
(ent-192b). 
A solution of 190b (99.0 mg, 0.20 mmol) and p-toluenesulfonic acid 
monohydrate (154 mg, 0.81 mmol) in CHCl3 (3 mL) was heated to 
reflux for 40 min.. The solution was cooled to room temperature, 
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diluted with chloroform (10 mL) and was washed sequentially with sat. aq. NaHCO3, 
H2O, brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, EtOAc, Rf = 0.24) afforded ent-
192b (66 mg, 0.15 mmol, 92%) as an orange oil; [α]D
20
 +136 (c 1.0, CHCl3) [Rp 
enantiomer –129 (c 1.0 CHCl3)]; CSP HPLC analysis (Chiralcel OD-H; eluent: 70:30 
hexanes/i-PrOH, 1.0 mL/min) determined 95.5:4.5 er, 91% ee [tR(minor) = 7.93 min, 
tR(major) = 10.69 min]; Spectroscopic data matched for antipode 192b: IR (KBr, neat) 
νmax 3154, 3092, 2979, 2919, 1690, 1639, 1487, 1409, 1114 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 6.75 (s, 1H), 4.90 (m, 1H), 4.26-4.25 (m, 1H), 4.22 (s, 5H), 4.17 (t, 1H, J = 2.7 
Hz), 3.70 (t, 2H, J = 6.9 Hz), 2.76 (t, 2H, J = 6.9 Hz), 2.41 (quin, 2H, J = 6.9 Hz), 2.16 (s, 
3H); EIMS [m/z(%)] 354 (M
+
, 23), 85 (65), 83 (100), 47 (21); HRMS (EI) calcd for 
C17H18N2OS
56
Fe: 354.0489; found 354.0491. 
(+)-2-[2Sp-(Iodo)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one(ent-
192c). 
A solution of 190c (120 mg, 0.21 mmol) and p-toluenesulfonic acid 
monohydrate (161 mg, 0.85 mmol) in CHCl3 (2 mL) was heated to 
reflux for 30 min.. The reaction mixture was cooled to room 
temperature, diluted with chloroform (10 mL) and was washed sequentially with sat. aq. 
NaHCO3, H2O, brine, dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. Purification by flash column chromatography (silica gel, 80:15:5 
EtOAc/hexanes/Et3N, Rf = 0.22) afforded ent-192c (79 mg, 0.22 mmol, 85%) as a viscous 
orange oil; [α]D
20
 +40 (c 1.1, CHCl3) [Rp enantiomer [α]D
20
 –38.9 (c 0.4, CHCl3)]; CSP 
HPLC analysis (Chiralcel OD-H; eluent: 80:20 hexanes/i-PrOH, 1.0 mL/min) determined 
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99:1 er, 98% ee [tR(minor) = 12.51 min, tR(major) = 13.46 min]; Spectroscopic data 
matched for antipode 192c: IR (KBr, neat) νmax 3153, 3092, 2961, 2901, 1681, 1639, 
1488, 1409, 1347, 1107 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 6.55 (s, 1H), 4.78 (m, 1H), 
4.40 (m, 1H), 4.25 (s, 6H), 3.75 (t, 2H, J = 6.3 Hz), 2.80 (t, 2H, J = 6.9 Hz), 2.42 (quin, 
2H, J = 6.6 Hz); EIMS [m/z (%)] 434 (M
+
, 17), 308 (50), 243 (57), 87 (93), 83 (53), 49 
(100), 43 (98); HRMS (EI) calcd for C16H15IN2O
56
Fe: 433.9578; found 433.9570. 
(+)-2-[(2Sp-Deutero)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-
c]imidazol-3-one (2Sp-D-syn-188i). 
A solution of syn-187 (200 mg, 0.45 mmol) in THF (4.5 mL) at –78 °C 
was exposed to t-BuLi (1.02 mL, 0.99 M in pentane, 1.00 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with methanol-d4 (0.04 mL, 1.14 mmol) and 
stirred for 30 min. at that temperature. Workup was conducted by addition of water (0.5 
mL), brine (5 mL) and, after warming to room temperature, the reaction mixture was 
extracted with diethyl ether (3 × 10 mL). The combined organic extract was dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 30:70 EtOAc/hexanes) afforded 2Sp-D-syn-188i (188 mg, 
0.43 mmol, 94%) as a diastereomerically enriched orange solid. mp 94-95 °C (EtOH, 
H2O); [α]D
20
 +124 (c 1.0, CHCl3); IR (KBr) νmax 3084, 2953, 2910, 2875, 1687, 1493, 
1410, 1084 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 5.41 (d, 1H, J = 6.3 Hz), 4.28 (s, 1H), 
4.17 (s, 5H), 4.02 (s, 1H), 3.92-3.87 (m, 2H), 3.63-3.55 (m, 1H), 3.12-3.04 (m, 1H), 1.95-
1.83 (m, 3H), 1.74-1.69 (m, 1H), 0.87 (t, 9H, J = 8.1 Hz), 0.56 (q, 6H, J = 8.1 Hz); 
13
C 
NMR (150.9 MHz, CDCl3) δ 159.0, 96.6, 82.4, 69.0, 65.0, 63.5, 61.8, 61.33 (t, J = 27.9 
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Hz), 61.31, 45.6, 26.3, 25.1, 6.6, 4.8; EIMS [m/z (%)] 441 (M
+
, 42), 309 (65), 244 (94), 
228 (36), 103 (100), 75 (81); HRMS (EI) calcd for C22H31DN2O2Si
56
Fe: 441.1645; found 
441.1637. 
(–)-2-[(2Rp-Deutero)ferrocenyl]-1S-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-
c]imidazol-3-one (2Rp-D-anti-190d). 
A solution of anti-187 (68.0 mg, 0.15 mmol) in THF (2 mL) at –78 °C 
was exposed to t-BuLi (0.32 mL, 1.07 M in pentane, 0.34 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with methanol-d4 (0.02 mL, 0.39 mmol) and 
stirred for 30 min. at that temperature. Workup was conducted by addition of water (0.5 
mL), brine (5 mL) and, after warming to room temperature, the reaction mixture was 
extracted with diethyl ether (3 × 10 mL). The combined organic extract was dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 30:70 EtOAc/hexanes) afforded 2Rp-D-anti-190d (63.0 mg, 
0.14 mmol, 93%) as a diastereomerically enriched orange solid. mp 75-76 °C 
(EtOH/H2O); [α]D
20
 –68 (c 1.1, CHCl3); IR (KBr) νmax 3091, 3082, 2954, 2897, 2873, 
1693, 1496, 1414, 1090 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 5.40 (s, 1H), 4.45 (s, 1H), 
4.15 (s, 5H), 4.05 (s, 1H), 3.98 (s, 1H), 3.78-3.69 (m, 1H), 3.43-3.38 (m, 1H), 3.15-3.07 
(m, 1H), 2.07-1.97 (m, 2H), 1.87-1.77 (m, 1H), 1.30-1.23 (m, 1H), 0.97 (t, 9H, J = 7.8 
Hz), 0.68 (m, 6H, J = 7.8 Hz); 
13
C NMR (150.9 MHz, CDCl3) δ 160.4, 97.2, 84.5, 68.9, 
66.7, 64.5, 63.9, 61.0 (t, J = 27.2 Hz), 59.0, 45.4, 28.5, 24.7, 6.8, 5.2; EIMS [m/z (%)] 
441 (M
+
, 15), 309 (71), 244 (97), 103 (100), 75 (77), 47 (19); HRMS (EI) calcd for 
C22H31DN2O2Si
56
Fe: 441.1645; found 441.1641.  
133 
 
 
(+)-2-[(2Sp-Deutero)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one 
(192d). 
A solution of 188i (178 mg, 0.40 mmol) and p-toluenesulfonic acid 
monohydrate (307 mg, 1.61 mmol) in CHCl3 (4 mL) was heated to 
reflux for 30 min.. The solution was cooled to room temperature, 
diluted with chloroform (10 mL) and was washed sequentially with sat. aq. NaHCO3, 
H2O, brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, EtOAc, Rf = 0.20) afforded 
192d (112 mg, 0.36 mmol, 90%) as an orange solid; [α]D
20
 +4 (c 1.0, CHCl3); mp 190-
191 °C IR (KBr) νmax 3105, 3051, 2981, 2952, 2889, 1678, 1633, 1498, 1458, 1413 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 6.13 (s, 1H), 4.70 (s, 1H), 4.19 (s, 5H), 4.07 (s, 2H), 3.74 
(m, 2H), 2.75 (t, 2H, J = 6.6 Hz), 2.40 (m, 2H) EIMS [m/z(%)]; 
13
C NMR (75.5 MHz, 
CDCl3) δ 149.5, 126.9, 101.7, 94.9, 69.0, 64.7, 60.8, 60.7 (t, J = 27.2 Hz), 42.1, 27.8, 
22.7; EIMS [m/z (%)] 309 (M
+
, 82), 308 (58), 245 (21), 244 (100), 243 (74), 50 (27); 
HRMS (EI) calcd for C16H15DN2O
56
Fe: 309.0674; found 309.0672. 
(−)-2-[(2Rp-Deutero)ferrocenyl ]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one 
(ent-192d). 
A solution of 190d (58.0 mg, 0.13 mmol) and p-toluenesulfonic acid 
monohydrate (100 mg, 0.52 mmol) in CHCl3 (2 mL) was heated to 
reflux for 30 min.. The solution was cooled to room temperature, diluted 
with chloroform (10 mL) and was washed sequentially with sat. aq. NaHCO3, H2O, brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
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flash column chromatography (silica gel, EtOAc, Rf = 0.20) afforded ent-192d (38 mg, 
0.12 mmol, 94%) as an orange solid; mp 189-190 °C [α]D
20
 –4 (c 0.7, CHCl3) [Rp 
enantiomer [α]D
20
 +4 (c 1.0, CHCl3)]; IR (KBr) νmax 3105, 2967, 2890, 2859, 1678, 1498, 
1413, 1347, 1101 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 6.13 (t, 1H, J = 1.2 Hz), 4.69 (q, 
1H, J = 2.1 Hz), 4.18 (s, 5H), 4.06 (d, 2H, J = 1.8 Hz), 3.71 (t, 2H, J = 6.9 Hz), 2.74 (t, 
2H, J = 7.8 Hz), 2.44 (q, 2H, J = 6.9 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 149.5, 126.9, 
101.7, 94.9, 69.0, 64.7, 60.8, 60.7 (t, J = 27.2 Hz), 42.1, 27.8, 22.7; EIMS [m/z (%)] 309 
(M
+
, 79), 308 (17), 245 (19), 154 (12), 57 (13), 56 (15); HRMS (EI) calcd for 
C16H15DN2O
56
Fe: 309.0674; found 309.0672. 
 
To a solution of 188g (212.0 mg, 0.34 mmol) in CHCl3 (4 mL) was added p-
toluenesulfonic acid monohydrate (129.0 mg, 0.68 mmol) in one portion. After stirring 
for 5 min, a distinct color change from orange to brown was observed. The solution was 
quenched with saturated aqueous NaHCO3 (1 mL). The organic layer was washed with 
water and brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure 
to give 194 (117 mg, 70%) as a 4:1 mixture of anti/syn epimers. Purification by flash 
column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf (syn) = 0.43, Rf (anti) = 0.23) 
separated syn-194 (21 mg, 0.04 mmol, 13%),  and anti-194 (96 mg, 0.20 mmol, 57%). 
(+)-2-[(2Sp-5,5-Diphenyl-ferrocenyl](6aR,6bS)-6b,7,8,9-tetrahydro-5H-pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazin-11(6aH)-one (syn-194). 
The following data were obtained for syn-194 (glassy solid): [α]D
20
 +70 
(c 0.8, CHCl3); CSP HPLC analysis (Chiralcel OD-H; eluent: 80:20 
hexanes/i-PrOH, 1.0 mL/min) determined >99:1 er, >98% ee [tR(minor) 
135 
 
= 5.59 min, tR(major) = 10.77 min]; IR (KBr) νmax 3085, 3058, 3026, 2954, 1714, 1504, 
1402 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 7.50 (d, 2H, J = 7.5 Hz), 7.40 (t, 2H, J = 7.5 
Hz), 7.31 (d, 1H, J = 6.9 Hz ), 7.25-7.22 (m, 3H), 7.17-7.14 (m, 2H), 4.93 (d, 1H, J = 7.5 
Hz),  4.69 (s, 1H), 4.16-4.07 (m, 2H), 3.87-3.74 (m, 7H), 3.19-3.11 (m, 1H), 2.36-2.28 
(m, 1H), 2.182.12 (m, 2H), 1.98-1.93 (m, 1H); 
13
C NMR (150.9 MHz, CDCl3) δ 159.8, 
146.3, 145.1, 128.0, 127.9, 127.8, 127.7, 126.7, 125.6, 94.1, 82.2, 80.5, 77.6, 69.8, 63.4, 
62.7, 61.1, 56.0, 45.7, 25.4, 25.0; EIMS [m/z (%)] 490 (M
+
, 16), 105 (100), 84 (48), 77 
(33), 49 (58); HRMS (EI) calcd for C29H26N2O2
56
Fe: 490.1343; found 490.1345. 
(+)-2-[(2Sp-5,5-Diphenyl-ferrocenyl](6aS,6bS)-6b,7,8,9-tetrahydro-5H-pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazin-11(6aH)-one (anti-194). 
The following data were obtained for anti-194 (orange solid): mp 251-
252 °C (CH2Cl2/hexanes); [α]D
20
 +168 (c 0.5, CHCl3); CSP HPLC 
analysis (Chiralcel OD-H; eluent: 80:20 hexanes/i-PrOH, 1.0 mL/min) 
determined >99:1 er, >98% ee [tR(minor) = 8.64 min, tR(major) = 10.09 min]; IR (KBr) 
νmax 3085, 3058, 2968, 2896, 1712, 1502, 1392, 1028, 1001 cm
–1
; 
1
H NMR (600 MHz, 
CDCl3) δ 7.74 (d, 2H, J = 7.8 Hz), 7.53 (t, 2H, J = 7.2 Hz), 7.43 (t, 1H, J = 7.2 Hz), 7.15-
7.10 (m, 3H), 6.88-6.87 (m, 2H), 5.46 (s, 1H), 5.17 (s, 1H), 4.11 (t, 1H, J = 2.7 Hz), 3.90-
3.85 (m, 2H), 3.70 (s, 5H), 3.68-3.63 (m, 1H), 3.18-3.14 (m, 1H), 2.23-2.18 (m, 1H), 
2.11-2.07 (m, 1H), 1.99-1.94 (m, 1H), 1.58-1.52 (m, 1H); 
13
C NMR (75.5 MHz, CDCl3) δ 
158.7, 146.6, 144.9, 127.9, 127.7, 127.6, 127.5, 127.3, 126.4, 92.5, 83.1, 82.8, 80.7, 69.9, 
64.2, 64.1, 63.5, 60.5, 45.3, 28.4, 25.7; EIMS [m/z (%)] 490 (M
+
, 8), 86 (64), 84 (100), 
49 (17), 47 (19); HRMS (EI) calcd for C29H26N2O2Fe: 490.1343; found 490.1336. Anal. 
calcd for C29H26N2O2
56
Fe: C, 71.03; H, 5.34. Found: C, 70.51; H, 5.14.  
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Scale-up: Repetition of the above procedure using 188g (1.2 g, 1.90 mol) and p-
toluenesulfonic acid monohydrate (716.0 mg, 3.76 mmol) in CHCl3 (20 mL) afforded 
only anti-194. Following work up described above; the crude mixture was dissolved in 
minimum amount of CH2Cl2 and hexane was added to precipitate out orange solid which 
was recrystallized from CH2Cl2/hexanes in 70% yield (645 mg, 1.32 mmol). 
(+)-2-[(2Sp-5,5-Diphenyl-ferrocenyl](6aS,6bS)-6a,6b,7,8,9,11-hexahydro-5H-pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazine (195). 
To a solution of anti-194 (610 mg, 1.24 mmol) in THF (60 mL) at –
78 °C was added DIBAL-H (5.00 mL, 1.00 M solution in hexanes, 
4.98 mmol). The reaction mixture was allowed to warm to room 
temperature overnight. After 16 h, the solution was cooled to 0 °C, diluted with EtOAc 
and quenched with sat. aq. potassium sodium tartrate (2 mL) and stirred for another 15 
min. to separate organic and aqueous layers. The organic layer was washed with water 
and brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 50:45:5 EtOAc/hexanes/Et3N, Rf 
= 0.23) afforded 195 as orange crystalline solid (470 mg, 0.99 mmol, 79%); mp 203-204 
°C; [α]D
20
 +312 (c 0.5, CHCl3); IR (KBr) νmax 3085, 3023, 2958, 2937, 2861, 2848, 1490, 
1469, 1360, 1136, 1105 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 7.73 (d, 2H, J = 7.2 Hz), 
7.45 (t, 2H, J = 7.2 Hz), 7.39 (t, 1H, J = 7.5 Hz ), 7.12-7.09 (m, 3H), 6.96-6.93 (m, 2H), 
4.89 (s, 1H), 4.45 (s, 1H), 3.99-3.97 (m, 1H), 3.89 (dd, 2H, J = 12.3 Hz, 6.9Hz), 3.84-
3.80 (m, 2H), 3.68 (s, 5H), 3.21-3.22 (m, 1H), 2.88-2.87 (m, 1H), 2.25-2.24 (m, 1H), 
1.86-1.77 (m, 3H); 
13
C NMR (75.5 MHz, CDCl3) δ 147.8, 146.0, 127.7, 127.5, 127.4, 
127.1, 126.9, 126.6, 100.2, 91.2, 81.7, 81.4, 75.2, 70.2, 70.0, 63.9, 63.3, 61.9, 56.0, 20.6, 
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26.7; EIMS [m/z (%)] 476 (M
+
, 44),  83 (100), 55 (12); HRMS (EI) calcd for 
C29H28N2O1Fe: 476.1551; found 476.1554. Anal. calcd for C29H26N2O2
56
Fe: C, 73.11; H, 
5.92. Found: C, 72.81; H, 6.05. 
(–)-Chloro[η4-1,5-cyclooctadiene]2-[2Sp-5,5-diphenyl-ferrocenyl](6aS,6bS)-
6a,6b,7,8,9,11-hexahydro-5H- pyrrolo[1',2':3,4] imidazol-2-ylidene]iridium (197). 
A solution of 195 (200 mg, 0.42 mmol) and tritylium tetrafluoroborate 
(139 mg, 0.42 mmol) in CH2Cl2 (4 mL) was stirred in a Schlenk flask 
at room temperature covered from light. After 5 h, solvent was 
removed in vacuo and the crude solid was washed with dry diethyl ether (3 x 5 mL) and 
dried in vacuo. To this was added Ir(μ-Cl)(cod)]2 (141.0 mg, 0.21 mmol) and degassed 
THF (14 mL) in glovebox. The solution was cooled to –78 °C and with increased flow of 
argon, KOtBu (47.0 mg, 0.42 mmol) was added at –78 °C. After 1 h, the cold bath was 
removed and the volatiles were removed under reduced pressure. Purification of the 
residue by flash column chromatography (silica gel, 2:8 EtOAc/hexanes) afforded a 4:1 
mixture of coordination isomers. The minor isomer was found to convert to major in 
>95% when stirred in CH2Cl2 for 16 h. Data for major isomer 197: [194 mg, 0.24 mmol, 
57%, Rf = 0.25 (2:8 EtOAc/hexanes)] as an orange crystalline solid; mp 222-223 °C 
(CH3CN); [α]D
20 –245 (c 0.5, CHCl3); X-Ray diffractometry was performed on an orange 
crystal (0.16 × 0.05 × 0.04 mm
3
): C37H38ClFeIrN2O: M = 810.19 g/mol, triclinic, P1, a = 
9.6609(9) Å, b = 11.9882(12) Å, c = 14.7752(14) Å, V = 1614.8(3) Å
3
, α = 74.139(2)°, β 
= 89.285(2)°, γ = 79.066(2)°, Z = 2, Dc = 1.666  g/cm3, F(000) = 804, T = 147(2) K; 
26631 data were collected. The structure was solved by Direct Methods (SHELXTL) and 
refined by full-matrix least squares on F2 resulting in final R, Rw and GOF [for 13430 
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data with F> 2σ(F)] of 0.0395, 0.0804 and 0.965, respectively, for solution using the Sp 
enantiomer model [Flack parameter = –0.024(5)]; [CCDC 1030224 contains the 
crystallographic data for 197]; IR (KBr) νmax 2956, 2922, 2873, 2828, 1699, 1518, 1413 
cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 7.69 (d, 2H, J = 7.5 Hz), 7.52 (t, 2H, J = 7.2 Hz), 
7.43 (t, 1H, J = 7.2 Hz ), 7.16-7.11 (m, 3H), 6.88-6.84 (m, 2H), 6.28-6.27 (m, 1H), 5.73 
(d, 1H, J = 4.2 Hz), 4.85-4.80 (m, 1H), 4.69-4.63 (m, 1H), 4.48-4.39 (m, 1H), 4.19 (t, 1H, 
J = 2.7 Hz), 4.05-3.98 (m, 1H), 3.93-3.91 (m, 1H), 3.78 (s, 5H), 3.54-3.46 (m, 1H), 3.24-
3.20 (m, 1H), 2.87-2.81 (m, 1H), 2.36-2.15 (m, 12H); 
13
C NMR (75.5 MHz, CDCl3) δ 
206.4, 146.4, 144.8, 127.8, 127.7, 127.6, 127.4, 126.1, 93.9, 89.4, 86.5, 86.3, 83.6, 81.4, 
70.63, 68.5, 64.6, 64.0, 63.0, 54.7, 51.1, 46.3, 34.0, 32.8, 29.6, 28.9, 28.5, 25.5; FABMS 
[m/z (%)] 810 (M
+
, 2), 95 (50), 91 (36), 67 (70), 55 (100), 43 (99), 39 (54), 29 (73); 
HRMS (FAB) calcd for C37H38N2OClFeIr: 810.1651; found 810.1419. Anal. calcd for 
C37H38N2OCl
56
FeIr: C, 54.85; H, 4.73. Found: C, 54.57; H, 4.75. 
(–)-[η4-1,5-cyclooctadiene][triphenylphosphine]2-[2Sp-5,5-diphenyl-ferrocenyl] 
(6aS,6bS)6a,6b,7,8,9,11-hexahydro-5H-pyrrolo[1',2':3,4]imidazol-2-ylidene]iridium 
hexafluorophosphate (198). 
To a solution of 197 (100 mg, 0.12 mmol) in CH2Cl2 (1 mL) was 
added a solution of triphenylphosphine (32.0 mg, 0.12 mmol) in 
CH2Cl2 (1 mL) and resulting red solution was stirred for 3 h at room 
temperature and then concentrated. The residue was dissolved in minimum amount of 
CH3CN and KPF6 (29.0 mg, 0.16 mmol) in CH3CN was added and stirred at room 
temperature for another hour, passed through Celite and washed with CH2Cl2. Volatiles 
were removed under reduced pressure and resulting red solid was triturated with pentane 
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to afford 198 as red crystalline solid (131 mg, 0.13 mmol, 90%). mp 189-190 °C; [α]D
20 –
72 (c 0.5, CHCl3); IR (KBr) νmax 2918, 2880, 2850, 1500, 1436, 838 cm
–1
; 
1
H NMR (300 
MHz, CDCl3) δ 7.57-7.52 (m, 14H), 7.41 (m, 4H), 7.33 (m, 2H), 7.16-7.14 (m, 3H), 6.91 
(d, 2H, J = 6.3 Hz), 5.77 (s, 1H), 5.24 (s, 1H), 4.74 (m, 1H), 4.35 (s, 1H), 4.24 (m, 2H), 
4.01 (m, 1H), 3.75 (m, 1H), 3.55-3.46 (m, 7H), 3.29-3.28 (m, 1H), 2.42-2.35 (m, 1H), 
2.29-2.17 (m, 3H), 1.97-1.91 (m, 6H), 1.60-1.49 (m, 1H), 1.15-1.12 (m, 1H); 
31
P NMR 
(121.5 MHz, CDCl3) 16.18 (s), –144.2 (septet, J = 713.2 Hz); 
19
F NMR (282.4 MHz, 
CDCl3) –73.5 (d, J = 711.6 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 202.9, 145.6 (d, J = 6.8 
Hz), 133.7 (d, J = 19 Hz) , 131.8, 129.2 (d, J = 9.8 Hz), 128.7, 128.4, 128.2, 128.0 (t, J = 
9.1 Hz), 127.6, 125.5, 94.0, 90.5 (d, J = 8.3 Hz), 86.5, 85.1, 83.1, 81.4, 81.2, 80.7, 71.4, 
70.2, 65.4, 64.1, 62.4, 45.2, 33.2, 32.2, 29.2, 29.0, 25.9, 24.8; FABMS [m/z (%)] 1037 
(M
+
, 8), 83 (29), 71 (30), 69 (60), 67 (38), 55 (100), 43 (94); HRMS (FAB) calcd for 
C55H53N2OPFeIr: 1037.2874; found 1037.2830. Anal. calcd for C55H53N2OP
56
FeIr
+
PF6
–
: 
C, 55.89; H, 4.52. Found: C, 55.72; H, 4.66. 
(–)-2-[(2Rp-(Diphenylhydroxymethyl)ferrocenyl]-1S-triethylsilyloxy-7aS hexahydro 
pyrrolo[1,2-c]imidazol-3-one (190e). 
To a solution of anti-187 (809 mg, 1.84 mmol) in THF (15 mL) at –78 
°C was added t-BuLi (4.00 mL, 1.04 M in hexanes, 4.04 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched a solution of Ph2CO (837 mg, 4.59 mmol) in 
THF (5 mL) and stirred for 30 min. at that temperature. Workup was conducted by 
addition of water (0.5 mL) and, after warming to room temperature, the reaction mixture 
was extracted with diethyl ether (2 × 40 mL). The combined organic extract was washed 
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with water, brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 2:8 EtOAc/hexanes, Rf = 0.43) 
afforded 190e (1.1 g, 1.80 mmol, 93%) as a diastereomerically enriched orange 
crystalline solid; mp 181-182 ºC (EtOH/H2O); [α]D
20
 –67 (c 1.0, CHCl3); IR (KBr) νmax 
3221, 3086, 3054, 2954, 2909, 1686, 1460 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 7.74 (d, 
2H, J = 7.2 Hz), 7.46 (d, 2H, J = 6.9 Hz), 7.31-7.29 (m, 1H), 7.23-7.14 (m, 5H), 5.37 (s, 
1H), 4.40 (s, 5H), 4.31- 4.29 (m, 1H), 4.02 (t, 1H, J = 2.7 Hz), 3.45-3.43 (m, 1H), 3.38-
3.29 (m, 1H), 3.23-3.18 (m, 1H), 2.96-2.90 (m, 1H), 1.82-1.81 (m, 1H), 1.74-1.66 (m, 
2H), 0.97 (t, 10H, J = 7.8 Hz), 0.67 (q, 6H, J = 7.8 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 
161.5, 147.5, 145.9, 127.6, 127.3, 127.2, 127.1, 126.3, 126.2, 92.0, 90.8, 87.2, 76.1, 70.4, 
70.1, 66.4, 66.0, 63.5, 45.3, 28.3, 24.9, 6.8, 5.2; EIMS [m/z (%)] 622 (M
+
, 3), 490 (56), 
105 (58), 103 (100), 75 (79); HRMS (EI) calcd for C35H42N2O3Si
56
Fe: 622.2314; found 
622.2285. Anal. calcd for C35H42N2O3SiFe: C, 67.51; H, 6.80. Found: C, 67.25; H, 6.72. 
To a solution of 190e (1.10 g, 2.00 mmol) in CHCl3 (20 mL) was added p-toluenesulfonic 
acid monohydrate (761 mg, 4.00 mmol). After stirring for 5 min, a distinct color change 
from orange to brown was observed. The solution was quenched with sat. aq. NaHCO3. 
The organic layer was washed with water and brine, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to give 199 (650 mg, 1.33 mmol, 66%) as a 1.4:1 
mixture of syn/anti epimers. Purification by flash column chromatography (silica gel, 3:7 
EtOAc/hexanes, Rf (anti) = 0.32, Rf (syn) = 0.29) separated syn-199 (380 mg, 0.77 mmol, 
39%), and anti-199 (270 mg, 0.55 mmol, 27%).  
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(–)-2-[(2Rp-5,5-Diphenyl-ferrocenyl](6aR,6bS)-6b,7,8,9-tetrahydro-5H- pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazin-11(6aH)-one (syn-199). 
The following data were obtained for syn-199 (orange solid):  mp 97-
98 ºC; [α]D
20
 –303 (c 1.0, CHCl3); CSP HPLC analysis (Chiralcel 
OD-H; eluent: 60:40 hexanes/i-PrOH, 0.5 mL/min) determined >99:1 
er, >98% ee [tR(minor) = 10.85 min, tR(major) = 11.56 min]; IR (KBr) νmax 3086, 3057, 
3026, 2924, 2853, 1713, 1504, 1492, 1398 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.72 (d, 
2H, J = 7.2 Hz), 7.52 (t, 2H, J = 7.8 Hz), 7.42 (t, 1H, J = 7.2 Hz), 7.14-7.08 (m, 3H), 
6.87-6.84 (m, 2H), 5.58 (d, 1H, J = 6.6 Hz), 5.08-5.06 (m, 1H), 4.21-4.15 (m, 1H),  4.09 
(t, 1H, J = 2.7 Hz), 3.81-3.79 (m, 1H), 3.75 (s, 5H), 3.73-3.67 (m, 1H), 3.14-3.06 (m, 
1H), 2.14-2.08 (m, 1H), 1.91-1.83 (m, 3H); 
13
C NMR (75.5 MHz, CDCl3) δ 159.1, 146.9, 
144.8, 127.7, 127.7, 127.6, 127.4, 127.3, 125.6, 93.1, 82.6, 80.9, 80.5, 70.0, 64.0, 60.4, 
60.3, 46.2, 45.6, 26.5, 24.3; EIMS [m/z(%)] 490 (M
+
, 4), 87 (12), 85 (59), 83 (100), 47 
(18); HRMS (EI) calcd for C29H26N2O2Fe: 490.1343; found 490.1342. Anal. calcd for 
C29H26N2O2Fe: C, 71.03; H, 5.34. Found: C, 70.75; H, 5.53.  
 (–)-2-[(2Rp-5,5-Diphenyl-ferrocenyl](6aS,6bS)6b,7,8,9-tetrahydro-5H-pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazin-11(6aH)-one (anti-199). 
The following data were obtained for anti-199: mp 119-120 ºC; [α]D
20
 –
230 (c 2.0, CHCl3); CSP HPLC analysis (Chiralcel OD-H; eluent: 90:10 
hexanes/i-PrOH, 1.0 mL/min) determined >99:1 er, >98% ee [tR(major) 
= 6.13 min, tR(minor) = 9.88 min]; IR (KBr) νmax 3085, 3058, 3006, 2970, 2920, 1714, 
1489, 1392, 1329 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 7.57 (d, 2H, J = 7.5 Hz), 7.40 (t, 
2H, J = 7.2 Hz), 7.32-7.28 (m, 1H), 7.23-7.19 (m, 3H), 7.17-7.14 (m, 2H), 4.60 (d, 1H, J 
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= 1.5 Hz), 4.59-4.57 (m, 1H), 4.11 (t, 1H, J = 8.4 Hz), 4.07 (t, 1H, J = 2.7 Hz), 3.97-3.92 
(m, 1H), 3.84 (s, 5H), 3.66-3.58 (m, 1H), 3.25-3.16 (m, 1H), 2.05-1.86 (m, 3H), 1.26 (m, 
1H); 
13
C NMR (75.5 MHz, CDCl3) δ 160.5, 145.9, 145.1, 128.4, 127.9, 127.8, 127.7, 
126.8, 125.7, 93.1, 82.5, 82.3, 81.5, 69.9, 63.7, 62.8, 57.2, 46.3, 45.4, 28.7, 25.6; EIMS 
[m/z (%)] 490 (M
+
, 83), 86 (65), 84 (96), 51 (44), 49 (100), 47 (20), 47 (18); HRMS (EI) 
calcd for C29H26N2O2
56
Fe: 490.1343; found 490.1348. 
(–)-2-[(2Rp-5,5-Diphenyl-ferrocenyl](6aS,6bS)6a,6b,7,8,9,11-hexahydro-5H-pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazine (anti-200). 
To a solution of anti-199 (195 mg, 0.40 mmol) in THF (20 mL) at –78 
°C was added DIBAL-H (1.80 mL, 1.00 M solution in hexanes, 1.60 
mmol). The reaction mixture was allowed to warm to room 
temperature overnight. After 16h, the solution was cooled to 0 °C and quenched with sat. 
aq. potassium sodium tartrate. It was then stirred for 15 min. to separate aqueous and 
organic layers. The organic layer was washed with water and brine, dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 50:45:5 EtOAc/hexanes/Et3N, Rf = 0.40) afforded anti-200 
(114 mg, 0.24 mmol, 60%); mp 88-90 °C; [α]D
20
 –343 (c 1.0, CHCl3); IR (KBr) νmax 
3084, 3026, 2954, 2919, 2865, 1491, 1473 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 7.51 (d, 
2H, J = 7.5 Hz), 7.37 (t, 2H, J = 7.2 Hz), 7.28-7.23 (m, 6H), 4.32 (d, 1H, J = 7.5 Hz), 
4.21 (d, 1H, J = 7.5 Hz), 4.12-4.11 (m, 1H),  4.06 (t, 1H, J = 2.7 Hz), 3.98 (d, 1H, J = 2.7 
Hz), 3.87-3.82 (m, 1H), 3.80-3.79 (m, 1H), 3.77 (s, 5H), 3.20-3.13 (m, 1H), 2.72-2.64 (m, 
1H), 2.15-2.07 (m, 1H), 1.79-1.68 (m, 2H), 1.61-1.55 (m, 1H); 
13
C NMR (75.5 MHz, 
CDCl3) δ 146.7, 145.5, 128.1, 127.8, 127.6, 127.3, 126.4, 125.6, 102.6, 88.7, 84.2, 81.0, 
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78.6, 70.2, 68.8, 63.0, 62.3, 54.9, 54.0, 29.4, 25.7; EIMS [m/z (%)] 476 (M
+
, 84), 83 
(100), 56 (76), 57 (46), 41 (40); HRMS (EI) calcd for C29H28N2O
56
Fe: 476.1551; found 
476.1544. 
(–)-2-[(2Rp-5,5-Diphenyl-ferrocenyl](6aR,6bS)6a,6b,7,8,9,11-hexahydro-5H- 
pyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazine (syn-200). 
To a solution of syn-199 (150 mg, 0.31 mmol) in THF (15 mL) at –78 
°C was added DIBAL-H (1.40 mL, 1.00 M solution in hexanes, 1.60 
mmol). The reaction mixture was allowed to warm to room 
temperature overnight. After 16 h, the solution was cooled to 0 °C and quenched with sat. 
aq. potassium sodium tartrate. It was then stirred for 15 min. to separate aqueous and 
organic layers. The organic layer was washed with water and brine, dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 50:45:5 EtOAc/hexanes/Et3N, Rf = 0.23) afforded syn-200 
(115 mg, 0.24 mmol, 78%); mp 56-57 °C;  [α]D
20
 –318 (c 1.5, CHCl3); IR (KBr) νmax 
3085, 3056, 2954, 2917, 2867, 1508, 1490, 1473 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 
7.66 (d, 2H, J = 7.5 Hz), 7.48 (t, 2H, J = 7.2 Hz), 7.40-7.37 (m, 1H), 7.14-7.12 (m, 3H), 
6.99-6.96 (m, 2H), 5.07 (d, 1H, J = 4.5 Hz), 4.33 (s, 1H), 4.19 (d, 1H, J = 4.8 Hz), 4.04-
3.99 (m, 2H), 3.89-3.88 (m, 1H), 3.72 (s, 5H), 3.56 (d, 1H, J = 4.8 Hz), 3.05-3.00 (m, 
1H), 2.58-2.54 (m, 1H), 2.30-2.26 (m, 1H), 1.87-1.76 (m, 3H); 
13
C NMR (75.5 MHz, 
CDCl3) δ 147.7, 146.1, 127.6, 127.5, 127.5, 127.0, 126.9, 126.4, 102.9, 86.3, 81.9, 81.7, 
77.4, 74.7, 69.6, 67.0, 63.7, 63.0, 59.6, 55.2, 26.9, 24.5; EIMS [m/z (%)] 476 (M
+
, 78),  
83 (100), 56 (63), 41 (34), 43 (31); HRMS (EI) calcd for C29H28N2O
56
Fe: 476.1551; 
found 476.1547. 
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(–)-Chloro[η4-1,5-cyclooctadiene][(–)-2-[(2Rp-5,5-diphenyl-ferrocenyl](6aR,6bS)-
6a,6b,7,8,9,11-hexahydro-5H-pyrrolo[1',2':3,4]imidazol-2-ylidene]iridium (201). 
A solution of syn-200 (60.0 mg, 0.13 mmol) and tritylium 
tetrafluoroborate (42.0 mg, 0.13 mmol) in CH2Cl2 (2 mL) was stirred in 
a Schlenk flask at room temperature covered from light. After 5 h, 
solvent was removed in vacuo and the crude solid was washed with diethyl ether (3 x 5 
mL) and dried in vacuo. To this was added Ir(μ-Cl)(cod)]2 (42.0 mg, 0.06 mmol) and 
degassed THF (4 mL) in glovebox. The solution was cooled to –78 °C and with increased 
flow of argon, KOtBu (14.0 mg, 0.13 mmol) was added at –78 °C. The reaction mixture 
was allowed to warm to room temperature. After 16 h, the volatiles were removed under 
reduced pressure and purification of the residue by flash column chromatography (silica 
gel, 2:8 EtOAc/hexanes) afforded 201 (26 mg, 0.03 mmol, 25%) as orange crystalline 
solid; Rf = 0.40 (3:7 EtOAc/hexanes); mp 157-158 °C; [α]D
20 –49 (c 0.5, CHCl3); IR 
(KBr) νmax 3132, 2954, 2924, 2873, 1734, 1519, 1400 cm
–1
; 
1
H NMR (300 MHz, CDCl3) 
δ 7.76 (d, 2H, J = 7.5 Hz), 7.53 (t, 2H, J = 7.2 Hz), 7.45 (t, 1H, J = 7.2 Hz ), 7.12-7.10 
(m, 3H), 6.95-6.92 (m, 2H), 6.13 (s, 1H), 5.69 (d, 1H, J = 7.8 Hz), 4.80-4.75 (m, 1H), 
4.68-4.61 (m, 1H), 4.57-4.52 (m, 1H), 4.21-4.13 (m, 2H), 3.80-3.75 (s, 6H), 3.55-3.51 
(m, 1H), 3.28-3.26 (m, 1H), 3.08-3.06 (m, 1H),  2.45-2.33 (m, 3H), 2.20-2.13 (m, 2H), 
2.03-1.98 (m, 3H), 1.89-1.81 (m, 2H), 1.74-1.68 (m, 2H); 
13
C NMR (75.5 MHz, CDCl3) δ 
206.8, 146.6, 143.9, 128.2, 127.9, 127.7, 127.6, 127.5, 126.9, 94.4, 86.9, 86.6, 84.9, 83.1, 
82.7, 70.2, 65.9, 65.0, 64.6, 61.7, 54.9, 49.6, 48.3, 34.7, 32.5, 30.4, 28.4, 25.9, 23.9; 
FABMS [m/z (%)] 810 (M
+
, 2), 95 (50), 91 (36), 67 (70), 55 (100), 43 (99), 39 (54), 29 
(73); HRMS (FAB) calcd for C37H38N2OCl
56
FeIr: 810.1651; found 810.1613. 
145 
 
(–)-[η4-1,5-Cyclooctadiene][triphenylphosphine][2-[(2Rp-5,5-diphenyl ferrocenyl] -
(6aR,6bS)6a,6b,7,8,9,11-hexahydro-5H-pyrrolo[1',2':3,4]imidazol-2-ylidene]iridium 
hexafluorophosphate (202). 
To a solution of 201 (13.0 mg, 0.02 mmol) in CH2Cl2 (0.5 mL) was 
added a solution of triphenylphosphine (4.00 mg, 0.02 mmol) in 
CH2Cl2 (0.5 mL) and resulting red solution was stirred for 3 h at room 
temperature and then concentrated. The residue was dissolved in minimum amount of 
CH3CN and KPF6 (3.50 mg, 0.02 mmol) in CH3CN was added and stirred at room 
temperature for another hour, passed through Celite and washed with CH2Cl2. Volatiles 
were removed under reduced pressure and resulting red solid was triturated with pentane 
to afford 202 as red crystalline solid (17 mg, 0.02 mmol, 90%). mp 138-140 °C; [α]D
20 –
319 (c 0.4, CHCl3); IR (KBr) νmax 3061, 2929, 2887, 1493, 1436, 1096, 847 cm
–1
; 
1
H 
NMR (300 MHz, acetone-d6) δ 7.68-7.58 (m, 2H), 7.56-7.49 (m, 3H), 7.46-7.39 (m, 4H), 
7.37-7.29 (m, 6H), 7.26-7.14 (m, 5H), 7.04 (t, 1H, J = 7.2 Hz), 6.87 (t, 2H, J = 7.8 Hz), 
6.57 (d, 2H, J = 7.5 Hz), 6.16 (d, 1H, J = 7.8 Hz), 5.85-5.84 (m, 1H), 4.87-4.86 (m, 1H), 
4.66-4.53 (m, 3H), 4.51-4.45 (m, 1H), 4.37-4.36 (m, 1H), 3.80 (s, 5H), 3.59-3.47 (m, 
1H), 3.40-3.36 (m, 1H), 3.00-2.93 (m, 2H), 2.80-2.78 (m, 3H), 2.62-2.50 (m, 4H), 1.95-
1.75 (m, 3H), 1.70 (m, 1H), 1.58-1.51 (m, 1H); 
31
P NMR (242.9 MHz, CDCl3) 18.9 (s), –
144.3 (septet, J = 714.1 Hz); 
19
F NMR (564.7 MHz, CDCl3) –73.6 (d, J = 711.6 Hz);
13
C 
NMR (150.9 MHz, CDCl3) δ 198.3 (d, J
 
= 7.5 Hz), 146.9, 146.0, 134.0 (d, J
 
 = 12.1 Hz), 
131.5 (d, J = 15.1 Hz), 128.6 (t, J  = 10.6 Hz), 128.3, 127.9, 127.8, 127.7, 127.6, 95.2, 
92.2, 85.6, 85.0, 84.1 (d, J  = 13.6 Hz), 83.6, 80.2, 79.8, 70.8, 67.2, 65.7, 63.8, 63.1, 45.0, 
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35.1, 34.7, 28.1, 27.2, 25.7, 21.2. FABMS [m/z (%)] 1037 (M
+
, 17), 81 (42), 67 (41), 55 
(100), 43 (93); HRMS (FAB) calcd for C55H53N2OP
56
FeIr: 1037.2874; found 1037.2682. 
Hydrogenation of quinolines: 
(S)-2-methyl-l,2,3,4-tetrahydroquinoline (203a).
87, 90
 
A solution of 2-methyl quinoline (0.07 mL, 0.51 mmol), triphenyl 
phosphine (1.31 mg, 1 mol%) and iridium catalyst 198 (6.00 mg, 1 
mol%) in toluene (2 mL) in a vial was sealed in an autoclave. The autoclave was 
evacuated and back-filled with hydrogen three times, pressurized to 5 atm, and the 
mixture was stirred for 6 h at room temperature. The solvent was removed under reduced 
pressure and the crude reaction mixture was passed through a plug of silica gel, eluting 
with 2:94:4 EtOAc/hexanes/Et3N to give 203a (69 mg, 0.39 mmol, 94 %) as colorless oil. 
[α]D
20 –53 (c 3.0, CHCl3) [lit
83b
 (R)- 203a : [α]D
20 
+84 (c 0.2, CHCl3, 99% ee)]. CSP 
HPLC analysis (Chiralcel OD-H; eluent: 98:2 hexanes/i-PrOH, 0.5 mL/min) determined 
79:21 er, 58% ee [tR(minor) = 14.16 min, tR(major) = 16.17 min]; 
1
H NMR (300 MHz, 
CDCl3) δ 7.01-6.97 (m, 2H), 6.63 (t, 1H, J = 7.6 Hz), 6.51-6.48 (m, 1H), 3.45-3.39 (m, 
1H), 2.90-2.71 (m, 2H), 1.99-1.91 (m, 1H), 1.68-1.55 (m, 1H), 1.23 (d, 3H, J = 6.3 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 144.7, 129.2, 126.6, 121.0, 116.9, 113.9, 47.1, 30.0, 26.5, 
22.5. 
(S)-6-Fluoro-2-methyl-1,2,3,4-tetrahydroquinoline (203b).
87, 90
 
A solution of 6-fluoro-2-methyl quinoline (80.6 mg, 0.51 mmol), 
triphenyl phosphine (1.31 mg, 1 mol%) and iridium catalyst 198 (6.00 
mg, 1 mol%) in toluene (2 mL) in a vial was sealed in an autoclave. The autoclave was 
evacuated and back-filled with hydrogen three times, pressurized to 5 atm, and the 
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mixture was stirred for 10 h at room temperature. The solvent was removed under 
reduced pressure and the crude reaction mixture was passed through a plug of silica gel, 
eluting with 2:94:4 EtOAc/hexanes/Et3N to give 203b (77 mg, 0.47 mmol, 93%) as a 
white solid. [α]D
20 –77 (c 0.6, CHCl3) [lit
83b
 (R)- 203b : [α]D
20 
+80 (c 0.2, CHCl3, 98% 
ee)]; CSP HPLC analysis (Chiralcel OD-H; eluent: 98:2 hexanes/i-PrOH, 0.5 mL/min) 
determined 90:10 er, 80% ee [tR(minor) = 12.55 min, tR(major) = 16.66 min]; 
1
H NMR 
(300 MHz, CDCl3) δ 6.71-6.65 (m, 2H), 6.43-6.38 (m, 1H), 3.40-3.32 (bm, 2H), 2.83-
2.67 (m, 2H), 1.95-1.88 (m, 1H), 1.63-1.50 (m, 1H), 1.21 (d, 3H, J = 6.3 Hz); 
13
C NMR 
(75.5 MHz, CDCl3) δ 157.0, 153.9, 140.9, 122.5, 122.4, 115.5, 115.2, 114.7, 114.6, 
113.3, 113.0, 47.3, 29.8, 26.7, 22.4. 
(S)-6-Methoxy-2-methyl-1,2,3,4-tetrahydroquinoline (203c).
83b, 87, 90
 
A solution of 6-methoxy-2-methyl quinoline (86.6 mg, 0.50 mmol), 
triphenyl phosphine (1.31 mg, 1 mol%) and iridium catalyst 198 
(6.00 mg, 1 mol%) in toluene (2 mL) in a vial was sealed in an autoclave. The autoclave 
was evacuated and back-filled with hydrogen three times, pressurized to 5 atm, and the 
mixture was stirred for 24 h at room temperature. The solvent was removed under 
reduced pressure and the crude reaction mixture was passed through a plug of silica gel, 
eluting with 10:86:4 EtOAc/hexanes/Et3N to give 203c (69 mg, 0.39 mmol, 78%) as an 
yellow oil, which solidifies on standing. [α]D
20 –60 (c 1.0, CHCl3) [lit
83b
 (R)- 203c : [α]D
20 
+80 (c 0.19, CHCl3, >99% ee)]; CSP HPLC analysis (Chiralcel OD-H; eluent: 98:2 
hexanes/i-PrOH, 0.5 mL/min) determined 79:21 er, 58% ee [tR(minor) = 19.58 min, 
tR(major) = 22.85 min]; 
1
H NMR (300 MHz, CDCl3) δ 6.62-6.58 (m, 2H), 6.47-6.44 (m, 
1H, J = 8.1Hz), 3.73 (s, 3H), 3.33 (bs, 1H), 2.85-2.69 (m, 2H), 1.96-1.88 (m, 1H), 1.65-
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1.51 (m, 1H), 1.22-1.20 (d, 3H, J = 6.3 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 151.8, 
138.8, 122.5, 115.5, 114.6, 112.8, 55.8, 47.4, 30.3, 26.9, 22.5. 
(S)-2-Propyl-l,2,3,4-tetrahydroquinoline (203d).
87, 90
 
A solution of 2-propyl quinoline (0.08 mL, 0.50 mmol), triphenyl 
phosphine (1.31 mg, 1 mol%) and iridium catalyst 198 (6.00 mg, 1 
mol%) in toluene (2 mL) in a vial was sealed in an autoclave. The autoclave was 
evacuated and back-filled with hydrogen three times, pressurized to 5 atm, and the 
mixture was stirred for 24 h at room temperature. The solvent was removed under 
reduced pressure and the crude reaction mixture was passed through a plug of silica gel, 
eluting with 2:94:4 EtOAc/hexanes/Et3N to give 203d (68 mg, 0.39 mmol, 78%) as 
colorless oil. [α]D
20 –48 (c 1.1, CHCl3) [lit
83b
 (R)- 203d: [α]D
20 
+80 (c 0.2, CHCl3, 99% 
ee)]. CSP HPLC analysis (Chiralcel OD-H; eluent: 98:2 hexanes/i-PrOH, 0.5 mL/min) 
determined 69:31 er, 38% ee [tR(minor) = 12.46 min, tR(major) = 14.84 min]; 
1
H NMR 
(300 MHz, CDCl3) δ 6.98 (t, 2H, J = 6.6 Hz), 6.61 (t, 1H, J = 7.8 Hz), 6.50 (d, 1H, J = 
8.1Hz), 3.80 (bs, 1H) 3.29-3.25 (m, 1H), 2.84-2.75 (m, 2H), 2.01-1.95 (m, 1H), 1.66-1.59 
(m, 1H), 1.54-1.42 (m, 4H), 0.98 (t, 3H, J = 6.9 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 
144.6, 129.2, 126.6, 121.4, 116.9, 114.0, 51.3, 38.8, 28.1, 26.4, 18.9, 14.2. 
(R)-2-Phenyl-1,2,3,4-tetrahydroquinoline (203e).
83b, 87, 90, 135
 
A solution of 2-phenyl quinoline (103 mg, 0.50 mmol), triphenyl 
phosphine (1.31 mg, 1 mol%) and iridium catalyst 198 (6.00 mg, 1 
mol%) in toluene (2 mL) in a vial was sealed in an autoclave. The 
autoclave was evacuated and back-filled with hydrogen three times, pressurized to 5 atm, 
and the mixture was stirred for 24 h at room temperature. The solvent was removed under 
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reduced pressure and the product was separated by using preparative TLC, with 5:95 
EtOAc/hexanes to give 203e (26 mg, 0.12 mmol, 25%) as an yellow solid. [α]D
20 
+18 (c 
0.4, CHCl3) [lit
136
 (R)- 203e : [α]D
20 
+42 (c 1.0, CHCl3, 98% ee)]; CSP HPLC analysis 
(Chiralcel OD-H; eluent: 95:5 hexanes/i-PrOH, 0.6 mL/min) determined 75:25 er, 50% 
ee [tR(minor) = 17.68 min, tR(major) = 22.35 min]; 
1
H NMR (300 MHz, CDCl3) δ 7.42-
7.27 (m, 5H), 7.01 (t, 2H, J = 6.9 Hz), 6.65 (t, 1H, J = 7.5 Hz), 6.54 (d, 1H, J = 8.1 Hz), 
4.45 (dd, 1H, J = 9.3, 3.3 Hz), 4.07 (bs, 1H), 2.99-2.90 (m, 1H), 2.74 (dt, 1H, J = 16.5, 
4.8 Hz), 2.17-2.03 (m, 2H); 
13
C NMR (75.5 MHz, CDCl3) δ 144.8, 144.7, 129.3, 128.5, 
127.4, 126.9, 126.5, 120.8, 117.1, 113.9, 56.2, 30.9, 26.4. 
(+)-2-[2Sp-(Phenylhydroxymethyl)ferrocenyl]-1R-triethylsilyloxy-7aS hexa 
hydropyrrolo[1,2-c]imidazol-3-one (188j). 
A solution of  syn-187 (1.00 g, 2.27 mmol) in THF (26 mL) at –78 °C 
was exposed to t-BuLi (4.99 mL, 1.00 M in pentane, 4.99 mmol). After 
stirring for 30 min, a distinct colour change from orange to orange-red 
was observed. The solution was quenched with benzaldehyde (0.58 mL, 5.68 mmol) and 
stirred for 2 h. Workup was conducted by addition of water (0.5 mL) and, after warming 
to room temperature, the reaction mixture was extracted with diethyl ether (2 × 40 mL). 
The combined organic extract was washed with water, brine, dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 0.8:9:0.2 EtOAc/hexanes/Et3N, Rf = 0.06) afforded 188j (696 
mg, 1.27 mmol, 56%) as yellow solid; mp 121-124 ºC; [α]20D = +112 (c 1.0, acetone); IR 
(KBr) νmax 3298, 2954, 2910, 2874, 1680, 1476, 1413, 1286, 1242, 1088, 1001 cm
–1
; 
1
H 
NMR (300MHz, acetone-d6) δ 7.45 (d, 2H, J = 8.4 Hz), 7.36 (t, 2H, J = 8.1 Hz), 7.25 (t, 
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1H, J = 7.2 Hz), 5.88 (d, 1H, J = 1.5 Hz), 5.63 (d, 1H, J = 6.9 Hz), 5.39 (s, 1H), 4.56 (t, 
1H, J = 2.4 Hz), 4.42 (s, 5H), 4.14-4.07 (m, 1H), 3.98 (t, 1H, J = 2.4 Hz), 3.65-3.59 (m, 
2H), 3.19-3.11 (m, 1H),  2.01-1.99 (m, 3H), 1.85-1.81 (m, 1H), 0.85 (t, 9H, J = 7.8 Hz), 
0.49 (dq, 6H, J = 7.8, 2.0 Hz); 
13
C NMR (75.5 MHz, acetone-d6) δ 161.3, 145.7, 128.9, 
128.0, 93.4, 91.8, 85.6, 70.9, 69.2, 68.8, 68.6, 64.2, 63.1, 47.6, 27.4, 26.4, 7.6, 5.8; EIMS 
[m/z (%)] 546 (M
+
, 1.3), 414 (25),  243 (13), 150 (22), 135 (100), 121 (17), 107 (48), 103 
(64); HRMS (EI) calcd for C29H38N2O3Si
56
Fe: 546.2001; found 546.1998. Anal. calcd for 
C29H38N2O3Si
56
Fe: C, 63.79; H, 7.01. Found: C, 64.18, H, 6.97. 
(+)-2-[2Sp-Ferrocenyl-(5S,6aR,6bS)-5-phenyl-6b,7,8,9-tetrahydro-5H-
pyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazin-11(6aH)-one (204). 
To a solution of 188j (695 mg, 1.27 mmol) in CHCl3 (40 mL) at room 
temperature was added p-toluenesulfonic acid monohydrate (483 mg, 
2.54 mmol). After stirring for 5 min, a distinct color change from 
orange to orange-brown was observed. The solution was quenched with saturated 
aqueous NaHCO3 (15 mL). The organic layer was washed with water and brine, dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash 
column chromatography (silica gel, 1.3:8.5:0.2 EtOAc/hexanes/Et3N, Rf = 0.35) afforded 
204 (265 mg, 0.64 mmol, 50%) as yellow solid; mp 160 ºC; [α]20D = +80 (c 1.0, CHCl3); 
IR (KBr) νmax 2971, 2867, 2726, 1702, 1462, 1452, 1377, 1215, 761 cm
–1
; 
1
H NMR (600 
MHz, acetone-d6) δ 7.62 (d, 2H, J = 7.2 Hz), 7.49 (t, 2H, J = 3.6 Hz), 7.38 (t, 1H, J = 3.6 
Hz), 5.77 (s, 1H), 5.40 (d, 1H, J = 3.6 Hz), 4.35 (s, 1H), 4.13 (q, 1H, J = 3.9, 3.6 Hz), 
3.95 (s, 1H) 3.80 (s, 5H), 3.79 (s, 1H), 3.72-3.70 (m, 1H), 3.10-3.06 (m, 1H), 2.34-2.29 
(m, 1H) 2.09-1.97 (m, 4H); 
13
C NMR (150.9 MHz, acetone-d6) δ 159.7, 140.1, 128.0, 
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127.3, 125.5, 93.2, 83.4, 80.1, 75.7, 69.4, 63.0, 61.0, 60.7, 55.9, 45.8, 25.5, 24.8; EIMS 
[m/z (%)] 414 (M
+
, 100), 412 (11), 121 (16), 56 (13); HRMS (EI) calcd for 
C23H22N2O2
56
Fe: 414.1030; found 414.1038. Anal. calcd for C23H22N2O2
56
Fe: C, 66.68; 
H, 5.35. Found: C, 67.14, H, 5.60. 
(+)-2-[2Sp-Ferrocenyl-(5S,6aR,6bS)-5-phenyl-6b,7,8,9-tetrahydro-5H-pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazine (205). 
To a solution of 204 (260 mg, 0.63 mmol) in THF (30 mL) at –78 °C 
was added drop-wise a solution of DIBAL-H (2.51 mL, 1.00 M in 
hexanes, 2.51 mmol). The solution was left to warm up to room 
temperature for 18 h. The solution was cooled to 0 °C and quenched with sat. aq. 
potassium sodium tartrate. It was then stirred for 15 min. to separate aqueous and organic 
layers. The organic layer was washed with water and brine, dried over anhydrous Na2SO4 
and concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 5:4.5:0.5 EtOAc/hexanes/Et3N, Rf = 0.43) afforded 205 (101 mg, 0.25 mmol, 
40%) as yellow crystals; mp 165 ºC; [α]20D = +104 (c 0.9, acetone); IR (KBr) νmax 2953, 
2908, 2863, 2726, 1462, 1377, 1302, 724 cm
–1
; 
1
H NMR (300 MHz, acetone-d6) δ 7.55 
(d, 2H, J = 7.5 Hz), 7.48 (t, 2H, J = 7.5 Hz), 7.34 (t, 1H, J = 7.5 Hz), 5.55 (s, 1H), 4.63 
(d, 1H, J = 4.8 Hz), 4.28 (d, 1H, J = 6.0 Hz), 4.17 (d, 1H, 5.7 Hz), 3.88 (t, 1H, J = 2.7 
Hz), 3.81 (s, 6H), 3.73-3.67 (m, 1H), 3.61 (dd, 1H, J = 2.4, 1.2 Hz), 3.22-3.08 (m, 2H), 
2.46-2.32 (m, 1H), 2.20-2.08 (m, 1H), 1.91-1.88 (m, 2H); 
13
C NMR (75.5 MHz, acetone-
d6): δ 142.1, 128.5, 127.5, 126.0, 106.7, 90.6, 83.1, 77.4, 76.4, 69.2, 67.6, 62.9, 60.1, 
54.4, 53.1, 26.4, 24.0; EIMS [m/z (%)] 400 (M
+
, 10), 205 (12), 79 (10), 59 (28), 43 (100); 
HRMS (EI) calcd for C23H24N2O
56
Fe: 400.1238; found 400.1235. 
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(–)-Chloro[η4-1,5-cyclooctadiene-2-[2Sp-Ferrocenyl-(5S,6aR,6bS)-5-phenyl-6b,7,8,9-
tetrahydro-5H-pyrrolo[1',2':3,4]imidazol-2-ylidene]iridium (207). 
A solution of 205 (100 mg, 0.24 mmol) and tritylium 
tetrafluoroborate (80.0 mg, 0.24 mmol) in CH2Cl2 (4 mL) was stirred 
in a Schlenk flask at room temperature covered from light. After 16 
h, solvent was removed in vacuo and the crude solid was washed 
with dry diethyl ether (3 × 5 mL) and dried in vacuo. To this was added Ir(μ-Cl)(cod)]2 
(81.1 mg, 0.12 mmol) and degassed THF (8 mL) in glovebox. The solution was cooled to 
–78 °C and with increased flow of argon, KOtBu (27.0 mg, 0.24 mmol) was added at –78 
°C. The solution was allowed to warm up to room temperature and stirred for 16 h. The 
volatiles were removed under reduced pressure and  purification of the residue by flash 
column chromatography (silica gel, 0.8:8.8:0.4 EtOAc/hexanes/Et3N, Rf = 0.19) afforded 
207 (32 mg, 0.04 mmol, 36 %); mp 175 ºC (decomposition); [α]20D = –182 (c 0.8, 
acetone); IR (KBr) νmax 3020, 2928, 2857, 1507, 1420, 1216, 929, 758, 670 cm
–1
; 
1
H 
NMR (300 MHz, CDCl3) δ 7.56 (d, 2H, J = 7.2 Hz), 7.47 (t, 2H, J = 7.2 Hz), 7.38 (t, 1H, 
J = 6.9 Hz), 5.90 (dd, 1H, J = 2.4, 1.2 Hz), 5.78 (s, 1H), 5.32 (d, 1H, J = 8.1 Hz), 4.96-
4.91 (m, 2H), 4.57 (td, 1H, J = 10.5, 5.1 Hz), 4.06-4.04 (m, 5H), 3.91-3.90 (m, 2H), 3.45-
3.41 (m, 1H), 3.23 (t, 1H, J = 7.05 Hz), 2.62 (dt, 1H, J = 7.5, 3.6 Hz), 2.52- 2.37 (m, 4H), 
2.35-1.86 (m, 4H), 1.77-1.47 (m, 5H); 
13
C NMR (75.5 MHz, CDCl3) δ 210.7, 139.2, 
128.2, 128.0, 127.8, 127.3, 125.3, 94.8, 90.2, 87.2, 86.5, 70.9, 64.7, 63.0, 61.1, 57.8, 56.7, 
51.2, 49.3, 35.0, 31.9, 31.0, 29.7, 27.9, 24.6, 24.0; FABMS [m/z (%)] 732 (M
+
, 1.9), 243 
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(41), 220 (13), 211 (40), 205 (51), 183 (94); HRMS (FAB) calcd for 
C31H34N2O
56
FeCl
191
Ir: 732.1318; found 732.1290. 
(–)-[η4-1,5-Cyclooctadiene][triphenylphosphine]{2-[2Sp-Ferrocenyl-(5S,6aR,6bS)-5-
phenyl-6b,7,8,9-tetrahydro-5H-pyrrolo[1',2':3,4]imidazol-2-ylidene}iridium 
hexafluorophosphate (208). 
To a solution of 207 (16.0 mg, 0.02 mmol) in CH2Cl2 (1 mL) was 
added a solution of triphenylphosphine (5.80 mg, 0.02 mmol) in 
CH2Cl2 (1 mL) and resulting red solution was stirred for 3 h at room 
temperature and then concentrated under reduced pressure. The residue was dissolved in 
minimum amount of CH3CN and KPF6 (4.80 mg, 0.03 mmol) in CH3CN (1 mL) was 
added. Addition of a small amount CH2Cl2 (0.3 mL) was needed to achieve complete 
solvation. The solution was stirred at room temperature for another hour, passed through 
Celite and washed with CH2Cl2. Volatiles were removed under reduced pressure and 
resulting red solid was triturated with pentane to afford 207 as red crystalline solid (16 
mg, 0.02 mmol, 66%). mp 225-227 °C (dec.); [α]D
20 –100 (c 0.8, CHCl3); IR (KBr) νmax 
2955, 2860, 2726, 1733, 1462, 1377, 723 cm
–1
; 
1
H NMR (300 MHz, acetone-d6) δ 7.77-
7.70 (m, 15H), 7.57 (t, 3H, J = 7.2 Hz), 7.47-7.32 (m, 4H), 7.39 (t, 2H, J = 6.3, 1.2Hz), 
6.00 (s, 1H), 5.59 (d, 1H, J = 9.3 Hz), 5.25 (t, 1H, J = 1.2 Hz), 4.93-4.89 (m, 1H), 4.46-
4.44 (m, 1H), 4.35 (t, 1H, J = 2.4Hz), 4.31-4.26 (m, 1H), 4.23 (t, 1H, J = 1.05 Hz), 3.69 
(t, 2H, J =7.8 Hz), 3.52-3.48 (m, 1H), 3.35 (s, 5H), 2.75-2.70 (m, 2H), 2.56-2.43 (m, 1H), 
2.35-2.27 (m, 2H), 2.02-1.95 (m, 5H),  1.87-1.79 (m, 3H); 
31
P NMR (242.9 MHz, CDCl3) 
20.61 (s), –144.3 (septet, J = 707.0 Hz); 19F NMR (282.4 MHz, CDCl3) –73.6 (d, J = 
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711.6 Hz); FABMS [m/z (%)] 961 (M
+
, 0.9), 167 (20), 150 (17), 149 (100), 113 (19), 95 
(14); HRMS (FAB) calcd for C49H49N2O
56
FeP
191
Ir: 961.2561; found 961.2507. 
 
(–)-2-[2Sp-Ferrocenyl](6aS,6bS)6b,7,8,9 tetrahydrospiro[pyrrolo[1',2':3,4] 
imidazo[5,1-b][1,3]oxazine-5,9'-xanthen]-11(6aH)-one (209). 
To a solution of syn-187 (760 mg, 1.73 mmol) in THF (15 mL) at –
78 °C was added t-BuLi (4.20 mL, 0.90 M in pentane, 3.80 mmol). 
After stirring for 30 min, a distinct color change from orange to 
orange-red was observed. The solution was quenched with a 
solution of xanthone (847 mg, 4.32 mmol) in THF (5 mL) and stirred for 30 min. at that 
temperature. On addition of xanthone, reaction mixture turned reddish-brown in color. 
Workup was conducted by addition of water (0.5 mL) and after warming to room 
temperature, the reaction mixture was extracted with diethyl ether (2 × 50 mL). The 
combined organic extract was washed with water, brine, dried over anhydrous Na2SO4 
and concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 3:7 EtOAc/hexanes, Rf = 0.30) afforded a mixture of starting material and 
product which was taken to the next step. The mixture was dissolved in CHCl3 and p-
toluenesulfonic acid monohydrate (657 mg, 3.45 mmol) was added and stirred for 10 
min.. The solution was quenched with saturated aqueous NaHCO3 (10 mL). The organic 
layer was washed with water and brine, dried over anhydrous Na2SO4 and concentrated 
under reduced pressure. Purification by flash column chromatography (silica gel, 3:7 
EtOAc/hexanes, R f= 0.20) afforded 209 (444 mg, 0.88 mmol, 51% over two steps); mp 
>230 ºC; [α]D
20
 –14 (c 1.0, CHCl3); IR (KBr) νmax 3075, 3040, 2959, 2928, 2893, 1713, 
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1598, 1510, 1450, 1394, 1238, 1042 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 7.97 (dd, 1H, J 
= 7.5, 1.2 Hz), 7.46-7.28 (m, 4H), 7.20-7.08 (m, 2H), 6.98 (td, 1H, J = 7.8, 1.2 Hz), 6.21 
(s, 1H), 4.98 (s, 1H), 4.03-3.97 (m, 1H), 3.90-3.86 (m, 6H), 3.78-3.69 (m, 1H), 3.55 (s, 
1H), 3.28-3.22 (m, 1H), 2.34-2.25 (m, 1H), 2.20-2.11 (m, 1H), 2.08-1.98 (m, 1H), 1.76-
1.62 (m, 1H); 
13
C NMR (75.5 MHz, CDCl3) δ 158.7, 150.4, 149.5, 130.5, 128.8, 128.5, 
128.3, 126.0, 125.1, 123.8, 122.9, 116.8, 116.3, 89.6, 85.7, 839, 72.3, 69.7, 64.4, 64.1, 
62.0, 59.3, 45.5, 28.5, 25.8; EIMS [m/z (%)] 504 (M
+
, 100), 407 (16), 181 (47), 70 (15), 
44 (16), 43 (49); HRMS (EI) calcd for C29H24N2O3
56
Fe: 504.1136; found 504.1148. Anal. 
calcd for C29H24N2O3
56
Fe: C, 69.06; H, 4.80. Found: C, 69.07, H, 4.85. 
(–)-2-[2Sp-Ferrocenyl](6aS,6bS)-6a,6b,7,8,9,11-hexahydrospiro[pyrrolo[1',2':3,4] 
imidazo[5,1-b][1,3]oxazine-5,9'-xanthene (210). 
To a solution of 209 (123 mg, 0.24 mmol) in THF (30 mL) at –78 
°C was added drop-wise a solution of DIBAL-H (1.10 mL, 1.00 M 
in hexanes, 2.51 mmol). The solution was left to warm up to room 
temperature for 20 h. The solution was cooled to 0 °C and quenched 
with sat. aq. potassium sodium tartrate. It was then stirred for 15 min. to separate aqueous 
and organic layers. The organic layer was washed with water and brine, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 5:4.5:0.5 EtOAc/hexanes/Et3N, Rf = 0.15) afforded 210 (60 
mg, 0.12 mmol, 50%) as an yellow solid; mp 220 ºC (dec.); [α]18D = +3 (c 1.5, CHCl3); 
IR (KBr) νmax 3072, 2925, 2850, 1469, 1448, 1362, 1278 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 7.83 (d, 1H, J = 7.5 Hz), 7.51 (d, 1H, J = 7.5 Hz), 7.41-7.30 (m, 3H), 7.20-7.13 
(m, 2H), 7.02-6.96 (m, 1H), 5.67 (s, 1H), 4.24 (s, 1H), 4.11 (d, 1H, J = 6.9 Hz), 4.04-3.99 
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(m, 1H, J = 6.6 Hz), 3.86 (d, 1H, J = 7.2 Hz), 3.78 (s, 5H), 3.73-3.72 (m, 2H), 3.32-3.26 
(m, 1H), 2.95-2.88 (m, 1H), 2.40-2.34 (m, 1H), 2.04-1.81 (m, 3H); 
13
C NMR (75.5 MHz, 
CDCl3): δ 150.9, 150.6, 132.0, 131.2, 128.2, 127.8, 125.0, 124.1, 123.5, 123.0, 116.7, 
116.5, 97.4, 93.8, 84.1, 75.5, 71.5, 70.8, 69.5, 63.4, 62.1, 59.2, 56.2, 30.6, 26.8; EIMS 
[m/z (%)] 490 (M
+
, 14), 86 (61), 84 (100), 71 (23), 69 (19), 55 (27); HRMS (EI) calcd for 
C29H26N2O2
56
Fe: 490.1343; found 490.1345. Anal. calcd for C29H26N2O2
56
Fe: C, 71.03; 
H, 5.34. Found: C, 71.01, H, 5.59. 
(–)-2-[2Sp-(9-Hydroxy-9H-fluoren-9-yl)ferrocenyl]-1R-triethylsilyloxy-7aS-hexa 
hydropyrrolo[1,2-c]imidazol-3-one (188k). 
To a solution of syn-187 (2.00 g, 4.54 mmol) in THF (40 mL) at 
–78 °C was added t-BuLi (10.0 mL, 1.00 M in pentane, 9.99 
mmol). After stirring for 30 min, a distinct color change from 
orange to orange-red was observed. The solution was quenched with a solution of 
fluorenone (2.03 g, 11.2 mmol) in THF (30 mL) and stirred for 30 min. at that 
temperature. Workup was conducted by addition of water (1.0 mL) and, after warming to 
room temperature, the reaction mixture was extracted with diethyl ether (2 × 50 mL). The 
combined organic extract was washed with water, brine, dried over anhydrous Na2SO4 
and concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 3:7 EtOAc/hexanes, Rf = 0.27) afforded 188k (2.04 g, 3.30 mmol, 71%) as a 
diastereomerically enriched orange solid; mp 205-206 ºC; [α]D
18
 +53 (c 1.0, CHCl3); IR 
(neat) νmax 3165, 2953, 2909, 2875, 1673, 1459, 1097, 1001 cm
–1
; 
1
H NMR (300 MHz, 
acetone-d6) δ 8.03 (s, 1H), 7.99-7.96 (m, 1H), 7.68-7.63 (m, 2H), 7.51 (d, 1H, J = 7.5 
Hz), 7.45-7.37 (m, 2H), 7.17 (t, 1H, J = 7.2 Hz), 7.07 (t, 1H, J = 7.5 Hz), 5.89 (d, 1H, J = 
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7.2 Hz), 4.78 (t, 1H, J = 1.8 Hz), 4.47 (m, 5H), 4.10-4.07 (m, 1H), 3.91 (t, 1H, J = 2.7 
Hz), 3.80-3.74 (m, 1H), 3.25-3.18 (m, 2H), 2.14-2.09 (m, 2H), 2.01-1.95 (m, 2H), 0.65 (t, 
9H, J = 7.8 Hz), 0.47-0.39 (m, 6H); 
13
C NMR (75.5 MHz, acetone-d6) δ 162.1, 153.7, 
152.2, 140.6, 138.8, 129.3, 128.4, 127.8, 127.7, 126.5, 126.4, 120.4, 119.9, 91.5, 88.8, 
84.3, 81.0, 70.9, 69.5, 68.7, 64.0, 63.2, 47.6, 26.4, 26.0, 6.83, 5.06; EIMS [m/z (%)] 498 
(M
+
, 5), 236 (20), 221 (35), 198 (11), 281 (28), 180 (100); HRMS (EI) calcd for 
C35H40N2O3Si
56
Fe: 620.2157; found 620.2149. Anal. calcd for C35H40N2O3Si
56
Fe: C, 
67.73; H, 6.50. Found: C, 68.00, H, 6.63. 
(–)-2-[2Sp-Ferrocenyl](6aS,6bS)6b,7,8,9-tetrahydrospiro[pyrrolo[1',2':3,4] 
imidazo[5,1-b][1,3]oxazine-5,9'-fluoren]-11(6aH)-one (211). 
To a solution of 188k (800 mg, 1.29 mmol) in CHCl3 (20 mL) at 
room temperature was added p-toluenesulfonic acid monohydrate 
(981 mg, 5.16 mmol). After stirring for 5 min, a distinct color 
change from orange to orange-brown was observed. The solution 
was quenched with saturated aqueous NaHCO3 (10 mL). The organic layer was washed 
with water and brine, dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. Purification by flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf 
= 0.14) afforded 211 (402 mg, 0.82 mmol, 64%), as an yellow solid; mp 210-212 ºC; 
[α]18D = –15 (c 1.0, CHCl3); IR (neat) νmax 3092, 2944, 2928, 2894, 2873, 1698, 1496, 
1448, 1392, 1106, 1027 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 8.14 (d, 1H, J = 3.6 Hz), 
7.68-7.66 (m, 1H), 7.54-7.45 (m, 3H), 7.27-7.23 (m, 1H), 7.10 (t, 1H, J = 7.5 Hz), 6.85 
(d, 1H, J = 7.5 Hz), 6.07 (s, 1H), 5.22 (s, 1H), 4.22 (s, 5H), 3.98 (s, 1H), 3.73-3.65 (m, 
2H), 3.22-3.14 (m, 2H), 2.13-1.95 (m, 2H), 1.93-1.89 (m, 1H), 1.66-1.62 (m, 1H); 
13
C 
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NMR (75.5 MHz, CDCl3) δ 158.7, 150.2, 148.1, 140.6, 137.7, 129.6, 129.0, 128.6, 127.2, 
125.9, 124.4, 120.2, 119.4, 92.5, 84.3, 83.8, 69.8, 63.9, 63.8, 60.9, 60.0, 45.3, 28.4, 25.7; 
EIMS [m/z (%)] 488 (M
+
, 75), 362 (14), 70 (15), 61 (15), 45 (15), 43 (100); HRMS (EI) 
calcd for C29H24N2O2
56
Fe: 488.1187; found 488.1177.  
(+)-2-[2Sp-Ferrocenyl](6aS,6bS)6a,6b,7,8,9,11-hexahydrospiro[pyrrolo[1',2':3,4] 
imidazo[5,1-b][1,3]oxazine-5,9'-fluorene (212). 
To a solution of 211 (402 mg, 0.82 mmol) in THF (30 mL) at –78 
°C was added drop-wise a solution of DIBAL-H (3.60 mL, 0.90 M 
in hexanes, 3.29 mmol). The solution was left to warm up to room 
temperature for 20 h. The solution was cooled to 0 °C and quenched 
with sat. aq. potassium sodium tartrate. It was then stirred for 15 min. to separate aqueous 
and organic layers. The organic layer was washed with water and brine, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 5:4.5:0.5 EtOAc/hexanes/Et3N, Rf = 0.20) afforded 212 (96 
mg, 0.20 mmol, 25%) as an yellow solid; mp 215-216 ºC; [α]18D = +94 (c 0.5, CHCl3); IR 
(neat) νmax 3080, 3022, 2922, 2870, 1497, 1447, 1151, 1028, 730 cm
–1
; 
1
H NMR (300 
MHz, CDCl3) δ  8.14 (t, 1H, J = 4.8 Hz), 7.69-7.66 (m, 1H), 7.55 (d, 1H, J = 7.2 Hz), 
7.46-7.43 (m, 2H), 7.30-7.25 (m, 1H), 7.12 (t, 1H, J = 7.2 Hz), 6.92 (d, 1H, J = 7.5 Hz), 
5.49 (s, 1H), 4.44 (s, 1H), 4.17 (s, 5H), 4.04 (q, 2H, J = 6.9 Hz), 3.87 (s, 1H), 3.65-3.63 
(m, 1H), 3.25 (s, 2H), 2.95-2.93 (m, 1H), 2.23-2.21 (m, 1H), 1.99-1.83 (m, 3H); 
13
C 
NMR (75.5 MHz, CDCl3): δ 150.9, 149.5, 140.4, 138.3, 129.1, 128.8, 128.2, 127.0, 
126.1, 124.4, 120.0, 119.3, 101.0, 91.5, 83.5, 77.2, 76.7, 75.2, 70.5, 69.6, 62.9, 61.3, 59.8, 
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55.8, 30.4, 26.5; EIMS [m/z (%)] 474 (M
+
, 84), 391 (16), 362 (14), 84 (24), 83 (100), 56 
(23); HRMS (EI) calcd for C29H26N2O
56
Fe: 474.1394; found 474.1382.  
 
(–)-Chloro[η4-1,5-cyclooctadiene[(–)-2-[2Sp-ferrocenyl-(6aS,6bS)6a,6b,7,8,9,11-hexa 
hydrospiropyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazine-5,9'-fluorene] 
ylidene]iridium (214). 
A solution of 212 (45.0 mg, 0.09 mmol) and tritylium 
tetrafluoroborate (31.0 mg, 0.09 mmol) in CH2Cl2 (2 mL) was 
stirred in a Schlenk flask at room temperature covered from light. 
After 16 h, solvent was removed in vacuo and the crude solid was 
washed with dry diethyl ether (3 × 5 mL) and dried in vacuo. To this was added Ir(μ-
Cl)(cod)]2 (32.0 mg, 0.05 mmol) and degassed THF (3 mL) in glovebox. The solution 
was cooled to –78 °C and with increased flow of argon, KOtBu (10.0 mg, 0.24 mmol) 
was added at –78 °C. The solution was allowed to warm up to room temperature and 
stirred for 16 h. The volatiles were removed under reduced pressure and purification of 
the residue by flash column chromatography (silica gel, 2:8 EtOAc/hexanes, Rf = 0.20) 
afforded 214 (21 mg, 0.02 mmol, 27 %). [α]18D = –6 (c 1.2, CHCl3); IR (CHCl3) νmax 
2981, 2926, 2876, 2853, 2838, 1518, 1448, 1428, 1215, 972, 913 cm
–1
; 
1
H NMR (600 
MHz, CDCl3)  δ 8.14 (s, 1H), 7.66 (d, 1H, J = 6.6 Hz), 7.54 (d, 1H, J = 7.2 Hz), 7.50-7.45 
(m, 3H), 7.10 (t, 1H, J = 7.8 Hz), 6.71 (d, 1H, J = 7.2 Hz), 6.39 (d, 1H, J = 3.0 Hz), 6.26 
(s, 1H), 4.85 (m, 1H), 4.71-4.70 (m, 1H), 4.52-4.48 (m, 1H), 4.34 (s, 5H), 4.05 (s, 1H), 
3.87 (m, 1H), 3.54 (m, 1H), 3.32-3.26 (m, 2H), 2.93 (m, 1H), 2.37-2.15 (m, 7H), 2.01-
1.99 (m, 1H), 1.88-1.72 (m, 4H); 
13
C NMR (150.9 MHz, CDCl3) δ 206.6, 140.5, 137.8, 
160 
 
129.9, 129.2, 128.7, 128.6, 127.6, 125.8, 124.0, 120.2, 119.8, 89.9, 86.9, 86.8, 85.0, 79.3, 
70.6, 69.4, 54.9, 51.4, 46.4, 34.1, 32.9, 29.8, 29.7, 29.1, 28.7, 28.0, 25.5; EIMS [m/z(%)] 
808 (M
+
, 24), 806 (14), 244 (13), 180 (28), 165 (17); HRMS (EI) calcd for 
C37H36N2O1
56
Fe
35
Cl
191
Ir: 808.1495; found 808.1512. 
(–)-2-[2Sp-(Dimethylhydroxymethyl)ferrocenyl]-1R-triethylsilyloxy-7aS hexahydro 
pyrrolo[1,2-c]imidazol-3-one (188l). 
To a solution of syn-187 (1.20 g, 2.72 mmol) in THF (25 mL) at –78 °C 
was added t-BuLi (5.30 mL, 1.12 M in pentane, 5.98 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with (CH3)2CO (0.55 mL, 6.80 mmol) and 
stirred for 30 min. at that temperature. Workup was conducted by addition of water (0.5 
mL) and, after warming to room temperature, the reaction mixture was extracted with 
diethyl ether (2 × 40 mL). The combined organic extract was washed with water, brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.26) afforded 188l 
(537 mg, 1.1 mmol, 36%) as a diastereomerically enriched orange solid; mp 129-131 ºC; 
[α]D
20
 –6 (c 1.0, acetone); IR (KBr) νmax 3302, 3102, 2955, 2910, 2877, 1680, 1469, 1382, 
1287 cm
–1
; 
1
H NMR (300 MHz, acetone-d6) δ 6.03 (s, 1H), 5.65 (d, 1H, J = 7.2 Hz), 4.48 
(t, 1H, J = 2.1 Hz), 4.33 (s, 5H), 4.19 (t, 1H, J = 2.7 Hz), 4.05-3.98 (m, 2H), 3.61-3.54 
(m, 1H), 3.11-3.03 (m, 1H), 1.95-1.86 (m, 4H), 1.42 (s, 3H), 1.27 (s, 3H), 0.81 (t, 9H, J = 
8.1 Hz), 0.47 (q, 6H, J = 7.8 Hz); 
13
C NMR (75.5 MHz, acetone-d6) δ 161.2, 92.9, 91.4, 
85.3, 70.4, 68.5, 67.5, 67.3, 63.8, 62.8, 47.3, 32.0, 31.2, 30.6, 26.4, 26.2, 7.0, 5.2; EIMS 
[m/z (%)] 498 (M
+
, 8), 415 (18), 366 (30), 348 (43), 267 (76), 243 (17); HRMS (EI) calcd 
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for C25H38N2O3Si
56
Fe: 498.2001; found 498.2012. Anal. calcd for C25H38N2O3Si
56
Fe: C, 
60.23; H, 7.68. Found: C, 60.75, H, 7.77. 
 
(–)-2-[2Sp-5,5-Dimethyl-ferrocenyl](6aS,6bS)6b,7,8,9-tetrahydro-5H-pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazin-11(6aH)-one (215). 
To a solution of 188l (493 mg, 1.00 mmol) in CHCl3 (10 mL) at room 
temperature was added p-toluenesulfonic acid monohydrate (380 mg, 
2.00 mmol). After stirring for 5 min, a distinct color change from 
orange to orange-brown was observed. The solution was quenched with saturated 
aqueous NaHCO3 (10 mL). The organic layer was washed with water and brine, dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash 
column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.20) afforded 215 (158 mg, 
0.43 mmol, 32%), as an yellow solid and recovered 188l (101 mg, 0.20 mmol, 20%); mp 
166-167 ºC; [α]20D = –186 (c 1.0, CHCl3); IR (KBr) νmax 3026, 3009, 2980, 1700, 1507, 
1452, 1380, 1400, 1253 cm
–1
; 
1
H NMR (300 MHz, acetone-d6) δ 5.52 (s, 1H), 4.86 (s, 
1H), 4.22 (s, 5H), 3.98 (t, 1H, J = 4.8 Hz), 3.93 (s, 1H), 3.60-3.44 (m, 2H), 3.03-2.95 (m, 
1H), 2.16-2.04 (m, 1H), 1.98-1.85 (m, 2H), 1.82 (s, 3H), 1.68-1.61 (m, 1H), 1.29 (s, 3H); 
13
C NMR (75.5 MHz, acetone-d6) δ 159.2, 93.2, 83.0, 82.1, 75.1, 70.0, 64.3, 63.1, 61.0, 
60.3, 46.1, 32.7, 31.1, 29.0, 26.2; EIMS [m/z (%)] 366 (M
+
, 100), 267 (39), 121 (19), 56 
(14); HRMS (EI) calcd for C19H22N2O2
56
Fe: 366.1030; found 366.1039. Anal. calcd for 
C19H22N2O2
56
Fe: C, 62.31; H, 6.05. Found: C, 62.38, H, 6.09. 
(–)-2-2Sp-Ferrocenyl-[(S)-2-(2-(methyl(pyrrolidin-2-ylmethyl)amino)phenyl)] 
propan-2-ol (216). 
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To a solution of 215 (20.0 mg, 0.05 mmol) in THF (2 mL) at –78 °C 
was added drop-wise a solution of DIBAL-H (0.10 mL, 1.00 M in 
hexanes, 0.11 mmol). The solution was left to warm up to room 
temperature for 20 h. The solution was cooled to 0 °C and quenched with sat. aq. 
potassium sodium tartrate. It was then stirred for 15 min. to separate aqueous and organic 
layers. The organic layer was washed with water and brine, dried over anhydrous Na2SO4 
and concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 5:4.6:0.4 EtOAc/hexanes/Et3N, Rf = 0.14) afforded 216 (15 mg, 0.04 mmol, 
76%), as an yellow oil; [α]18D = –506 (c 0.8, CHCl3); IR (neat) νmax 3548, 3341, 3092, 
2967, 2941, 2835, 2778, 1508, 1148 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 4.19 (s, 5H), 
3.84 (m, 3H), 3.11 (t, 1H, J = 5.7 Hz), 3.01 (m, 1H), 2.91-2.87 (m, 1H), 2.41 (s, 4H), 2.25 
(q, 1H, J = 6.6 Hz), 1.99-1.93 (m, 1H), 1.86-1.81 (m, 3H), 1.80 (s, 3H), 1.78 (s, 3H); 
13
C 
NMR (75.5 MHz, CDCl3) δ 85.1, 70.0, 69.1, 67.9, 64.9, 63.0, 60.9, 57.5, 54.7, 49.7, 40.8, 
30.5, 29.5, 27.1, 22.8; EIMS [m/z (%)] 356 (M
+
, 5), 338 (20), 211 (12), 133 (10), 132 
(26), 131 (31); HRMS (EI) calcd for C19H28N2O
56
Fe: 356.1551; found 356.1546. 
 (+)-2-[2Sp-(Hydroxymethyl)ferrocenyl]-1R-triethylsilyloxy-7aS hexahydropyrrolo 
[1,2-c]imidazol-3-one (217). 
To a solution of 188h (aldehyde above) (780 mg, 0.67 mmol) in MeOH 
(15 mL) at 0 ºC was added NaBH4 (126 mg, 3.34 mmol) in H2O (2 mL). 
After stirring for 30 min, a distinct color change from red-orange to 
orange was observed. The solution was quenched a solution of NH4Cl (2 mL). The crude 
mixture was washed with water, brine, dried over anhydrous Na2SO4 and concentrated 
under reduced pressure. Purification by flash column chromatography (silica gel, 3:7 
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EtOAc/hexanes, Rf = 0.20) afforded 217 (454 mg, 0.96 mmol, 58%) as an orange solid; 
mp 161-165 ºC; [α]D
20
 +16 (c 1.0, acetone); IR (KBr) νmax 3400, 3084, 2963, 2935, 2906, 
1713, 1500, 1394, 1331 cm
–1
; 
1
H NMR (300 MHz, acetone-d6) δ 5.63 (d, 1H, J = 6.0 Hz), 
4.33-4.32 (m, 1H), 4.29 (s, 5H), 4.25-4.24 (m, 1H), 4.19-4.15 (m, 1H), 4.12-4.10 (m, 
3H), 4.07 (t, 1H, J = 2.7 Hz), 3.50-3.42 (m, 1H), 3.12-3.05 (m, 1H), 2.00-1.96 (m, 2H), 
1.86-1.84 (m, 1H), 1.33-1.31 (m, 1H), 0.93 (t, 9H, J = 8.1 Hz), 0.68-0.61 (m, 6H); 
13
C 
NMR (75.5 MHz, acetone-d6) δ 159.6, 93.8, 85.7, 85.2, 69.2, 67.6, 64.3, 63.6, 61.6, 57.4, 
45.3, 26.6, 25.1, 6.22, 4.7; EIMS [m/z (%)] 470 (M
+
, 3), 338 (82), 149 (25), 121 (33), 103 
(100), 97 (12); HRMS (EI) calcd for C23H34N2O3Si
56
Fe: 470.1689; found 470.1690.  
(–)2-[2Sp-Ferrocenyl](6aR,6bS)-6b,7,8,9-tetrahydro-5H-pyrrolo[1',2':3,4]imidazo 
[5,1-b][1,3]oxazin-11(6aH)-one (218). 
To a solution of 217 (450 mg, 0.95 mmol) in CHCl3 (10 mL) at room 
temperature was added p-toluenesulfonic acid monohydrate (363 mg, 
1.91 mmol).  After stirring for 5 min, a distinct color change from 
orange to orange-brown was observed. The solution was quenched with saturated 
aqueous NaHCO3 (15 mL). The organic layer was washed with water and brine, dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash 
column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.30) afforded 218 (108 mg, 
0.32 mmol, 33%) as an yellow solid; mp 150-152 ºC; [α]20D = –96 (c 1.0, acetone); IR 
(KBr)  νmax 3084, 2976, 2928, 1716, 1503, 1402, 1382, 1257 cm
–1
; 
1
H NMR (300 MHz, 
acetone-d6) δ 5.05 (d, 1H, J = 7.5 Hz), 4.82 (d, 1H, J = 13.2 Hz), 4.64 (t, 1H, J = 13.5 
Hz), 4.31 (s, 1H), 4.07-4.01 (m, 7H), 3.92 (d, 1H, J = 2.4 Hz), 3.68-3.60 (m, 1H), 3.09-
3.01 (m, 1H), 2.11-1.86 (m, 4H); 
13
C NMR (75.5 MHz, acetone-d6) δ 160.5, 94.7, 84.0, 
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75.7, 70.7, 70.5, 66.9, 63.7, 61.5, 60.9, 56.4, 46.5, 26.4, 25.4; EIMS [m/z (%)] 338 (M
+
, 
100), 121 (17), 56 (11);  HRMS (EI) calcd for C17H18N2O2
56
Fe: 338.0717; found 
338.0714. Anal. calcd for C17H18N2O2
56
Fe: C, 60.38; H, 5.36. Found: C, 60.29, H, 5.53. 
(–)2-2Sp[(S)-N,2-Dimethyl-N-(pyrrolidin-2-ylmethyl)]ferrocene (219). 
To a solution of 218 (104 mg, 0.31 mmol) in THF (15 mL) at –78 °C 
was added drop-wise a solution of DIBAL-H (1.40 mL, 1.00 M in 
hexanes, 1.23 mmol). The solution was left to warm up to room 
temperature for 20 h. As the reaction was incomplete, the reaction mixture was again 
cooled to 0 °C and another four equivalents of DIBAL-H (1.40 mL) was added to it and 
stirred for another 5 h at room temperature. The solution was cooled to 0 °C and 
quenched with sat. aq. potassium sodium tartrate. It was then stirred for 15 min. to 
separate aqueous and organic layers. The organic layer was washed with water and brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
flash column chromatography (silica gel, 5:4.6:0.4 EtOAc/hexanes/Et3N, Rf = 0.3) 
afforded 219 (80 mg, 0.26 mmol, 82%) as an yellow oil; [α]18D = –166 (c 1.0, CHCl3); IR 
(neat) νmax 3433, 3386, 3336, 3091, 2963, 2943, 2836, 2782, 1512, 1469, 1210 cm
–1
; 
1
H 
NMR (300 MHz, CDCl3) δ 4.03 (s, 5H), 3.87 (s, 1H), 3.73-3.70 (m, 2H), 3.14-3.06 (m, 
2H), 3.01-2.95 (m, 1H), 2.68-2.64 (m, 1H), 2.47-2.42 (m, 4H), 2.24 (q, 1H, J = 9.0 Hz), 
1.99-1.77 (m, 4H), 1.75-1.69 (m, 3H); 
13
C NMR (75.5 MHz, CDCl3) δ 109.7, 70.2, 68.4, 
65.4, 64.8, 60.1, 57.6, 54.1, 48.4, 40.6, 28.8, 22.9; EIMS [m/z (%)] 312 (M
+
, 100), 200 
(47), 121 (87), 77 (49), 56 (58); HRMS (EI) calcd for C17H24N2
56
Fe: 312.1289; found 
312.1289.   
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 (–)-2-[2Sp-1-(Bis(3,5-bis(trifluoromethyl)phenyl)phosphino)-5,5-diphenyl-
ferrocenyl](6aS,6bS)-6b,7,8,9-tetrahydro-5H-pyrrolo[1',2':3,4]imidazo[5,1-
b][1,3]oxazin-11(6aH)-one (220a). 
To a solution of anti-194 (300 mg, 0.61 mmol) and TMEDA 
(0.15 mL, 0.73 mmol) in THF (12 mL) at –78 °C was added t-
BuLi (0.60 mL, 1.25 M in pentane, 0.73 mmol). After stirring for 
30 min, a distinct color change from orange to orange-red was 
observed. The solution was quenched with 1-chloro-3,5-bis-trifluoromethyl benzene 
(0.30 mL, 0.92 mmol) and stirred for 1 h at that temperature. Workup was conducted by 
addition of water (0.5 mL) and, after warming to room temperature, the reaction mixture 
was extracted with diethyl ether (2 × 20 mL). The combined organic extract was washed 
with water, brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.40) 
afforded 220a (300 mg, 0.32 mmol, 52%) as orange solid; mp 129-130 °C; [α]20D = −41 
(c 1.0, CHCl3); IR (KBr) νmax 3090, 3028, 2964, 2925, 1719, 1619, 1475, 1279 cm
–1
; 
1
H 
NMR (300 MHz, CDCl3) δ  8.02-7.97 (m, 3H), 7.80 (s, 1H), 7.72-7.66 (m, 4H), 7.55 (t, 
3H, J = 6.9 Hz), 7.47 (t, 1H, J = 7.2 Hz), 7.24-7.20 (m, 2H), 6.92-6.89 (m, 2H), 5.60 (s, 
1H), 4.26 (d, 1H, J = 2.4 Hz), 3.87 (dd, 1H, J = 10.5, 6 Hz), 3.65-3.56 (m, 2H), 3.49 (s, 
5H), 3.14-3.06 (m, 1H), 2.25-1.89 (m, 3H), 1.97 (m, 1H); 
13
C NMR (75.5 MHz, CDCl3) δ 
158.5, 146.3, 144.7 (t, J = 9.1 Hz), 141.9 (d, J = 18.1 Hz), 135.5 (d, J = 26.4 Hz), 131.4 
(d, J = 30.2 Hz), 128.1 (d, J = 3.8 Hz), 127.8 (d, J = 4.5 Hz), 126.1, 125.1, 124.8, 123.5, 
122.0, 121.2, 97.6 (d, J = 27.9 Hz), 85.1 (d, J = 4.5 Hz), 83.4, 82.5, 70.9, 67.7, 66.7, 66.4, 
63.8, 45.4, 27.7, 25.6; 
31
P NMR (242.9 MHz, CDCl3) –19.1; 
19
F NMR (564.7 MHz, 
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CDCl3) –62.8 (d, J = 16.9 Hz); FABMS [m/z (%)] 946 (M
+
, 100), 105 (39), 82 (16), 77 
(18), 70 (29), 56 (23), 55 (19); HRMS (FAB) calcd for C45H31O2F12PN2
56
Fe: 946.1281; 
found 946.1110. Anal. calcd for C45H31O2F12PN2
56
Fe·H2O: C, 56.03; H, 3.45. Found: C, 
56.02, H, 3.38.   
(–)-2-[2Sp-1-(Bis(4-(trifluoromethyl)phenyl)phosphino)-5,5-diphenyl] 
(6aS,6bS)-6b,7,8,9-tetrahydro-5H-pyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazin-
11(6aH)-one (220b). 
To a solution of anti-194  (300 mg, 0.61 mmol) and TMEDA (0.15 
mL, 0.73 mmol) in THF (10 mL) at –78 °C was added t-BuLi (0.70 
mL, 1.00 M in pentane, 0.73 mmol). After stirring for 30 min, a 
distinct color change from orange to orange-red was observed. The 
solution was quenched with 1-chloro-4-trifluoromethyl benzene (327 mg, 0.92 mmol) in 
THF (2 mL) and stirred for 1 h at that temperature. Workup was conducted by addition of 
water (0.5 mL) and, after warming to room temperature, the reaction mixture was 
extracted with diethyl ether (2 × 20 mL). The combined organic extract was washed with 
water, brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 2:8 EtOAc/hexanes, Rf = 0.33) 
afforded 220b (239 mg, 0.29 mmol, 62%) as an glassy orange solid; [α]20D = –58 (c 0.8, 
CHCl3); IR (KBr) νmax 3091, 3060, 3031, 2952, 2923, 2852, 1720, 1466, 1322, 1124 cm
–
1
; 
1
H NMR (300 MHz, CDCl3) δ 7.77-7.63 (m, 6H), 7.56-7.50 (s, 4H), 7.45-7.34 (m, 3H), 
7.23-7.20 (m, 3H), 6.99-6.95 (m, 2H), 5.62 (s, 1H), 4.21 (d, 1H, J = 2.1 Hz), 3.89-3.79 
(m, 2H), 3.71-3.62 (m, 1H), 3.47 (s, 5H), 3.12-3.04 (m, 1H), 2.22-2.11 (m, 2H), 1.96-
1.91 (m, 1H), 1.66-1.55 (m, 2H); 
13
C NMR (75.5 MHz, CDCl3): δ 158.6, 146.6, 145.1, 
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136.5 (d, J = 23.4 Hz), 132.0 (d, J = 16.6 Hz), 128.1, 128.0, 127.9, 127.7, 127.6, 126.1, 
124.9, 124.5, 96.7, 84.2, 83.5, 82.4, 71.0, 67.5 (d, J = 5.3 Hz), 67.1, 63.7, 45.6, 27.7, 
25.6; 
31
P NMR (121.5 MHz, CDCl3) –20.9; 
19
F NMR (282.4 MHz, CDCl3) –62.6 (d, J = 
70.6 Hz); FABMS [m/z(%)] 810 (M
+
, 26), 71 (52), 67 (59), 57 (87), 55 (100), 43 (99), 41 
(96); HRMS (FAB) calcd for C43H33O2F6PN2
56
Fe: 810.1533; found 810.1372. Anal. 
calcd for C43H33O2F6PN2
56
Fe: C, 63.72; H, 4.10. Found: C, 63.03, H, 4.53. 
(+)-2-[2Sp-1-Iodo-5,5-diphenyl-ferrocenyl](6aS,6bS)-6b,7,8,9-tetrahydro-5H- 
pyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazin-11(6aH)-one (221). 
To a solution of anti-194 (903 mg, 1.84 mmol) and TMEDA (0.45 mL, 
2.21 mmol) in THF (20 mL) at –78 °C was added t-BuLi (2.00 mL, 
1.00 M in pentane, 2.21 mmol). After stirring for 30 min, the reaction 
mixture became orange-red. The solution was quenched with 1, 2- diiodoethane (779 mg, 
2.76 mmol) in THF (2 mL) and stirred for 1 h at that temperature. Workup was conducted 
by addition of water (0.5 mL) and, after warming to room temperature, the reaction 
mixture was extracted with diethyl ether (2 × 40 mL). The combined organic extract was 
washed with water, brine, dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. Purification by flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf 
= 0.17) afforded 221 (824 mg, 1.33 mmol, 73%) as orange solid; mp > 230 °C; [α]20D = 
+4 (c 3.0, CHCl3); IR (neat) νmax 3084, 3057, 2963, 2925, 2892, 1718, 1469, 1445, 1377, 
1319, 1215, 1175, 1107, 751, 695 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ  7.63-7.61 (d, 2H, 
J = 7.5 Hz), 7.53-7.48 (t, 2H, J = 7.2 Hz), 7.44-7.39 (t, 1H, J = 7.2 Hz), 7.14-7.13 (m, 
3H), 6.91-6.90 (m, 2H), 5.64 (s, 1H), 4.41 (s, 1H), 4.16 (s, 1H), 3.85-3.75 (m, 1H), 3.68 
(m, 6H), 3.17-3.11 (t, 1H, J = 8.4 Hz), 2.16-2.04 (m, 2H), 1.97-1.95 (m, 1H), 1.69-1.60 
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(q, 1H, J = 9.3 Hz); 
13
C NMR (75.5 MHz, CDCl3): δ 159.3, 146.2, 145.3, 127.9, 127.7, 
127.5, 126.1, 96.1, 83.6, 82.2, 81.7, 73.5, 72.1, 65.8, 63.5, 45.8, 32.5, 27.0, 25.6; EIMS 
[m/z (%)] 616 (M
+
, 100), 390 (37), 334 (38), 128 (34), 127 (37), 105 (52), 65 (48); 
HRMS (EI) calcd for C29H25O2N2
56
FeI: 616.0310; found 616.0339. Anal. calcd for 
C29H25O2N2
56
FeI: C, 56.52; H, 4.09. Found: C, 56.70, H, 4.24. 
(+)-2-[2Sp-1-Iodo-5,5-diphenyl-ferrocenyl](6aS,6bS)-6a,6b,7,8,9,11-hexahydro-5H- 
pyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazine (222). 
To a solution of 221 (500 mg, 0.82 mmol) in THF (30 mL) at –78 °C 
was added drop-wise a solution of DIBAL-H (4.00 mL, 0.90 M in 
hexanes, 3.25 mmol). The solution was left to warm up to room 
temperature for 20 h. The reaction mixture was cooled to 0 °C and quenched with sat. aq. 
potassium sodium tartrate. It was then stirred for 15 min. to separate aqueous and organic 
layers. The organic layer was washed with water and brine, dried over anhydrous Na2SO4 
and concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 5:4.5:0.5 EtOAc/hexanes/Et3N, Rf = 0.16) afforded 222 (277 mg, 0.46 mmol, 
57%) as orange solid; mp 198-199 ºC; [α]20D = +141 (c 3.5, CHCl3); IR (KBr) νmax 3086, 
2965, 2917, 2869, 2842, 1459, 1447, 1105, 1001, 754 cm
–1
; 
1
H NMR (300 MHz, CDCl3) 
δ  7.65 (d, 2H, J = 8.1 Hz), 7.48 (t, 2H, J = 7.2 Hz), 7.38 (t, 1H, J = 7.2 Hz), 7.14-7.09 
(m, 3H), 6.97-6.94 (m, 2H), 5.01 (s, 1H), 4.45 (d, 1H, J = 7.2 Hz), 4.31 (d, 1H, J = 2.4 
Hz), 4.00 (d, 1H, J = 2.4 Hz), 3.84 (t, 2H, J = 7.8 Hz), 3.69 (s, 5H), 3.34-3.29 (m, 1H), 
3.02-2.94 (m, 1H), 2.34-2.28 (m, 1H), 1.96-1.81 (m, 3H); 
13
C NMR (75.5 MHz, CDCl3) δ 
147.1, 145.7, 127.8, 127.6, 127.3, 127.1, 126.3, 101.5, 92.1, 81.7, 81.2, 73.4, 73.0, 69.8, 
69.2, 64.7, 56.0, 37.6, 30.7, 26.7; EIMS [m/z(%)] 602 (M
+
, 29), 270 (16), 86 (11), 83 
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(100), 55 (11); HRMS (EI) calcd for C29H27IN2O
256
Fe: 602.0517; found 602.0531. Anal. 
calcd for C29H27IN2O
256
Fe: C, 57.83; H, 4.52. Found: C, 58.02, H, 4.63. 
(+)-2-[2Sp-1-(Diphenylphosphino)-5,5-diphenyl-ferrocenyl](6aS,6bS)-6a,6b,7,8,9,11-
hexahydro-5H-pyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazine (223). 
To a solution of 222 (153 mg, 0.25 mmol) in THF (3 mL) at –78 °C 
was added n-BuLi (0.25 mL, 1.50 M in hexanes, 0.37 mmol). After 
stirring for 1h, the solution was quenched with 1-chloro-diphenyl 
phosphine (0.09 mL, 0.50 mmol) and stirred for 1 h at that temperature. Workup was 
conducted by addition of water (1 mL) and, after warming to room temperature, the 
reaction mixture was extracted with CH2Cl2 (2 × 20 mL). The combined organic extract 
was washed with water, brine, dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. Purification by flash column chromatography (silica gel, 3:6.5:0.5 
EtOAc/hexanes/Et3N, Rf = 0.25) afforded 223 (104 mg, 0.16 mmol, 63%) as an orange 
solid; mp 114-115 ºC; [α]D
20
 +160 (c 1.2, CHCl3); IR (neat) νmax 3054, 2956, 2920, 2849, 
1492, 1447, 1432, 1165, 1130, 696 cm
–1
; 
1
H NMR (300 MHz, CD2Cl2) δ 7.69-7.67 (m, 
2H), 7.64-7.58 (m, 2H), 7.52 (t, 2H, J = 7.8 Hz), 7.42-7.32 (m, 9H), 7.23-7.18 (m, 3H), 
7.03-7.00 (m, 2H), 5.02 (d, 1H, J = 0.6 Hz), 4.11 (d, 1H, J = 2.7 Hz), 3.68 (dd, 1H, J = 
2.7, 1.2 Hz), 3.65-3.60 (m, 1H), 3.55 (s, 5H), 3.52 (s, 2H), 3.05-3.00 (m, 1H), 2.27-2.19 
(m, 1H), 1.93-1.68 (m, 3H); 
13
C NMR (75.5 MHz, CD2Cl2) δ 146.7, 140.9 (d, J = 10.6 
Hz), 134.6 (d, J = 9.8 Hz), 135.5 (d, J = 21.1 Hz), 132.9 (d, J = 18.9 Hz), 129.6, 128.6 (t, 
J = 7.5 Hz), 128.5, 128.0 (d, J = 7.5 Hz), 127.6, 127.4, 126.8, 104.9 (d, J = 23.4 Hz), 
92.7, 84.9 (d, J = 4.5 Hz), 81.8, 75.7 (d, J = 5.3 Hz), 71.2, 71.1, 70.1, 67.1, 65.8, 56.5, 
31.1, 27.0; 
31
P NMR (121.5 MHz, CDCl3) –24.5; EIMS [m/z (%)] 660 (M
+
, 100), 228 
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(59), 183 (55), 160 (43), 56 (85); HRMS (EI) calcd for C41H37N2OP
56
Fe: 660.1993; 
found 660.1991. Anal. calcd for C41H37N2OP
56
Fe: C, 74.55; H, 5.65. Found: C, 74.03, H, 
6.11. 
(+)-2-[2Sp-5,5-Diphenyl-ferrocenyl](6aS,6bS)-6a,6b,7,8,9,11-hexahydro-5H-pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazin-1-yl)diphenyl(trityl)phosphonium 
tetrafluoroborate (224). 
A solution of 223 (66.0 mg, 0.10 mmol) and tritylium 
tetrafluoroborate (33.0 mg, 0.10 mmol) in CH2Cl2 (2 mL) was stirred 
in a Schlenk flask at room temperature covered from light. The color 
of the reaction mixture went reddish orange immediately and was stirred for 4 h at room 
temperature. To the reaction mixture was added Et2O, the resulting precipitate was 
filtered, washed with Et2O (3 × 5 mL) and dried to get 224 (40 mg, 0.04 mmol, 40 %) as 
an orange powder. mp 195-196 ºC; [α]D
20
 +77 (c 1.5, CHCl3); IR (neat) νmax 3054, 2956, 
2920, 2849,1593, 1492, 1439, 1107, 1047, 644 cm
–1
; 
1
H NMR (300 MHz, CD2Cl2) δ 
7.93-7.58 (m, 20H), 7.34-7.15 (m, 13H), 6.97 (s, 2H), 5.74 (s, 1H), 4.85 (s, 1H), 4.20 (s, 
1H), 3.99 (m, 1H), 3.74 (s, 5H), 3.55 (d, 1H, J = 6.6 Hz),  3.11 (m, 1H), 2.65 (d, 1H, J = 
6.0 Hz), 2.33 (m, 1H), 1.99-1.87 (m, 3H), 1.70 (m, 1H); 
13
C NMR (75.5 MHz, CD2Cl2) δ 
153.7, 146.1, 145.1, 142.3 (d, J = 5.3 Hz), 136.4, 134.4 (d, J = 11.3 Hz), 131.8 (d, J = 
13.6 Hz), 131.0 (d, J = 11.3 Hz), 129.7 (d, J = 2.3 Hz), 129.1, 128.9, 128.7, 128.5, 127.9, 
127.5, 126.1, 119.1, 117.8, 101.1, 91.9, 82.3, 77.9, 73.3, 72.9, 72.3, 71.2, 70.5, 70.4 (d, J 
= 9.1 Hz), 59.1, 57.7, 57.4, 57.1, 30.3, 26.5; 
31
P NMR (121.5 MHz, CDCl3) 27.5; 
11
B 
(96.3 MHz) –1.17; 19F (282.4 MHz) –152.0; MALDI-MS [m/z(%)] 903 (M+, 20), 821 
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(60), 820 (93), 684 (65), 622 (44); HRMS (MALDI-TOF) calcd for C60H52N2O
56
FeP
+
: 
903.3166; found 903.3112.  
(+)-2-[2Sp-5,5-Diphenyl-ferrocenyl](6aS,6bS)-6a,6b,7,8,9,11-hexahydro-5H-
pyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazin-1-yl)diphenylphosphine sulphide (225). 
To a solution of 223 (45.0 mg, 0.07 mmol) in benzene (2 mL) was 
added sulphur [2.00 mg (recrystallized from benzene), 0.07 mmol] and 
the solution was heated at reflux for 2 h. Benzene was removed under 
reduced pressure and the crude mixture was passed through a pad of deactivated silica 
and washed with EtOAc to obtain 225 (34 mg, 0.05 mmol, 72%) as orange solid. mp 145-
146 ºC; Rf = 0.15 (3:6.6:0.4 EtOAc/hexanes/Et3N); [α]
20
D = +147 (c 3.0, CHCl3); IR 
(neat) νmax 3052, 2955, 2916, 2862, 2838, 1479, 1447, 1147, 981 cm
–1
; 
1
H NMR (300 
MHz, CDCl3) δ  7.98-7.86 (m, 4H), 7.69-7.66 (m, 4H), 7.80 (s, 1H), 7.63 (d, 2H, J = 5.4 
Hz), 4.34 (dd, 1H, J = 7.8, 2.4 Hz), 4.19 (s, 5H), 4.17 (s, 1H), 4.44 (s, 5H), 4.26 (s, 1H), 
3.67 (d, 1H, J = 8.1 Hz), 3.56 (s, 2H), 2.92-2.89 (m, 1H), 2.79 (t, 1H, J = 8.4 Hz), 2.62 
(dd, 1H, J = 8.7, 2.4 Hz), 1.91-1.84 (m, 2H), 1.49-1.44 (m, 2H), 1.13-1.09 (m, 2H); 
13
C 
NMR (75.5 MHz, CDCl3): δ 138.3 (d, J = 66.6 Hz), 137.2 (d, J = 65.5 Hz), 137.6, 136.8, 
133.6, 133.2, 132.9 (d, J = 11.0 Hz), 132.1 (d, J = 11.2 Hz), 125.1 (s, J = 3.6 Hz), 121.7, 
109.3 (d, J = 8.9 Hz), 77.5, 72.1, 71.9, 71.3, 69.9, 66.4, 65.6 (d, J = 10.9 Hz), 65.1, 64.8 
(d, J = 9.2 Hz), 62.9, 57.8, 55.2, 32.5, 25.8; 
31
P NMR (121.5 MHz, CDCl3) 43.2; EIMS 
[m/z (%)] 692 (M
+
, 64), 629 (14), 627 (100), 545 (18), 544 (43), 83 (23), 55 (13); HRMS 
(EI) calcd for C41H37
56
FeN2OPS: 692.1713; found 692.1705. Anal. calcd for 
C41H37
56
FeN2OPS: C, 71.10; H, 5.38. Found: C, 71.15, H, 5.32. 
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(–)-Chloro[η4-1,5-cyclooctadiene]2-[2Sp-5,5-diphenyl-ferrocenyl](6aS,6bS)-
6a,6b,7,8,9,11-hexahydro-5H- pyrrolo[1',2':3,4] imidazol-2-ylidene]rhodium (226). 
A solution of 195 (80.0 mg, 0.17 mmol) and tritylium 
tetrafluoroborate (55.0 mg, 0.17 mmol) in CH2Cl2 (2 mL) was 
stirred in a Schlenk flask at room temperature covered from light. 
After 5 h, solvent was removed in vacuo and the crude solid was washed with dry diethyl 
ether (3 × 5 mL) and dried in vacuo. To this was added Rh(μ-Cl)(cod)]2 (41.0 mg, 0.08 
mmol) and degassed THF (6 mL) in glovebox. The solution was cooled to –78 °C and 
with increased flow of argon, KOtBu (19.0 mg, 0.17 mmol) was added at –78 °C and the 
reaction mixture was allowed to warm to room temperature and stirred for 16 h. The 
volatiles were removed under reduced pressure and purification of the residue by flash 
column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.25) afforded 226 (59 mg, 
0.08 mmol, 49%) as orange crystalline solid; mp 181-184 °C; [α]D
20 –216 (c 1.0, CHCl3); 
IR (KBr) νmax 2960, 2916, 2873, 2827, 1523, 1402, 1252 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 7.67 (d, 2H, J = 7.5 Hz), 7.51 (t, 2H, J = 7.2 Hz), 7.42 (t, 1H, J = 7.2 Hz ), 
7.14-7.12 (m, 3H), 6.86-6.83 (m, 2H), 6.53 (s, 1H), 5.71 (d, 1H, J = 3.6 Hz), 5.23-5.21 
(m, 1H), 5.11-5.06 (m, 1H), 4.66-4.57 (m, 1H), 4.27 (s, 1H), 3.96 (m, 2H), 3.81 (s, 5H), 
3.67-3.56 (m, 2H), 3.20-3.15 (m, 1H), 2.48-2.17 (m, 5H), 1.99-1.97 (m, 5H), 1.67-1.61 
(m, 2H); 
13
C NMR (75.5 MHz, CDCl3) δ 212.7, 146.5, 144.9, 127.9, 127.8, 127.7, 127.5, 
126.2, 100.4, 99.9, 99.8, 88.9, 81.5, 70.9, 70.6, 68.7, 67.3, 67.1, 64.8, 64.3, 62.1, 46.6, 
33.1, 32.7, 29.1, 28.6, 28.4, 25.6; FABMS [m/z (%)] 810 (M
+
, 2), 95 (50), 91 (36), 67 
(70), 55 (100), 43 (99), 39 (54), 29 (73); HRMS (FAB) calcd for C37H38N2OClFeRh: 
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720.1077; found 720.1023. Anal. calcd for C37H38N2OCl
56
FeRh·H2O: C, 61.64; H, 5.31. 
Found: C, 61.06; H, 5.61. 
(–)-2-[2Sp-(5,5-Diphenyl-ferrocenyl](6aS,6bS)-6a,6b,7,8,9,11-hexahydro-5H-
pyrrolo[1',2':3,4]imidazol-2-ylidene)diformylrhodium(IV) chloride (227). 
A solution of 226 (16.0 mg, 0.02 mmol) in CH2Cl2 (1 mL) was 
bubbled with carbon monoxide for 2 h. The volatiles were removed 
and purification by flash column chromatography (silicagel, 3:7 
EtOAc/hexanes, Rf = 0.44) afforded 227 (12 mg, 0.02 mmol, 92%) as glassy orange solid; 
[α]D
20 –248 (c 0.4, acetone); IR (CHCl3) νmax 3020, 2991, 2929, 2086, 2007, 1527, 1492, 
1271 cm
–1
; 
1
H NMR (600 MHz, acetone-d6) δ 7.85 (d, 2H, J = 7.8 Hz), 7.61 (t, 2H, J = 
7.2 Hz), 7.49 (t, 1H, J = 7.2 Hz), 7.21-7.15 (m, 3H), 6.95-6.92 (m, 2H), 6.02 (d, 1H, J = 
4.8 Hz), 5.84 (s, 1H), 4.31 (s, 1H), 4.31-4.25 (m, 2H), 4.23 (s, 1H), 3.84 (s, 5H), 3.59-
3.54 (m, 1H), 2.46-2.43 (m, 1H), 2.27-2.24 (m, 1H), 2.18-2.15 (m, 1H), 1.85 (m, 1H); 
13
C 
NMR (150.9 MHz, acetone-d6) δ 199.1 (d, J = 40.7 Hz), 186.9 (d, J = 52.8 Hz), 183.0 (d, 
J = 75.4 Hz), 146.6, 144.8, 128.9, 128.8, 128.8, 128.6, 128.5, 128.4, 127.3, 94.2, 90.0, 
84.6, 83.5, 71.2, 70.3, 69.4, 66.3, 65.2, 62.2, 46.4, 27.5, 25.2; FABMS [m/z (%)] 668 
(M
+
, 7), 640 (26), 136 (18), 121 (23), 69 (55), 55 (99), 43 (100), 41 (88); HRMS (FAB) 
calcd for C31H26N2O3Cl
56
FeRh: 668.0036; found 667.9966. 
(−)-2-Ferrocenyl-7aS-tetrahydropyrrolo[1,2-c]imidazol-3-one (229). 
To a solution of syn-187 (203 mg, 0.46 mmol) in MeOH (4 mL) was 
added NaBH3CN (218 mg, 3.57 mmol) and stirred at room 
temperature. After 1 h, the reaction mixture was cooled to 0 ºC and 
acetic acid (1 mL) was added to it. Removed cold bath, and the reaction mixture was 
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stirred at room temperature for 16 h. Work up was conducted by washing the organic 
layer sequentially with sat. aq. NaHCO3, H2O, brine, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 5:5 EtOAc/hexanes, Rf = 0.38) afforded 229 (102 mg, 0.33 mmol, 71%) as an 
orange solid; mp 98 °C; [α]D
20
 –10 (c 1.0, CHCl3); IR (KBr) νmax 3100, 2965, 2898, 2866, 
1699, 1504, 1475, 1417, 1391 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 4.74 (s, 1H), 4.47 (s, 
1H), 4.17 (s, 5H), 4.00-3.95 (m, 2H), 3.83-3.69 (m, 3H), 3.50 (d, 1H, J = 7.2 Hz), 3.12-
3.09 (m, 1H), 2.04-1.74 (m, 3H), 1.38-1.37 (m, 1H); 
13
C NMR (75.5 MHz, CDCl3) δ 
160.9, 98.6, 68.4, 64.4, 63.8, 58.9, 58.5, 56.3, 48.1, 45.6, 31.1, 25.0; EIMS [m/z (%)] 310 
(M
+
, 100), 245 (70), 56 (11), 43 (12); HRMS (EI) calcd for C16H18IN2O1
56
Fe: 310.0768; 
found 310.0764. 
(+)-(S)-2-Ferrocenylhexahydro-1H-pyrrolo[1,2-c]imidazole (228). 
To a solution of syn-187 (500 mg, 1.14 mmol) in THF (60 mL) at –78 °C 
was added DIBAL-H (7.00 mL, 1.00 M solution in hexanes, 6.82 mmol).  
The reaction mixture was allowed to warm to room temperature 
overnight. After 16 h, the solution was cooled to 0 °C and quenched with sat. aq. 
potassium sodium tartrate (2 mL) and stirred for another 15 min. to separate organic and 
aqueous layers. The organic layer was washed with water and brine, dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 95:5 EtOAc/Et3N, Rf = 0.20) afforded 228 as an orange 
crystalline solid (204 mg, 0.69 mmol, 61%); mp 56-57 °C (EtOAc); [α]D
18 –12 (c 1.0, 
CHCl3); IR (neat) νmax 3097, 3076, 2959, 2932, 2863, 1507, 1206, 1152, 838 cm
–1
; 
1
H 
NMR (400 MHz, CDCl3) δ 4.19 (s, 5H), 3.92 (t, 2H, J = 2 Hz), 3.87 (d, 1H, J = 7.2 Hz), 
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3.81-3.77 (m, 2H), 3.68 (q, 2H, J = 2.0 Hz), 3.22-3.17 (m, 1H), 2.98 (t, 1H, J = 8.8 Hz), 
2.85 (dd, 1H, J = 8.8, 4.4 Hz), 2.75-2.68 (m, 1H), 2.15-2.11 (m, 1H), 1.92-1.77 (m, 2H), 
1.69-1.62 (m, 1H); 
13
C NMR (100.0 MHz, CDCl3) δ 110.6, 75.2, 67.1, 63.3 (t, J = 5 Hz), 
56.5, 56.4, 55.8, 55.7, 32.5, 26.1; EIMS [m/z (%)] 296 (100), 227 (20), 213 (38), 186 
(19), 121 (27), 84 (12), 83 (71); HRMS (EI) calcd for C16H20N2
56
Fe: 296.0976; found 
296.0971. 
(–)-Chloro [η4-1,5-cyclooctadiene] ((S)-2-ferrocenylhexahydro-1H-pyrrolo[1,2-c] 
imidazol-2-ylidene)iridium (230). 
A solution of 228 (45.0 mg, 0.15 mmol) and tritylium tetrafluoroborate 
(50.0 mg, 0.15 mmol) in CH2Cl2 (1.5 mL) was stirred in a Schlenk flask 
at room temperature covered from light. After 5 h, solvent was removed 
in vacuo and the crude solid was washed with dry diethyl ether (3 × 5 mL) and dried in 
vacuo. To this was added Ir(μ-Cl)(cod)]2 (51.0 mg, 0.08 mmol) and degassed THF (3.5 
mL) in glovebox. The solution was cooled to –78 °C and with increased flow of argon, 
KOtBu (17.0 mg, 0.15 mmol) was added at –78 °C. After 1h, the cold bath was removed 
and the volatiles were removed under reduced pressure. Purification of the residue by 
flash column chromatography (silica gel, 3:7 EtOAc/hexanes) afforded a 4:1 mixture of 
coordination isomers. The minor isomer was found to convert to major in >95% when 
stirred in CH2Cl2 for 16 h. Data for major isomer 230: [44 mg, 0.07 mmol, 47%, Rf = 0.4 
(5:5 EtOAc/hexanes)] as an orange crystalline solid; [α]D
20 –266 (c 0.5, CHCl3); IR (KBr) 
νmax 3448, 3428, 3388, 2956, 2923, 2876, 2830, 1492, 1450, 1261, 1103 cm
–1
; 
1
H NMR 
(300 MHz, CDCl3) δ 5.93 (dd, 1H, J = 2.7, 1.5 Hz), 4.83-4.77 (m, 1H), 4.67-4.58 (m, 
3H), 4.22 (s, 5H), 4.11-4.09 (m, 1H), 4.06-4.04 (m, 1H), 3.94-3.84 (m, 3H), 3.50-3.42 
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(m, 1H), 3.14-3.12 (m, 1H), 2.79 (td, 1H, J = 7.2, 4.2 Hz), 2.16-2.02 (m, 6H), 1.93-1.84 
(m, 1H), 1.75-1.42 (m, 6H); 
13
C NMR (75.5 MHz, CDCl3) δ 208.6, 100.0, 84.8, 83.9, 
69.0, 65.0, 64.9, 64.5, 62.1, 59.4, 55.4, 54.7, 50.9, 47.9, 33.7, 32.9, 31.6, 29.4, 29.2, 24.5; 
FABMS [m/z (%)] 631 (3), 163 (12), 109 (12), 105 (15), 95 (24); HRMS (EI) calcd for 
C24H31N2
56
FeIrCl: 630.10260; found 630.10430. 
(+)-2-[(2Rp-Bis(3,5-bis(trifluoromethyl)phenyl)ferrocenyl]-1R-triethylsilyloxy-7aS-
hexahydropyrrolo[1,2-c]imidazol-3-one (231a). 
To a solution of syn-187 (200 mg, 0.45 mmol) in THF (5 mL) at –
78 °C was added t-BuLi (0.80 mL, 1.25 M in pentane, 0.99 
mmol). After stirring for 30 min, a distinct color change from 
orange to orange-red was observed. The solution was quenched 
with 1-chloro-3,5-bis-trifluoromethyl benzene (0.36 mL, 1.14 mmol) and stirred for 1 h at 
that temperature. Workup was conducted by addition of water (0.5 mL) and, after 
warming to room temperature, the reaction mixture was extracted with diethyl ether (2 x 
20 mL). The combined organic extract was washed with water, brine, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 1:9 EtOAc/hexanes, Rf = 0.30) afforded 231a (277 mg, 0.31 
mmol, 68%) as a diastereomerically enriched orange solid; mp 53-55 ºC; [α]D
20
 +271 (c 
1.7, CHCl3); IR (neat) νmax 3087, 2965, 2881, 2804, 1712, 1616, 1469, 1182 cm
–1
; 
1
H 
NMR (300 MHz, CDCl3) δ 8.08 (d, 2H, J = 6.3 Hz), 7.93 (s, 1H), 7.73-7.68 (m, 3H), 5.59 
(d, 1H, J = 6.6 Hz), 4.58-4.56 (m, 1H), 4.36 (t, 1H, J = 2.7 Hz), 3.96 (s, 5H), 3.92-3.88 
(m, 2H), 3.59-3.50 (m, 1H), 3.17-3.09 (m, 1H), 1.92-1.81 (m, 2H), 1.72-1.65 (m, 3H), 
1.29-1.26 (m, 1H), 0.91 (t, 9H, J = 10.5 Hz), 0.66-0.50 (m, 6H); 
13
C NMR (75.5 MHz, 
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CDCl3) δ 159.1, 143.0 (t, J = 38.5 Hz), 134.9 (d, J = 23.4 Hz), 131.8 (m, J = 18.1 Hz), 
125.0, 123.1, 121.9, 121.4, 100.0 (d, J = 27.9 Hz), 83.2, 70.4, 69.8, 69.6, 68.8 (d, J = 3.8 
Hz), 67.6, 66.6 (d, J = 5.3 Hz), 62.5, 46.1, 25.9, 25.3, 6.67, 4.92; 
31
P NMR (121.5 MHz, 
CDCl3) –18.9 (d, J = 9.7 Hz); 
19
F NMR (282.4 MHz, CDCl3) –62.8 (d, J = 22.6 Hz); 
EIMS [m/z (%)] 896 (M
+
, 96), 308 (21), 227 (18), 115 (23), 87 (100), 59 (82); HRMS 
(EI) calcd for C38H37N2O2PSiF12
56
Fe: 896.1519; found 896.1265. Anal. calcd for 
C38H37N2O2PSiF12
56
Fe: C, 50.90; H, 4.16. Found: C, 51.40, H, 4.30. 
(+)-2-[2Rp(S)-(Bis(3,5-bis(trifluoromethyl)phenyl)(2-(3-oxotetrahydro-1H-pyrrolo 
[1,2-c]imidazol-2(3H)-yl)phosphonio)ferrocenyl]trihydroborate (232a). 
To a solution of 231a (660 mg, 0.74 mmol) in THF was added 
BH3.THF (1.50 mL, 1.00 M, 1.47 mmol) at 0 ºC. Cold bath was 
removed and the reaction mixture was allowed to warm to room 
temperature followed by heating to reflux for 4 h. Work up was 
conducted by addition of water (1 mL) at 0 ºC and the reaction mixture was extracted 
with CH2Cl2 (2 x 30 mL). The combined organic extract was washed with water, brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
flash column chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.36) afforded 232a 
(440 mg, 0.58 mmol, 81%) as an orange glassy solid. The compound was found to be 
unstable to collect data, hence was taken to the next step. 
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(+)-2-[2Rp-(S)-(Bis(3,5-bis(trifluoromethyl)phenyl)(2-(tetrahydro-1H-pyrrolo[1,2-
c]imidazol-2(3H)-yl)phosphonio)ferrocenyl]trihydroborate (233a). 
To a solution of 232a (650 mg, 0.88 mmol) in THF (45 mL) at –78 
°C was added drop-wise a solution of DIBAL-H (6.00 mL, 0.90 M 
in hexanes, 5.28 mmol). The solution was left to warm up to room 
temperature for 20 h. The reaction mixture was cooled to 0 °C and quenched with sat. aq. 
potassium sodium tartrate. It was then stirred for 15 min. to separate aqueous and organic 
layers. The organic layer was washed with water and brine, dried over anhydrous Na2SO4 
and concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 3:6.5:0.5 EtOAc/hexanes/Et3N, Rf = 0.60) afforded 233a (465 mg, 0.61 mmol, 
69%) as an orange solid; mp 203-205 ºC; [α]20D = +78 (c 1.0, CHCl3); IR (neat) νmax 
2972, 2920, 2849, 2362, 2319, 2277, 1460, 1352, 1117 cm
–1
; 
1
H NMR (300 MHz, 
CDCl3) δ 8.00 (s, 1H), 7.90 (d, 2H, J = 6.9 Hz), 7.83 (s, 1H), 7.60 (d, 2H, J = 5.7 Hz), 
4.67 (q, 1H, J = 4.2 Hz), 4.29-4.28 (m, 1H), 4.24 (s, 5H), 4.21 (t, 1H, J = 2.7 Hz), 3.83-
3.74 (m, 2H), 3.35-3.29 (m, 1H), 3.22 (t, 1H, J = 1.5 Hz), 3.19-3.13 (m, 1H), 2.90- (d, 
1H, J = 9.0 Hz), 2.57-2.48 (m, 1H); 2.53-2.51 (m, 1H), 1.95 (m, 2H), 1.69-1.61 (m, 3H), 
1.50-1.40 (m, 1H); 
13
C NMR (75.5 MHz, CDCl3): δ 140.8, 138.5 (d, J = 15.8 Hz), 134.4 
(d, J = 22.6 Hz), 132.4 (m, J = 7.5 Hz), 131.7 (m, J = 21.8 Hz), 124.8, 123.9, 122.6, 
121.2, 110.4 (d, J = 20.3 Hz), 82.4 (d, J = 19.6 Hz), 71.0, 68.9, 67.4, 66.6, 64.6, 64.2, 
61.2, 56.6, 33.4, 25.3; 
31
P NMR (121.5 MHz, CDCl3) –15.2; 
19
F NMR (282.4 MHz, 
CDCl3) –63.0; 
11
B NMR (96.29 MHz, CDCl3) –11.3; EIMS [m/z (%)] 766 (M
+
, 3), 669 
(11), 103 (62), 86 (11), 84 (100), 75 (48), 57 (41); HRMS (EI) calcd for 
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C32H28F12PBN2
56
Fe: 766.1241; found 766.1092. Anal. calcd for C32H28F12PBN2
56
Fe: C, 
50.16; H, 3.68. Found: C, 50.17, H, 3.84. 
(+)-2-[2Rp-(S)-((2-(3-Oxotetrahydro-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl)phenyl) 
bis(4-(trifluoromethyl)phosphonio)ferrocenyl]trihydroborate (232b). 
To a solution of syn-187 (1.00 g, 2.27 mmol) in THF (22 mL) at –78 
°C was added t-BuLi (5.50 mL, 0.91 M in pentane, 5.00 mmol). After 
stirring for 30 min, a distinct color change from orange to orange-red 
was observed. The solution was quenched with 1-chloro-4-
trifluoromethyl benzene (2.00 g, 5.67 mmol) in THF (3 mL) and stirred for 1 h at that 
temperature. Workup was conducted by addition of water (0.5 mL) and, after warming to 
room temperature, the reaction mixture was extracted with diethyl ether (2 × 20 mL). The 
combined organic extract was washed with water, brine, dried over anhydrous Na2SO4 
and concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 1:9 EtOAc/hexanes, Rf = 0.30) afforded an inseparable mixture of starting 
material and product which was taken to the next step. 
To the crude mixture in THF (30 mL) was added BH3.THF (9.10 mL, 1.00 M, 9.08 
mmol) at 0 ºC. Cold bath was removed and the reaction mixture was allowed to warm to 
room temperature followed by heating to reflux for 4 h. Work up was conducted by 
addition of water (2 mL) at 0 ºC and the reaction mixture was extracted with CH2Cl2 (2 × 
50 mL). The combined organic extract was washed with water, brine, dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Purification by flash column 
chromatography (silica gel, 3:7 EtOAc/hexanes, Rf = 0.47) afforded 232b (1.05 g, 1.7 
mmol, 70%) as an orange solid; mp 182-184 ºC; [α]D
20
 –38 (c 1.0, CHCl3); IR (KBr) νmax 
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3094, 3046, 2963, 2927, 2904, 2420, 2379, 2347, 1689, 1460, 1326, 1130 cm
–1
; 
1
H NMR 
(300 MHz, CDCl3) δ 7.86-7.78 (m, 4H), 7.69 (t, 4H, J = 14.4 Hz), 4.55 (s, 2H), 4.38 (s, 
5H), 4.28 (s, 1H), 3.50-3.27 (m, 4H), 2.95 (t, 1H, J = 11.4 Hz), 1.95-1.90 (m, 2H), 1.77 
(m, 2H), 1.38-1.25 (m, 3H); 
13
C NMR (75.5 MHz, CDCl3) δ 162.5, 135.0, 134.2, 133.9, 
133.8, 133.6, 133.5, 133.3, 132.8, 125.1 (s, J = 3.8 Hz), 121.8, 99.2, 71.8 (d, J = 11.3 
Hz), 71.1, 70.4 (d, J = 5.3 Hz), 69.6 (d, J = 8.3 Hz), 66.5, 65.6, 55.9, 55.6, 45.3, 32.0, 
25.2; 
31
P (121.5 MHz, CDCl3) 17.1; 
11
B NMR (96.3 MHz, CDCl3) –37.0; EIMS [m/z 
(%)] 630 (M
+–BH3, 51), 86 (84), 84 (100), 49 (27), 47 (28); HRMS (EI) calcd for 
C30H25N2OPF6
56
Fe: 630.0958; found 630.0975; Anal. calcd for 
C30H28OPBN2F6
56Fe·C4H8O: C, 57.01; H, 5.07. Found: C, 56.77, H, 4.60. 
(+)-2-[2Rp-(S)-(2-(Tetrahydro-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl)-bis(4-
(trifluoromethyl)phenyl-phosphonio)ferrocenyl]trihydroborate (233b). 
To a solution of 232b (342 mg, 0.53 mmol) in THF (25 mL) at –78 °C 
was added drop-wise a solution of DIBAL-H (3.20 mL, 1.00 M in 
hexanes, 3.18 mmol). The solution was left to warm up to room 
temperature for 20 h. The reaction mixture was cooled to 0 °C and 
quenched with sat. aq. potassium sodium tartrate. It was then stirred for 15 min. to 
separate aqueous and organic layers. The organic layer was washed with water and brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification by 
flash column chromatography (silica gel, 3:6.5:0.5 EtOAc/hexanes/Et3N, Rf = 0.42) 
afforded 233b (215 mg, 0.35 mmol, 64%) as orange solid; mp 182-183 ºC; [α]20D = +69 
(c 0.5, CHCl3); IR (KBr) νmax 3092, 2979, 2924, 2833, 2367, 2320, 2268, 1469, 1325, 
1125 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ 7.66 (d, 2H, J = 7.8 Hz), 7.55 (dd, 4H, J = 
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16.5, 7.5 Hz), 7.30 (t, 2H, J = 6.9 Hz), 4.77 (dd, 1H, J = 7.8, 4.8 Hz), 4.20 (s, 5H), 4.19-
4.17 (m, 1H), 4.14 (t, 1H, J = 2.4 Hz), 3.81-3.71 (m, 2H), 3.39 (t, 1H, J = 1.2 Hz), 3.31-
3.26 (m, 1H), 3.10 (t, 1H, J = 7.2 Hz), 2.90 (d, 1H, J = 9.0 Hz), 2.51 (dt, 1H, J = 16.5, 6.3 
Hz), 2.25-2.20 (m, 1H), 1.99-1.93 (m, 2H), 1.67-1.64 (m, 2H), 1.53-1.49 (m, 2H); 
13
C 
NMR (150.9 MHz, CDCl3): δ 142.8 (d, J = 15.1 Hz), 140.5 (d, J = 12.1 Hz), 135.3 (d, J = 
21.1 Hz), 132.5 (d, J = 18.8 Hz), 131.7 (q, J = 31.7 Hz), 130.5 (q, J = 31.7 Hz), 126.7, 
125.1 (d, J = 18.1 Hz), 124.8 (d, J = 13.6 Hz), 123.0 (d, J = 12.1 Hz), 110.1 (d, J = 21.1 
Hz), 82.2 (d, J = 21.1 Hz), 71.0, 68.8, 68.1, 65.8, 64.4, 63.2, 63.0, 56.6, 33.5, 25.4; 
31
P 
NMR (121.5 MHz, CDCl3) –19.3; 
11
B NMR (96.29 MHz, CDCl3) –12.0; EIMS [m/z 
(%)] 616 (M
+–BH3, 100), 296 (19), 84 (25), 83 (58), 82 (29), 57 (10), 55 (17); HRMS 
(EI) calcd for C30H27F6PN2
56
Fe: 616.1165; found 616.1170. Anal. calcd for 
C30H27F6PN2
56
Fe: C, 57.18; H, 4.80. Found: C, 57.34, H, 4.90. 
(+)-2-[2Rp-(S)-2-(2-(Bis(3,5-bis(trifluoromethyl)phenyl)phosphine)ferrocenyl] 
hexahydro-1H-pyrrolo[1,2-c]imidazole (234a). 
To a solution of 233a (100 mg, 0.13 mmol) in benzene (2 mL) was 
added DABCO (15.0 mg, 0.13 mmol) and the solution was heated 
to reflux for 2 h. Benzene was removed under reduced pressure and 
the crude mixture was passed through a pad of deactivated silica 
and washed with EtOAc to obtain 234a (90 mg, 0.12 mmol, 92%) as an orange solid. mp 
53-54 ºC; Rf = 0.33 (9.6:4 EtOAc/Et3N); [α]
20
D = +27 (c 1.3, CHCl3); IR (KBr) νmax 3096, 
2965, 2923, 2872, 2826, 1466, 1356, 1279, 1134 cm
–1
; 
1
H NMR (600 MHz, CDCl3) δ  
7.98 (s, 1H), 7.89 (d, 2H, J = 6.6 Hz), 7.80 (s, 1H), 7.63 (d, 2H, J = 5.4 Hz), 4.34 (dd, 1H, 
J = 7.8, 2.4 Hz), 4.19 (s, 5H), 4.17 (s, 1H), 4.12 (t, 1H, J = 2.4 Hz), 3.77 (d, 1H, J = 7.8 
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Hz), 3.74-3.70 (m, 1H), 3.11 (s, 1H), 3.07-3.04 (m, 1H), 3.02 (t, 1H, J = 7.8 Hz), 2.89 
(dd, 1H, J = 8.4, 3.0 Hz), 2.21 (q, 1H, J = 6.6 Hz), 2.08-2.04 (m, 1H), 1.69-1.63 (m, 2H), 
1.49-1.43 (m, 1H); 
13
C NMR (150.9 MHz, CDCl3): δ 141.3 (d, J = 19.6 Hz), 139.3 (d, J = 
18.1 Hz), 134.6 (d, J = 21.1 Hz), 131.8 (m, J = 15.1 Hz), 125.8, 124.0 (d, J = 7.5 Hz), 
123.7, 122.2, 122.1 (d, 1H, J = 7.5 Hz), 113.0 (d, J = 19.6 Hz), 76.2 (d, J = 19.6 Hz), 
68.4, 67.0, 66.2, 63.5 (d, J = 3.0 Hz), 62.4, 56.9, 56.1, 32.7, 26.0; 
31
P NMR (242.9 MHz, 
CDCl3) –13.0; 
19
F NMR (564.7 MHz, CDCl3) –62.9 (d, J = 118.6 Hz); EIMS [m/z(%)] 
752 (M
+
, 26), 115 (14), 86 (44), 83 (62), 71 (42), 58 (53), 57 (100); HRMS (EI) calcd for 
C32H25F12PN2
56
Fe: 752.0913; found 752.0903. 
 (+)-2-[2Rp-(S)-2-(2-(bis(4-(Trifluoromethyl)phenyl)phosphiono)ferrocenyl] 
hexahydro-1H-pyrrolo[1,2-c]imidazole (234b). 
A solution of 233b (75.0 mg, 0.12 mmol) in Et2NH (2 mL) was stirred 
at room temperature for 4 h. The volatiles were removed under 
reduced pressure and the crude mixture was passed through a pad of 
deactivated silica and washed with EtOAc to obtain 234b (55 mg, 0.09 
mmol, 75%) as an orange solid. Rf = 0.25 (3:7 EtOAc/hexanes); mp 97-98 ºC; [α]
20
D = 
+78 (c 1.4, CHCl3); IR (KBr) νmax 3118, 3092, 3041, 2961, 2923, 1462, 1324, 1125 cm
–1
; 
1
H NMR (300 MHz, CDCl3) δ  7.66-7.50 (m, 6H), 7.34-7.29 (m, 2H), 4.35 (dd, 1H, J = 
7.5, 2.4 Hz), 4.16 (s, 5H), 4.06 (d, 2H, J = 2.1 Hz), 3.80 (d, 1H, J = 7.8 Hz), 3.73-3.65 
(m, 1H), 3.27 (s, 1H), 3.06-2.97 (m, 2H), 2.92 (dd, 1H, J = 9.0, 3.6 Hz), 2.31-2.22 (m, 
1H), 2.09-1.99 (m, 1H), 1.72-1.44 (m, 3H); 
13
C NMR (75.5 MHz, CDCl3): δ 141.5 (d, J = 
15.8 Hz), 141.4 (d, J = 13.6 Hz), 135.5 (d, J = 21.9 Hz), 132.4 (m, J = 9.1 Hz), 131.7, 
131.3, 130.4, 130.0, 125.9, 125.0 (s, J = 3.8 Hz), 122.3, 113.3 (d, J = 18.9 Hz), 76.3, 76.0, 
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68.3, 67.6, 65.4, 62.3, 61.0 (d, J = 9.8 Hz), 57.1 (d, J = 3.0 Hz), 55.8, 32.7, 26.0; 
31
P 
NMR (242.9 MHz, CDCl3) –16.5; 
19
F NMR (564.7 MHz, CDCl3) –62.7 (d, J = 22.6 Hz); 
EIMS [m/z(%)] 616 (M
+
, 80), 296 (21), 86 (59), 84 (100), 57 (29), 55 (33), 43 (25); 
HRMS (EI) calcd for C30H27F6PN2
56
Fe: 616.1165; found 616.1172. Anal. calcd for 
C30H27F6PN2
56
Fe: C, 58.46; H, 4.42. Found: C, 58.75, H, 4.80. 
(+)-2-[2Rp-(S)-(2-(Tetrahydro-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl)bis(4-
(trifluoromethyl)phosphiono)ferrocenyl]sulphide (235). 
To a solution of 234b (45.0 mg, 0.07 mmol) in benzene (2 mL) was 
added sulphur [2.00 mg (recrystallized from benzene), 0.07 mmol] and 
the solution was heated at 50 ºC for 18 h. Benzene was removed under 
reduced pressure and the crude mixture was passed through a pad of 
deactivated silica and washed with EtOAc to obtain 235 (34 mg, 0.05 mmol, 72%) as 
glassy orange solid. Rf = 0.10 (3:7 EtOAc/hexanes); [α]
20
D = −50 (c 1.0, CHCl3); IR 
(KBr) νmax 3097, 2972, 2928, 2851, 1458, 1398, 1318, 1160, 1056 cm
–1
; 
1
H NMR (300 
MHz, CDCl3) δ  7.98-7.86 (m, 4H), 7.69-7.66 (m, 4H), 7.80 (s, 1H), 7.63 (d, 2H, J = 5.4 
Hz), 4.34 (dd, 1H, J = 7.8, 2.4 Hz), 4.19 (s, 5H), 4.17 (s, 1H), 4.44 (s, 5H), 4.26 (s, 1H), 
3.67 (d, 1H, J = 8.1 Hz), 3.56 (s, 2H), 2.92-2.89 (m, 1H), 2.79 (t, 1H, J = 8.4 Hz), 2.62 
(dd, 1H, J = 8.7, 2.4 Hz), 1.91-1.84 (m, 2H), 1.49-1.44 (m, 2H), 1.13-1.09 (m, 2H); 
13
C 
NMR (75.5 MHz, CDCl3): δ 138.3 (d, J = 66.6 Hz), 137.2 (d, J = 65.5 Hz), 137.6, 136.8, 
133.6, 133.2, 132.9 (d, J = 11.0 Hz), 132.1 (d, J = 11.2 Hz), 125.1 (s, J = 3.6 Hz), 121.7, 
109.3 (d, J = 8.9 Hz), 77.5, 72.1, 71.9, 71.3, 69.9, 66.4, 65.6 (d, J = 10.9 Hz), 65.1, 64.8 
(d, J = 9.2 Hz), 62.9, 57.8, 55.2, 32.5, 25.8; 
31
P NMR (121.5 MHz, CDCl3) 43.2; 
19
F 
NMR (282.4 MHz, CDCl3) –63.1 (d, J = 6.8 Hz); EIMS [m/z (%)] 648 (M
+
, 53), 615 
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(42), 295 (11), 149 (25), 83 (100), 57 (86), 43 (88); HRMS (EI) calcd for 
C30H27SF6PN2
56
Fe: 648.0886; found 648.0873. 
 (–)-(S,E)-N-Ferrocenyl-(tetrahydropyrrolo[1,2-c]oxazol-3(1H)-ylidene)amine (237).  
A solution of 190a (50.0 mg, 0.15 mmol) in POCl3 (1.5 mL) was stirred at 
room temperature. After 16 h,  POCl3 was removed under reduced 
pressure and the crude mixture was passed through a pad of deactivated silica and washed 
with EtOAc to obtain 237 (26 mg, 0.08 mmol, 56%) as an orange solid. mp 107-109 ºC; 
Rf = 0.43 (9.6:0.4 EtOAc/Et3N); [α]
20
D = −44 (c 0.9, CHCl3); IR (neat) νmax 3089, 2970, 
2925, 2902, 2858, 1655, 1478, 1180, 812 cm
–1
; 
1
H NMR (400 MHz, CDCl3) δ  4.59 (t, 
1H, J = 8.4 Hz), 4.41 (s, 1H), 4.31 (s, 1H), 4.19 (dd, 1H, J = 8.4, 4.0 Hz), 4.09 (s, 5H), 
3.94 (t, 2H, J = 2.0 Hz), 3.92-3.87 (m, 1H), 3.71-3.64 (m, 1H), 3.29-3.23 (m, 1H), 2.05-
1.99 (m, 3H), 1.48-1.42 (m, 1H); 
13
C NMR (100.6 MHz, CDCl3): δ 157.6, 101.9, 70.5, 
68.9, 64.7, 64.6, 64.5, 63.8, 60.2, 49.0, 30.7, 26.1; EIMS [m/z (%)] 310 (M
+
, 63), 227 
(38), 149 (20), 85 (64), 83 (100), 55 (22); HRMS (EI) calcd for C16H18
56
FeN2O: 
310.0768; found 310.0767.  
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